Pyxus International (PYYX) 10-K6 Jun 232023 FY Annual reportFinancial data

Company Profile

Cover

Cover - USD ($) $ in Millions	12 Months Ended
Cover - USD ($) $ in Millions	Mar. 31, 2023	May 31, 2023	Sep. 30, 2022
Cover [Abstract]
Document Type	10-K
Document Annual Report	true
Document Period End Date	Mar. 31, 2023
Current Fiscal Year End Date	--03-31
Document Transition Report	false
Entity File Number	000-25734
Entity Registrant Name	Pyxus International, Inc.
Entity Incorporation, State or Country Code	VA
Entity Tax Identification Number	85-2386250
Entity Address, Address Line One	6001 Hospitality Court, Suite 100
Entity Address, City or Town	Morrisville,
Entity Address, State or Province	NC
Entity Address, Postal Zip Code	27560
City Area Code	919
Local Phone Number	379-4300
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	false
Entity Shell Company	false
Entity Public Float			$ 2.4
Entity Common Stock, Shares Outstanding		24,999,947
Documents Incorporated by Reference	DOCUMENTS INCORPORATED BY REFERENCE Certain information contained in the Proxy Statement for the 2023 Annual Meeting of Shareholders (to be held August 17, 2023) of the registrant is incorporated by reference into Part III hereof.
Entity Central Index Key	0000939930
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	FY
Amendment Flag	false

Audit Information

Audit Information	12 Months Ended
Audit Information	Mar. 31, 2023
Audit Information [Abstract]
Auditor Name	Deloitte & Touche LLP
Auditor Firm ID	34
Auditor Location	Raleigh, North Carolina

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Income Statement [Abstract]
Sales and other operating revenues	$ 1,914,881	$ 1,639,862
Cost of goods and services sold	1,653,864	1,412,805
Gross profit	261,017	227,057
Selling, general, and administrative expenses	151,531	142,021
Other expense, net	11,023	3,102
Restructuring and asset impairment charges	4,685	8,031
Goodwill impairment	0	32,186
Operating income	93,778	41,717
Loss on deconsolidation/disposition of subsidiaries	648	10,701
Loss on pension settlement	2,588	0
Debt retirement expense	0	1,997
Interest expense, net	113,164	108,383
Loss before income taxes and other items	(22,622)	(79,364)
Income tax expense	34,127	12,640
Income from unconsolidated affiliates, net	18,512	9,950
Net loss	(38,237)	(82,054)
Net income attributable to noncontrolling interests	904	65
Net loss attributable to Pyxus International, Inc.	$ (39,141)	$ (82,119)
Loss per share:
Basic (in USD per share)	$ (1.57)	$ (3.28)
Diluted (in USD per share)	$ (1.57)	$ (3.28)

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Loss - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Statement of Comprehensive Income [Abstract]
Net loss	$ (38,237)	$ (82,054)
Other comprehensive income, net of tax:
Foreign currency translation adjustment	2,481	(4,224)
Pension and other postretirement benefit plans	2,044	5,777
Cash flow hedges	(2,777)	8,974
Total other comprehensive income, net of tax	1,748	10,527
Total comprehensive loss	(36,489)	(71,527)
Comprehensive income attributable to noncontrolling interests	941	55
Comprehensive loss attributable to Pyxus International, Inc.	$ (37,430)	$ (71,582)

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2023	Mar. 31, 2022
Current assets
Cash and cash equivalents	$ 136,733	$ 198,777
Restricted cash	2,176	2,148
Trade receivables, net	185,351	247,677
Other receivables	17,387	12,511
Inventories, net	775,071	749,427
Advances to suppliers, net	42,305	48,932
Recoverable income taxes	5,815	7,906
Prepaid expenses	37,555	34,817
Other current assets	18,172	25,452
Total current assets	1,220,565	1,327,647
Restricted cash	0	389
Investments in unconsolidated affiliates	100,750	95,420
Other intangible assets, net	38,572	45,061
Deferred income taxes, net	6,662	6,498
Long-term recoverable income taxes	2,863	4,588
Other noncurrent assets	43,761	45,424
Right-of-use assets	35,892	35,979
Property, plant, and equipment, net	133,398	137,521
Total assets	1,582,463	1,698,527
Current liabilities
Notes payable to banks	382,544	378,612
Accounts payable	170,287	179,012
Advances from customers	42,472	52,998
Accrued expenses and other current liabilities	92,693	82,239
Income taxes payable	18,264	5,592
Operating leases payable	8,723	8,065
Current portion of long-term debt	75	107,856
Total current liabilities	715,058	814,374
Long-term taxes payable	4,978	6,703
Long-term debt	618,430	580,477
Deferred income taxes	9,900	11,670
Liability for unrecognized tax benefits	14,175	14,401
Long-term leases	25,581	28,604
Pension, postretirement, and other long-term liabilities	52,511	60,927
Total liabilities	1,440,633	1,517,156
Commitments and contingencies
Common Stock, Number of Shares, Par Value and Other Disclosures [Abstract]
250,000 authorized shares and 25,000 issued and outstanding for all periods	390,290	390,290
Retained deficit	(257,954)	(218,813)
Accumulated other comprehensive income	5,515	3,804
Total stockholders’ equity of Pyxus International, Inc.	137,851	175,281
Noncontrolling interests	3,979	6,090
Total stockholders' equity	141,830	181,371
Total liabilities and stockholders' equity	$ 1,582,463	$ 1,698,527

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2023	Mar. 31, 2022
Statement of Financial Position [Abstract]
Common stock, no par value (in USD per share)	$ 0	$ 0
Common stock authorized (in shares)	250,000,000	250,000,000
Common stock issued (in shares)	25,000,000
Common stock outstanding (in shares)	25,000,000

Consolidated Statements of Stoc

Consolidated Statements of Stockholders’ Equity - USD ($) $ in Thousands	Total	Common Stock	Retained Deficit	Currency Translation Adjustment	Pensions, Net of Tax	Derivatives, Net of Tax	Noncontrolling Interest
Balance at beginning of period at Mar. 31, 2021	$ 253,940	$ 391,089	$ (136,686)	$ (4,649)	$ 541	$ (2,625)	$ 6,270
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(11,628)		(11,508)				(120)
Other			(8)				8
Other comprehensive income (loss), net of tax	5,017			689	0	4,328
Balance at end of period at Jun. 30, 2021	247,329	391,089	(148,202)	(3,960)	541	1,703	6,158
Balance at beginning of period at Mar. 31, 2021	253,940	391,089	(136,686)	(4,649)	541	(2,625)	6,270
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(82,054)
Other comprehensive income (loss), net of tax	10,527			(4,224)	5,787	8,974
Balance at end of period at Mar. 31, 2022	181,371	390,290	(218,813)	(8,873)	6,328	6,349	6,090
Balance at beginning of period at Jun. 30, 2021	247,329	391,089	(148,202)	(3,960)	541	1,703	6,158
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(10,023)		(9,681)				(342)
Other	(88)						(88)
Other comprehensive income (loss), net of tax	(4,999)			(1,591)	(512)	(2,896)
Balance at end of period at Sep. 30, 2021	232,219	391,089	(157,883)	(5,551)	29	(1,193)	5,728
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(30,057)		(30,100)				43
Other	(954)	(799)					(155)
Other comprehensive income (loss), net of tax	(3,338)			(1,753)	(35)	(1,550)
Balance at end of period at Dec. 31, 2021	197,870	390,290	(187,983)	(7,304)	(6)	(2,743)	5,616
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(30,346)		(30,830)				484
Other comprehensive income (loss), net of tax	13,847			(1,569)	6,334	9,092	(10)
Balance at end of period at Mar. 31, 2022	181,371	390,290	(218,813)	(8,873)	6,328	6,349	6,090
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(14,505)		(14,663)				158
Other	(3,052)						(3,052)
Other comprehensive income (loss), net of tax	(556)			947		(1,503)
Balance at end of period at Jun. 30, 2022	163,258	390,290	(233,476)	(7,926)	6,328	4,846	3,196
Balance at beginning of period at Mar. 31, 2022	181,371	390,290	(218,813)	(8,873)	6,328	6,349	6,090
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(38,237)
Other comprehensive income (loss), net of tax	1,748			2,481	2,007	(2,777)
Balance at end of period at Mar. 31, 2023	141,830	390,290	(257,954)	(6,392)	8,335	3,572	3,979
Balance at beginning of period at Jun. 30, 2022	163,258	390,290	(233,476)	(7,926)	6,328	4,846	3,196
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(1,550)		(1,537)				(13)
Other comprehensive income (loss), net of tax	(8,131)			(4,801)	(1,562)	(1,768)
Balance at end of period at Sep. 30, 2022	153,577	390,290	(235,013)	(12,727)	4,766	3,078	3,183
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(2,237)		(2,333)				96
Other comprehensive income (loss), net of tax	4,406			4,855	(78)	(371)
Balance at end of period at Dec. 31, 2022	155,746	390,290	(237,346)	(7,872)	4,688	2,707	3,279
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(19,945)		(20,608)				663
Other comprehensive income (loss), net of tax	6,029			1,480	3,647	865	37
Balance at end of period at Mar. 31, 2023	$ 141,830	$ 390,290	$ (257,954)	$ (6,392)	$ 8,335	$ 3,572	$ 3,979

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Operating activities:
Net loss	$ (38,237)	$ (82,054)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	19,137	16,676
Debt amortization/interest	18,466	22,639
Loss on foreign currency transactions	6,028	2,885
Asset impairment charges	4,035	37,925
Loss on deconsolidation/disposition of subsidiaries	648	10,701
Loss on pension settlement	2,588	0
Bad debt expenses	426	4,404
Income from unconsolidated affiliates, net of dividends	(5,835)	4
Changes in operating assets and liabilities, net:
Trade and other receivables	(111,932)	(261,908)
Inventories and advances to tobacco suppliers	(21,110)	(31,461)
Deferred items	(14,758)	(10,929)
Recoverable income taxes	2,353	(2,603)
Payables and accrued expenses	5,147	59,324
Advances from customers	(10,693)	41,168
Prepaid expenses	4,761	4,710
Income taxes	13,116	(2,799)
Other operating assets and liabilities	5,698	3,173
Other, net	(17,660)	(10,620)
Net cash used in operating activities	(137,822)	(198,765)
Investing activities:
Purchases of property, plant, and equipment	(16,307)	(14,827)
Proceeds from sale of property, plant, and equipment	3,060	4,084
Collections from beneficial interests in securitized trade receivables	165,262	189,440
Loan to deconsolidated subsidiary	0	(5,229)
Collection of loan from deconsolidated subsidiary	0	10,996
Proceeds from settlement of debt claims from deconsolidated subsidiaries	2,011	0
Other, net	919	(3,223)
Net cash provided by investing activities	154,945	181,241
Financing activities:
Net proceeds of short-term borrowings	5,234	9,208
Proceeds from DDTL facility	0	117,600
Repayment of DDTL facility	(110,250)	(15,375)
Proceeds from DDTL term loan facility	100,000	0
Proceeds from revolving loan facilities	170,000	115,394
Repayment of revolving loan facilities	(235,000)	(93,500)
Proceeds from long-term borrowings	578,439	151
Repayment of long-term borrowings	(578,162)	(1,636)
Debt issuance costs	(7,686)	(8,097)
Fees paid to refinance the DDTL facility	(4,000)	0
Fees paid to exchange debt	(1,575)	0
Other, net	0	(485)
Net cash (used in) provided by financing activities	(83,000)	123,260
Increase (decrease) from exchange rate changes on cash	3,472	(2,135)
(Decrease) increase in cash, cash equivalents, and restricted cash	(62,405)	103,601
Cash and cash equivalents at beginning of period		198,777
Restricted cash at beginning of period		2,537
Cash, cash equivalents, and restricted cash at end of period	138,909	201,314
Other information:
Cash paid for income taxes, net	18,696	24,576
Cash paid for interest, net	93,425	86,852
Noncash investing activities:
Noncash amounts obtained as a beneficial interest in exchange for transferring trade receivables in a securitization transaction	$ 164,404	$ 205,515

Basis of Presentation and Summa

Basis of Presentation and Summary of Significant Accounting Policies	12 Months Ended
	Mar. 31, 2023
Accounting Policies [Abstract]
Basis of Presentation and Summary of Significant Accounting Policies	Basis of Presentation and Summary of Significant Accounting Policies Pyxus International, Inc. (the "Company" or "Pyxus") is a global agricultural company with 150 years of experience delivering value-added products and services to businesses and customers. The Company is a trusted provider of responsibly sourced, independently verified, sustainable, and traceable products and ingredients. As the context requires, the "Company" and "Pyxus" also includes the consolidated subsidiaries of Pyxus International, Inc. The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") and pursuant to the rules and regulations of the Securities and Exchange Commission applicable to annual reporting on Form 10-K. Principles of Consolidation The consolidated financial statements include the accounts of the Company and its majority-owned and controlled subsidiaries. Intercompany accounts and transactions have been eliminated. Equity Method Investments The Company’s equity method investments and its cost method investments are non-marketable securities. When not required to consolidate its investment in another entity, the Company uses the equity method if it (i) can exercise significant influence over the other entity, and (ii) holds common stock and/or in-substance common stock of the other entity. Under the equity method, investments are carried at cost, plus or minus the Company’s equity in the increases or decreases of the investee’s net assets after the date of acquisition. The Company continually monitors its equity method investments for factors indicating other-than-temporary impairment. The Company's proportionate share of the net income or loss of these entities is included in income from unconsolidated affiliates, net within the consolidated statements of operations. Dividends received from the investee reduce the carrying amount of the investment. Distributions from equity method investees are accounted for based on the cumulative earnings approach to determine whether they represent a return of investment, or a return on investment. Variable Interest Entities The Company holds variable interests in multiple variable interest entities, which primarily procure or process inventory on behalf of the Company or are securitization entities. These variable interests relate to equity investments, receivables, guarantees, and securitized receivables. The Company is not the primary beneficiary of the majority of these entities as it does not have the power to direct the activities that most significantly impact the economic performance of the entities, due to the entities’ management and board of directors’ structure. As a result, the majority of these variable interest entities are not consolidated. Creditors of the Company’s variable interest entities do not have recourse against the general credit of the Company. The Company's investments in unconsolidated variable interest entities are classified as investments in unconsolidated affiliates in the consolidated balance sheets. The Company's receivables with variable interest entities are classified as notes receivable, related parties and accounts receivable, related parties. See " Note 25. Related Party Transactions " for additional information. The Company's maximum exposure to loss in these variable interest entities is represented by the investments, receivables, guarantees, and the deferred purchase price on the sale of securitized receivables. Use of Estimates The preparation of these consolidated financial statements in conformity with U.S. GAAP requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements. These estimates and assumptions also affect the reported amounts of revenues and expenses during the reporting period. Actual results may differ from the Company's estimates and assumptions. Estimates are used in accounting for, among other things, revenue recognition, pension and postretirement health care benefits, inventory reserves, credit loss reserves, bank loan guarantees to suppliers and unconsolidated subsidiaries, advances to suppliers reserves, useful lives for depreciation and amortization, future cash flows associated with impairment testing for long-lived assets, deferred tax assets an d uncertain income tax positions, intrastate tax credits in Brazil, fair value determinations of financial assets and liabilities, including derivatives, securitized beneficial interests, and counterparty risk. Reclassifications Certain prior-period amounts were reclassified to conform to the current-year presentation in the consolidated statements of cash flows. Certain prior-period amounts were reclassified to conform to the current-year presentation in the reconciliation between income tax expense based on income before income taxes, equity in net income of investee companies, and minority interests and the amount computed by applying the U.S. statutory federal income tax rate to income. Certain prior-period amounts were reclassified to conform to the current-year presentation of deferred tax assets (liabilities). See " Note 6. Income Taxes " for additional information. Segment Information During the year ended March 31, 2022, the Company reevaluated its operating and reportable segments under ASC Topic 280 - Segment Reporting . Based on our reevaluation, the Company concluded that the economic characteristics of our five Leaf region operations in North America, South America, Europe, Asia, and Africa were similar. Each geographic region derives its revenues mainly from shipping processed tobacco to manufacturers of cigarettes and other consumer tobacco products around the world, with a smaller percentage of revenue in each region being derived from performing third-party tobacco processing services. The three product category operating segments other than Leaf do not individually or in the aggregate meet the quantitative and qualitative thresholds to be individually reportable and have been combined and reported in an "All Other" category. The one Leaf reportable segment is consistent with information used by the chief operating decision maker to assess performance, make operating decisions, and allocate resources. The Company evaluates the operating performance of its one segment based upon information included in management reports. Corporate general expenses are allocated to the segments based upon segment selling, general, and administrative expenses. As a result of this reevaluation, effective during the fourth quarter of the year ended March 31, 2022, the Company has eight operating segments organized by geographic area and product category that are aggregated into one reportable segment for financial reporting purposes: Leaf. The All Other category is included for purposes of reconciliation of respective balances for the Leaf segment to the consolidated financial statements. Revenue Recognition The Company's revenue consists primarily of the sale of processed tobacco and fees charged for processing and related services to the manufacturers of tobacco products. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer. The Company’s performance obligations are satisfied when the transfer of control of the distinct product or service to the customer occurs. For products, control is transferred and revenue is recognized at a point in time, in accordance with the shipping terms of the contract. For services, control is transferred and revenue is recognized over time using the input method based on a kilogram of packed tobacco. A kilogram of processed tobacco (or tobacco processing services resulting in a kilogram of processed tobacco) is the only material and distinct performance obligation for the Company’s tobacco revenue streams. Consideration is attributed to the performance of this obligation. The Company does not disclose information related to its unsatisfied performance obligations with an expected duration of one year or less. Revenue is measured as the amount of consideration to which the Company expects to be entitled to receive in exchange for transferring goods or providing services. Contract costs primarily include labor, material, shipping and handling, and overhead expenses. Contract Balances The Company generally records a receivable when revenue is recognized as the timing of revenue recognition may differ from the timing of payment from customers. Payment terms and conditions vary by contract, although terms generally include a requirement of payment within 30 to 60 days. The Company's trade receivables do not bear interest, and they are recorded at the invoiced amount less an estimated allowance for expected credit losses. In addition to estimating an allowance based on specific identification of certain receivables that have a higher probability of not being paid, the Company also records an estimate for expected credit losses for the remaining receivables in the aggregate using a loss-rate method that considers historical bad debts, age of customer receivable balances, and current customer receivable balances. Additionally, the Company considers future reasonable and supportable forecasts of economic conditions to adjust historical loss rate percentages, as necessary. Balances are written-off when determined to be uncollectible. T he provision for expected credit losses is recorded in selling, general, and administrative expenses in the consolidated statements of operations. Significant Judgments The Company identified two main forms of variable consideration in its contracts with customers: warehousing fees for storing customer-controlled tobacco until the customer requests shipment and claims resulting from tobacco that does not meet customer specifications. Warehousing fees are either included in the price of tobacco based on the customers' best estimate of the date they will request shipment or separately charged using a per-day storage rate. When the Company enters into a contract with a customer, the price communicated is the amount of consideration the Company expects to receive. Price adjustments for tobacco not meeting customer specifications for shrinkage, improper blend, or chemical makeup, etc. are handled through a claims allowance that is assessed quarterly. Since the Company has a large number of customer contracts with similar characteristics, the volume of tobacco sold each year is substantial, and the Company has historical data related to claims, the Company is able to estimate the amount of expected claims using the expected value method. Taxes Collected from Customers Certain subsidiaries are subject to value-added taxes on local sales. Value-added taxes on local sales are recorded in sales and other operating revenues and cost of goods and services sold in the consolidated statements of operations. Shipping and Handling The Company elected to account for shipping and handling as activities to fulfill its performance obligations, regardless of when control transfers. Shipping and handling fees that are billed to customers are recognized in sales and other operating revenues and the associated shipping and handling costs are recognized in cost of goods and services sold in the consolidated statements of operations. Income Taxes Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities reflect the expected future tax consequences of events that are recognized in the consolidated financial statements in different periods than they are recognized for tax purposes. Deferred tax assets and liabilities are established using enacted tax rates in effect for the year in which these items are expected to reverse. The realization of deferred tax assets is dependent on generating sufficient taxable income in the appropriate jurisdiction prior to the expiration of the carryforward periods. Deferred tax assets are reduced by a valuation allowance if it is more likely than not that some portion, or all, of the deferred tax assets will not be realized. When assessing the need for a valuation allowance, the Company considers carryback potential, historical earnings, future reversals of existing taxable temporary differences (including liabilities for unrecognized tax benefits), forecasted operating profits and tax planning strategies. The Company’s provision for income taxes is based on pre-tax income, statutory tax rates, and tax planning opportunities available in the various jurisdictions in which it operates. Tax laws are complex and subject to different interpretations by the taxpayer and respective governmental taxing authorities. The Company recognizes tax benefits from uncertainties if it believes it is more-likely-than-not it will be sustained based on the technical merits. Penalties and interest related to income taxes, if incurred, are included in income tax expense. Cash and Cash Equivalents Cash and cash equivalents include cash in banks and highly liquid investments with original maturities of three months or less and are stated at cost, which approximates fair value. Inventories, Net Costs in inventory include processed tobacco inventory, unprocessed tobacco inventory, and other inventory. Costs of unprocessed tobacco inventories are determined by the average cost method, which include the cost of green tobacco. Costs of processed tobacco inventories are determined by the average cost method, which include both the cost of unprocessed tobacco, as well as direct and indirect costs related to processing the product. Costs of other inventory are determined by the first-in, first-out method, which include costs of packing materials, non-tobacco agricultural products, and agricultural supplies including seed, fertilizer, herbicides, and pesticides. Inventories are carried at the lower of cost or net realizable value ("LCM"). The Company evaluates its inventories for LCM adjustments by country and type of inventory. Processed tobacco and unprocessed tobacco are evaluated separately for LCM purposes. The Company compares the cost of its processed tobacco to net realizable value based on the estimated selling price of similar grades when evaluating those balances for LCM adjustments. The Company also considers whether its processed tobacco is committed to a customer, whereby the expected sales price is utilized in determining the net realizable value for committed tobacco. In addition, the Company writes-down inventory balances for estimates of obsolescence. LCM and obsolescence inventory write-downs are recorded in cost of goods and services sold within the consolidated statements of operations. Advances to Tobacco Suppliers, Net The Company purchases seeds, fertilizer, pesticides, and other products related to growing tobacco and advances them to tobacco suppliers to assist in crop production. These seasonal advances are short term, represent prepaid inventory, and are recorded as advances to tobacco suppliers. Upon delivery of tobacco, part of the purchase price to the supplier is paid in cash and part through a reduction of the advance balance. The advances applied to the delivery are reclassified from advances to unprocessed inventory. The Company also has noncurrent advances, which generally represent the cost of advances to tobacco suppliers for infrastructure, such as curing barns, recovered through the delivery of tobacco to the Company by the tobacco suppliers. Tobacco suppliers may not be able to settle the entire amount of advances due in a given year. In these situations, the Company may allow the farmers to deliver tobacco over future crop years to recover its advances. Noncurrent advances to tobacco suppliers are recorded in other noncurrent assets in the consolidated balance sheets. The Company accounts for its advances to tobacco suppliers using a cost accumulation model, which reports advances at the lower of cost or recoverable amounts exclusive of the mark-up and interest. The mark-up and interest on its advances are recognized upon delivery of tobacco as a decrease in the cost of the current crop. Unrecovered advances are recorded in cost of goods and services sold in the consolidated statements of operations for abnormal yield adjustments or unrecovered advances from prior crops. Normal yield adjustments are capitalized into the cost of the current crop and are recorded in cost of goods and services sold as that crop is sold. Goodwill and Other Intangible Assets Goodwill is allocated to each reporting unit. A reporting unit is an operating segment, or one level below an operating segment, referred to as a component. The components within the Company’s operating segments are aggregated into eight reporting units due to their similar economic characteristics. Goodwill is not subject to amortization and is tested for impairment annually, on the first day of the fourth quarter of the fiscal year, or whenever events and circumstances indicate that impairment may have occurred. The Company's annual goodwill impairment test performed for the year ended March 31, 2022 resulted in goodwill being fully impaired. See " Note 13. Goodwill and Other Intangibles, Net " for additional information. The Company utilizes a qualitative assessment to evaluate whether it is more likely than not that the estimated fair value of a reporting unit is less than its carrying value. If the Company's qualitative assessment indicates that it is more likely than not that the estimated fair value of a reporting unit exceeds its carrying value, no further analysis is performed. Otherwise, the Company performs a quantitative assessment using the discounted cash flow ("DCF") method of the income approach. The future cash flows of the Company’s reporting units are projected based on estimates of future revenues, gross margins, operating income, excess net working capital, capital expenditures, and other factors. The Company utilizes estimated revenue growth rates and cash flow projections. The discount rates utilized in the DCF method are based on a weighted-average cost of capital determined from relevant market comparisons and adjusted for specific reporting unit risks, country risk premiums, and capital structure. A terminal value estimated growth rate is applied to the final year of the projected period and reflects the Company’s estimate of perpetual growth. The Company then calculates a present value of the respective cash flows for each reporting unit to arrive at an estimate of fair value under the income approach. The Company has intangible assets with definite useful lives. These intangible assets are assessed annually and tested for impairment whenever factors indicate that the carrying amount may not be recoverable. The trade name, customer relationship, and technology intangibles are amortized on a straight-line basis over fourteen nine three Leases The Company has operating leases for land, buildings, automobiles, and other equipment that expire at various dates through 2040. The Company does not have material finance leases. Leases for real estate generally have initial terms ranging from 2 to 15 years, excluding renewal options. Leases for equipment generally have initial terms ranging from 2 to 5 years excluding renewal options. Most leases have fixed rentals, with many of the real estate leases requiring additional payments for real estate taxes. These lease terms may include optional renewals, terminations or purchases, which are considered in the Company’s assessments when such options are reasonably certain to be exercised. The Company measures right-of-use assets and related lease liabilities based on the present value of remaining lease payments, including in-substance fixed payments, the current payment amount when payments depend on an index or rate (e.g., inflation adjustments, market renewals), and the amount the Company believes is probable to be paid to the lessor under residual value guarantees, when applicable. Lease contracts may include fixed payments for non-lease components, such as maintenance, which are included in the measurement of lease liabilities for certain asset classes based on the Company’s election to combine lease and non-lease components. The Company does not recognize short-term leases, those lease contracts with durations of twelve months or less, in the consolidated balance sheets. As applicable borrowing rates are not typically implied within the lease arrangements, the Company discounts lease payments based on its estimated incremental borrowing rate at lease commencement, or modification, which is based on the Company’s estimated credit rating, the lease term at commencement, and the contract currency of the lease arrangement. Property, Plant, and Equipment, Net Property, plant, and equipment is stated at cost and depreciated using the straight-line method over the estimated useful lives of the assets. Buildings are depreciated over a range of nine two ther expense, net in the consolidated statements of operations. Long-lived assets are tested for recoverability whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. The evaluation is performed at the lowest level of identifiable cash flows at which the asset could be bought or sold in a current transaction between willing parties and may be estimated using a number of techniques, including quoted market prices or valuations, present value techniques based on estimates of cash flows, or multiples of earnings or revenue performance measures. Guarantees The Company's guarantees are primarily related to bank loans to suppliers for crop production financing. The Company guarantees bank loans of certain unconsolidated subsidiaries in Asia and South America. Under longer-term arrangements, the Company may guarantee financing on suppliers’ construction of curing barns or other tobacco production assets. Guaranteed loans are generally repaid concurrent with the delivery of tobacco to the Company. The Company is obligated to repay guaranteed loans should the supplier default. If default occurs, the Company has recourse against its various suppliers and their production assets. The fair value of the Company's guarantees are recorded in accrued expenses and other current liabilities in the consolidated balance sheets and included in crop costs, except for the joint venture in Brazil, which are included in other receivables. In Brazil, certain suppliers obtain government subsidized rural credit financing from local banks that is guaranteed by the Company. Upon delivery of tobacco, the Company remits payments to the local banks on behalf of the suppliers before paying the supplier. Amounts owed to suppliers are recorded in accounts payable in the consolidated balance sheets. Rural credit financing repayment is due to local banks based on contractual due dates. Derivative Financial Instruments The Company uses forward or option currency contracts to manage risks associated with foreign currency exchange rates on foreign operations. These contracts are for green tobacco purchases, processing costs, and selling, general, and administrative expenses. The Company does not hold derivatives contracts for speculative or trading purposes. Derivative financial instruments are recorded in other current assets and other current liabilities in the consolidated balance sheets and are measured at fair value. Changes in fair value are recognized in earnings, unless the derivative is designated and qualifies to be in a hedge accounting relationship. For derivatives designated in a hedge accounting relationship, the Company evaluates hedge effectiveness at inception and on an ongoing basis. If a hedge relationship is no longer expected to be effective, the derivative in that relationship is de-designated and hedge accounting is discontinued. Changes in fair value of foreign currency derivatives designated in cash flow hedging relationships are recorded in accumulated other comprehensive income in the consolidated balance sheets and reclassified to earnings when the hedged item affects earnings. Cash flows from derivatives are classified in the consolidated statements of cash flows in the same category as the cash flows from the underlying hedged items. The Company has elected not to offset fair value amounts recognized for derivative instruments with the same counterparty under a master netting agreement. Pension and Other Postretirement Benefits Retirement Benefits The Company maintains various excess benefit and supplemental plans that provide additional benefits to certain individuals in key positions and individuals whose compensation and the resulting benefits that would have actually been paid are limited by regulations imposed by the Internal Revenue Code. In addition, a Supplemental Retirement Account Plan defined contribution plan is maintained. Additional non-U.S. plans sponsored by certain subsidiaries cover certain of the full-time employees located in Germany, Turkey, and the United Kingdom. Postretirement Health and Life Insurance Benefits The Company provides certain health and life insurance benefits to retired U.S. employees (and their eligible dependents) who meet specified age and service requirements. The plan excludes new employees after September 2005 and caps the Company’s annual cost commitment to postretirement benefits for retirees. The Company retains the right, subject to existing agreements, to modify or eliminate these postretirement health and life insurance benefits in the future. The Company provides certain health and life insurance benefits to retired Brazilian directors and certain retirees located in Europe including their eligible dependents who meet specified requirements. Plan Assets The Company's policy is to contribute amounts to the plans sufficient to meet or exceed funding requirements of local governmental rules and regulations. The Company's investment objectives for plan assets are to generate consistent total investment return to pay anticipated plan benefits, while minimizing long-term costs and portfolio volatility. The financial objectives underlying this policy include maintaining plan contributions at a reasonable level relative to benefits provided and assuring unfunded obligations do not grow to a level that would adversely affect the Company's financial health. Portfolio performance is measured against investment objectives and objective benchmarks, including but not limited to: FTSE 90 Day Treasury Bill, Bloomberg Intermediate Govt/Credit, Bloomberg Aggregate, Russell 1000 Value, Russell 1000 Growth, Russell 2500 Value, Russell 2500 Growth, MSCI EAFE, HFR Absolute Return, and HFR Equity Hedge. The portfolio objective is to exceed the actuarial return on assets assumption. The Company is exploring partial risk transfer and or full plan terminations. Management and the plan's consultant regularly review portfolio allocations and periodically rebalance the portfolio to the targeted allocations according to the guidelines set forth in the Company's investment policy. Equity securities do not include the Company's common stock. The Company's diversification and risk control processes serve to minimize the concentration and experience of risk. There are no significant concentrations of risk, in terms of sector, industry, geography, or individual company or companies. The Company’s plan assets primarily consist of cash and cash equivalents, equity and fixed income funds, real estate investments, and diversified investments. Plan assets are measured at fair value annually on March 31, the measurement date. The following are descriptions, valuation methodologies, and inputs used to determine the fair value of each major category of plan assets: • Cash and cash equivalents include short-term investment funds, primarily in diversified portfolios of investment grade money market instruments that are valued using quoted market prices or other valuation methods, and classified within Level 1 or Level 2 of the fair value hierarchy. • Investments in equity and fixed income mutual funds are publicly traded and valued primarily using quoted market prices and generally classified within Level 1 in the fair value hierarchy. Investments in commingled funds used in certain non-U.S. pension plans are not publicly traded, but the underlying assets held in these funds are traded in active markets and the prices for these assets are readily observable. Holdings in these commingled funds are generally classified as Level 2 investments. • Real estate investments include those in private limited partnerships that invest in various domestic and international commercial and residential real estate projects and publicly traded REIT securities. The fair values of private real estate assets are typically determined by using income and/or cost approaches or comparable sales approach, taking into consideration discount and capitalization rates, financial conditions, local market conditions, and the status of the capital markets, and are generally classified within Level 3 in the fair value hierarchy. Publicly traded REIT securities are valued primarily using quoted market prices and are generally classified within Level 1 in the fair value hierarchy. • Diversified investments include mutual funds with an absolute return strategy. Mutual fund investments with absolute return strategies are publicly traded and valued using quoted market prices and are generally classified within Level 1 in the fair value hierarchy. Foreign Currency Translation and Remeasurement The Company translates assets and liabilities of its foreign subsidiaries from their respective functional currencies to USD using exchange rates in effect at period end. The Company's results of operations and its cash flows are translated using average exchange rates for each reporting period. Resulting currency translation adjustments are reflected as a separate component of accumulated other comprehensive income in the consolidated balance sheets. The financial statements of foreign subsidiaries, for which the USD is the functional currency and which have certain transactions denominated in a local currency, are remeasured into USD. The remeasurement of local currencies into USD results in remeasurement adjustments that are included in net income. Exchange gains (losses) from remeasurement are recorded in cost of goods and services sold and o ther expense, net within the consolidated statements of operations. Securitized Receivables The Company sells trade receivables to unaffiliated financial institutions under multiple accounts receivable securitization facilities. Under the facilities, the receivables sold for cash are removed from the consolidated balance sheets. Under some of the facilities, a portion of the purchase price for the receivables is paid by the unaffiliated financial institutions in cash and the balance is a deferred purchase price receivable, which is paid as payments on the receivables are collected from account debtors. The net cash proceeds received by the Company in cash at the time of sale (cash purchase price) are disclosed as an operating activity in the statements of consolidated cash flows. The deferred purchase price receivable represents a continuing involvement and a beneficial interest in the transferred financial assets and is recognized at fair value as part of the sale transaction. The deferred purchase price receivables are included in trade and other receivables, net in the consolidated balance sheets and are valued using unobservable inputs (i.e., Level three inputs), primarily discounted cash flow. The net cash proceeds received by the Company as deferred purchase price are disclosed as an investing activity in the consolidated statements of cash flows. Additionally, beneficial interests received for transferring trade receivables in a securitization transaction are disclosed as a noncash investing activity in the consolidated statements of cash flows. The difference between the carrying amount of the receivables sold under these facilities and the sum of the cash and fair value of the other assets received at the time of transfer is recognized as a loss on sale of the related receivables and recorded in o ther expense, net in the consolidated statements of operations. Program costs are recorded in o ther expense, net in the consolidated statements of operations. Stock-Based Com

New Accounting Standards

New Accounting Standards	12 Months Ended
New Accounting Standards	Mar. 31, 2023
Accounting Policies [Abstract]
New Accounting Standards	New Accounting Standards Recently Adopted Accounting Pronouncements In December 2019, the FASB issued Accounting Standards Update ("ASU") No. 2019-12, Simplifying the Accounting for Income Taxes . ASU 2019-12 eliminates certain exceptions related to the approach for intra-period tax allocations, the methodology for calculating income taxes during interim periods when there are changes in tax laws or when year-to-date losses exceed anticipated losses, and the recognition of deferred tax liabilities for outside basis differences in foreign investments. This guidance also simplifies aspects of the accounting for franchise taxes that are partially based on income, separate financial statements of legal entities not subject to tax, and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The guidance became effective for the Company on April 1, 2021. The adoption of this new accounting standard did not have a material impact on the Company's financial condition, results of operations, cash flows, or disclosures. In November 2021, the FASB issued ASU No. 2021-10, Disclosures by Business Entities about Government Assistance . This ASU created ASC Topic 832, Government Assistance , and requires certain information be disclosed regarding assistance received from a government entity when either a grant or contribution accounting model is applied. The new disclosures are required for annual periods for transactions with a government entity that are within the scope of the Topic. The guidance became effective for the Company on April 1, 2022. The adoption of this new accounting standard did not have a material impact on the Company's disclosures for the fiscal year ended March 31, 2023.

Revenue Recognition

Revenue Recognition	12 Months Ended
Revenue Recognition	Mar. 31, 2023
Revenue from Contract with Customer [Abstract]
Revenue Recognition	Revenue Recognition Product revenue is primarily processed tobacco sold to the customer. Processing and other revenues are mainly contracts to process customer-owned green tobacco. During processing, ownership remains with the customers. All Other revenue is primarily composed of revenue from the sale of e-liquids and non-tobacco agriculture products. The following disaggregates sales and other operating revenues by major source, with the All Other category being included for purposes of reconciliation of the respective balances below of the Leaf segment (the Company's sole reportable segment) to the consolidated financial statements : Year Ended March 31, 2023 Year Ended March 31, 2022 Leaf: Product revenue $ 1,812,170 $ 1,531,805 Processing and other revenues 88,388 95,433 Total sales and other operating revenues 1,900,558 1,627,238 All Other: Total sales and other operating revenues 14,323 12,624 Total sales and other operating revenues $ 1,914,881 $ 1,639,862 Significant Judgments The following summarizes activity in the claims allowance: Year Ended March 31, 2023 Year Ended March 31, 2022 Balance, beginning of period $ 1,130 $ 1,830 Additions 4,680 1,586 Payments (3,460) (2,286) Balance, end of period $ 2,350 $ 1,130 Contract Balances The following summarizes activity in the allowance for expected credit losses: Year Ended March 31, 2023 Year Ended March 31, 2022 Balance, beginning of period $ (24,541) $ (20,900) Additions (2,316) (4,212) Write-offs 2,127 571 Balance, end of period (24,730) (24,541) Trade receivables 210,081 272,218 Trade receivables, net $ 185,351 $ 247,677 Taxes Collected from Customers Value-added taxes were $28,302 and $27,274 for the years ended March 31, 2023 and 2022, respectively.

Other Expense, Net

Other Expense, Net	12 Months Ended
Other Expense, Net	Mar. 31, 2023
Other Income and Expenses [Abstract]
Other Expense, Net	Other Expense, Net The following summarizes the significant components of other expense, net: Year Ended March 31, 2023 Year Ended March 31, 2022 Losses on sale of receivables (1) $ (10,434) $ (5,833) Foreign currency gains (losses) 1,057 (2,776) Note receivable write-off (2,050) — Gain on sale of fixed assets 1,389 3,818 Miscellaneous (expense) income, net (985) 1,689 Total $ (11,023) $ (3,102) (1) See " Note 17. Securitized Receivables " for additional information.

Restructuring and Asset Impairm

Restructuring and Asset Impairment Charges	12 Months Ended
Restructuring and Asset Impairment Charges	Mar. 31, 2023
Restructuring and Related Activities [Abstract]
Restructuring and Asset Impairment Charges	Restructuring and Asset Impairment Charges The Company continued its focus on cost saving initiatives. The employee separation and asset impairment charges for the period ended March 31, 2023 were primarily related to the restructuring of certain non-leaf agriculture operations. The employee separation and asset impairment charges for the periods ended March 31, 2022 were primarily related to the write-off of the Company's remaining industrial hemp cannabidiol ("CBD") extraction equipment and the continued restructuring of certain leaf operations. The following summarizes the Company's restructuring and asset impairment charges: Year Ended March 31, 2023 Year Ended March 31, 2022 Employee separation charges $ 650 $ 2,292 Asset impairment and other noncash charges 4,035 5,739 Total restructuring and asset impairment charges $ 4,685 $ 8,031

Income Taxes

Income Taxes	12 Months Ended
Income Taxes	Mar. 31, 2023
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes Accounting for Uncertainty in Income Taxes The following summarizes the changes to unrecognized tax benefits and related interest and penalties : Year Ended March 31, 2023 Year Ended March 31, 2022 Balance at April 1 $ 17,725 $ 18,358 Increase (decrease) for prior year tax positions 1,449 (660) Increase for current year tax positions 634 — Reduction for settlements (3,480) — Impact of changes in exchange rates (243) 27 Balance at March 31 (1) $ 16,085 $ 17,725 Accrued interest 1,753 1,777 Accrued penalties 1,447 831 Balance at March 31 (1) $ 19,285 $ 20,333 (1) As of March 31, 2023, $11,177 would impact the Company's effective tax rate, if recognized. The Company recognized $(24) and $303 of interest (benefit) expense, net as of March 31, 2023 and 2022, respectively. The Company recognized $616 and $61 of penalties expense as of March 31, 2023 and 2022, respectively. Due to the Company’s global operations, numerous tax audits may be ongoing throughout the world at any point in time. The Company's income tax liabilities are based on estimates of potential income taxes due upon the conclusion of such audits and are updated to reflect changes in facts and circumstances, as they become known. Due to the uncertain and complex application of tax regulations, it is possible that the resolution of audits may result in liabilities which could be materially different from these estimates. In such an event, the Company will record additional income tax expense or benefit in the period in which such resolution occurs or if estimates or judgments change. The Company does not expect to settle material uncertain tax positions in the next twelve months. The Company and its subsidiaries file a U.S. federal consolidated income tax return as well as returns in several U.S. states and a number of foreign jurisdictions. As of March 31, 2023, the Company’s earliest open tax year for U.S. federal income tax purposes was its year ended March 31, 2020. Open tax years in state and foreign jurisdictions generally range from three to six years. In applicable jurisdictions, the Company’s tax attributes from prior periods remain subject to adjustment. Income Tax Provision The components of (loss) income before income taxes and other items consisted of the following: Year Ended March 31, 2023 Year Ended March 31, 2022 U.S. $ (43,874) $ (68,489) Non-U.S. 21,252 (10,875) Total $ (22,622) $ (79,364) The details of the amount shown for income taxes in the consolidated statements of operations are as follows: Year Ended March 31, 2023 Year Ended March 31, 2022 Current: Federal (1) $ 16,353 $ 12 State 337 — Non-U.S. 17,593 16,515 Total Current 34,283 16,527 Deferred: Federal (592) (243) State 2 — Non-U.S. 434 (3,644) Total Deferred (156) (3,887) Income tax expense $ 34,127 $ 12,640 (1) Primarily due to the Debt Exchange Transactions (as defined below). Refer to " Note 16. Debt Arrangements " for further details regarding the Debt Exchange Transactions. The difference between income tax expense based on (loss) income before income taxes and other items and the amount computed by applying the U.S. statutory federal income tax rate to income are as follows: Year Ended March 31, 2023 Year Ended March 31, 2022 Tax benefit at U.S. statutory rate $ (4,750) $ (16,666) Effect of non-U.S. income taxes (3,418) (961) U.S. taxes on non-U.S. earnings 6,389 205 Increase (decrease) in reserves for uncertain tax positions 2,397 (315) Withholding tax expense 3,058 1,488 Tax credits (3,853) (1,150) Tax incentives (2,280) — Nondeductible interest 2,559 2,610 Waived intercompany interest expense — 3,960 Exchange effects and currency translation 3,101 4,344 Goodwill impairment — 7,148 Change in valuation allowance (1) 30,412 8,053 Other, net 512 3,924 Income tax expense $ 34,127 $ 12,640 (1) The change in valuation allowance, which is presented without exchange effects and currency translation, for the year ended March 31, 2023 was primarily driven by $20,823 of deferred tax assets generated by the Debt Exchange Transactions for which the Company is not likely to realize a future benefit. Refer to " Note 16. Debt Arrangements " for further details regarding the Debt Exchange Transactions. The following summarizes deferred tax assets (liabilities): March 31, 2023 March 31, 2022 Deferred tax assets: Non-deductible interest carryforward $ 24,331 $ 23,074 Original issue discount (1) 20,326 — Reserves and accruals 25,734 21,896 Tax loss carryforwards 15,886 13,728 Other 5,686 9,573 Gross deferred tax assets 91,963 68,271 Valuation allowance (1) (59,506) (32,641) Total deferred tax assets $ 32,457 $ 35,630 Deferred tax liabilities: Unremitted earnings of foreign subsidiaries $ (29,045) $ (27,918) Derivative transactions (1,318) (2,790) Intangible assets (1,884) (2,776) Other (3,448) (7,318) Total deferred tax liabilities $ (35,695) $ (40,802) Net deferred tax liability $ (3,238) $ (5,172) (1) The increase in valuation allowance as of March 31, 2023 was primarily driven by $20,823 of deferred tax assets generated by the Debt Exchange Transactions for which the Company is not likely to realize a future benefit. Refer to " Note 16. Debt Arrangements " for further details regarding the Debt Exchange Transactions. The following summarizes the breakdown between deferred tax assets (liabilities): March 31, 2023 March 31, 2022 Noncurrent asset $ 6,662 $ 6,498 Noncurrent liability (9,900) (11,670) Net deferred tax liability $ (3,238) $ (5,172) The following summarizes the change in the valuation allowance for deferred tax assets: Balance at March 31, 2021 $ 25,273 Changes to expenses 8,624 Changes to other comprehensive income (1,256) Balance at March 31, 2022 32,641 Changes to expenses (1) 27,598 Changes to other comprehensive income (733) Balance at March 31, 2023 $ 59,506 (1) The increase in valuation allowance as of March 31, 2023 was primarily driven by $20,823 of deferred tax assets generated by the Debt Exchange Transactions for which the Company is not likely to realize a future benefit. Refer to " Note 16. Debt Arrangements " for further details regarding the Debt Exchange Transactions. The following summarizes the gross amount and expiration dates of our operating loss carryforwards at March 31, 2023: Expiration Date Amounts Non-U.S. net operating loss and tax credit carryforwards 2024-2028 $ 20,927 Non-U.S. net operating loss and tax credit carryforwards Thereafter 5,170 Non-U.S. net operating loss and tax credit carryforwards Indefinite 31,899 Total $ 57,996 Under current U.S. tax regulations, in general, repatriation of foreign earnings to the U.S. can be completed without incurring material incremental U.S. tax. However, repatriation of foreign earnings could subject the Company to U.S. state and non-U.S. jurisdictional taxes (including withholding taxes) on distributions or sales of minority owned investments. The Company has not recorded a deferred tax liability for U.S. federal, U.S. state, or foreign tax from foreign subsidiary unremitted earnings and profits where an indefinite reinvestment assertion was made on the basis that this group of foreign subsidiaries does not expect to have available excess cash and cash equivalents to remit in the foreseeable future or has specific needs for available excess cash. The unrecorded tax liability associated with indefinitely reinvested foreign subsidiary earnings is not practicable to estimate due to the inherent complexity of the Company's global operations.

Loss Per Share

Loss Per Share	12 Months Ended
Loss Per Share	Mar. 31, 2023
Earnings Per Share [Abstract]
Loss Per Share	Loss Per Share The following summarizes the computation of loss per share: Year Ended March 31, 2023 Year Ended March 31, 2022 Basic and diluted loss per share: Net loss attributable to Pyxus International, Inc. $ (39,141) $ (82,119) Shares: Weighted Average Number of Shares Outstanding 25,000 25,000 Basic and diluted loss per share $ (1.57) $ (3.28)

Inventories, Net

Inventories, Net	12 Months Ended
Inventories, Net	Mar. 31, 2023
Inventory Disclosure [Abstract]
Inventories, Net	Inventories, Net The following summarizes the composition of inventories, net, with the All Other category being included for purposes of reconciliation of the respective balances below of the Leaf segment to the consolidated financial statements : March 31, 2023 March 31, 2022 Processed tobacco $ 498,398 $ 517,613 Unprocessed tobacco 231,651 193,406 Other tobacco related 39,670 29,694 All Other 5,352 8,714 Total $ 775,071 $ 749,427

Advances to Suppliers, Net

Advances to Suppliers, Net	12 Months Ended
Advances to Suppliers, Net	Mar. 31, 2023
Revenue from Contract with Customer [Abstract]
Advances to Suppliers, Net	Advances to Suppliers, Net The following summarizes the composition of advances to suppliers, net: March 31, 2023 March 31, 2022 Advances to tobacco suppliers, net $ 38,111 $ 46,705 Advances to non-tobacco suppliers 4,194 2,227 Total in current assets 42,305 48,932 Long-term advances to tobacco suppliers, net (1) 1,564 428 Total current and long-term $ 43,869 $ 49,360 (1) Classified as other noncurrent assets in the consolidated balance sheets.

Acquisitions and Dispositions

Acquisitions and Dispositions	12 Months Ended
Acquisitions and Dispositions	Mar. 31, 2023
Business Combination and Asset Acquisition [Abstract]
Acquisitions and Dispositions	Acquisitions and Dispositions Disposition of Humble Juice Co., LLC On November 23, 2021, the Company disposed of its ownership interests in Humble Juice Co., LLC ("Humble Juice"), a manufacturer and distributor of flavored e-liquids, in exchange for royalties on future revenue. Humble Juice's financial results are included in the Company's consolidated results through the transaction date within the All Other category . On the date of the transaction, Humble Juice's assets, liabilities, and equity components were eliminated from the Company's consolidated financial statements . The Company recognized a loss on the disposition of Humble Juice of $5,374 during the year ended March 31, 2022.

Equity Method Investments

Equity Method Investments	12 Months Ended
Equity Method Investments	Mar. 31, 2023
Equity Method Investments and Joint Ventures [Abstract]
Equity Method Investments	Equity Method Investments The following summarizes the Company's equity method investments as of March 31, 2023: Investee Name Location Primary Purpose The Company's Ownership Percentage Basis Difference (1) Adams International Ltd. Thailand purchase and process tobacco 49 % $ (4,526) Alliance One Industries India Private Ltd. India purchase and process tobacco 49 % (5,770) China Brasil Tobacos Exportadora SA Brazil purchase and process tobacco 49 % 44,199 Oryantal Tutun Paketleme Turkey process tobacco 50 % (416) Purilum, LLC U.S. produce flavor formulations and consumable e-liquids 50 % 4,589 Siam Tobacco Export Company Thailand purchase and process tobacco 49 % (6,098) (1) Basis differences for the Company's equity method investments were primarily due to fair value adjustments recorded during the year ended March 31, 2021. The following summarizes aggregate financial information for these equity method investments: Operations statement: Year Ended March 31, 2023 Year Ended March 31, 2022 Sales $ 489,532 $ 292,777 Gross profit 76,206 56,752 Net income 40,447 22,729 Company's dividends received 12,677 9,671 Balance sheet: March 31, 2023 March 31, 2022 Current assets $ 419,229 $ 375,015 Property, plant, and equipment and other assets 48,174 42,841 Current liabilities 323,899 289,816 Long-term obligations and other liabilities 3,887 2,999

Variable Interest Entities

Variable Interest Entities	12 Months Ended
Variable Interest Entities	Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Variable Interest Entities	Variable Interest Entities The Company holds variable interests in multiple entities that primarily procure or process inventory or are securitization entities. These variable interests relate to equity investments, receivables, guarantees, and securitized receivables. The following summarizes the Company's financial relationships with its unconsolidated variable interest entities: March 31, 2023 March 31, 2022 Investments in variable interest entities $ 93,754 $ 88,118 Receivables with variable interest entities 2,617 2,211 Guaranteed amounts to variable interest entities (not to exceed) 68,265 55,884

Goodwill and Other Intangible A

Goodwill and Other Intangible Assets, Net	12 Months Ended
Goodwill and Other Intangible Assets, Net	Mar. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Other Intangible Assets, Net	Goodwill and Other Intangible Assets, Net The following summarizes the changes in the Company's goodwill and other intangible assets, net: Year Ended March 31, 2023 Weighted Average Remaining Useful Life Beginning Carrying Amount, Net Amortization Expense Ending Intangible Assets, Net Intangibles subject to amortization: Customer relationships 9.4 years $ 23,568 $ (3,086) $ 20,482 Technology 5.2 years 11,471 (2,596) 8,875 Trade names 11.4 years 10,022 (807) 9,215 Total $ 45,061 $ (6,489) $ 38,572 Year Ended March 31, 2022 Weighted Average Remaining Useful Life Beginning Carrying Amount, Net Additions Amortization Expense Disposition of Humble Juice (1) Impairment (2) Ending Intangible Assets, Net Intangibles subject to amortization: Customer relationships 10.3 years $ 27,730 $ — $ (2,427) $ (1,735) $ — $ 23,568 Technology 5.8 years 12,858 840 (2,227) — — 11,471 Trade names 12.4 years 10,829 — (807) — — 10,022 Intangibles not subject to amortization: Goodwill 36,853 — — (4,667) (32,186) — Total $ 88,270 $ 840 $ (5,461) $ (6,402) $ (32,186) $ 45,061 (1) See " Note 10. Acquisitions and Dispositions " for additional information. (2) $372 of the impairment occurred during the three-month period ended December 31, 2021. The remaining $31,814 of impairment occurred during the three-month period ended March 31, 2022. Goodwill During the year ended March 31, 2022, the Company performed its annual assessment of goodwill for its reporting units. The assessment of qualitative factors indicated that it was more likely than not that the fair value of each reporting unit was less than its carrying value primarily due to a sustained decline in the implied value of the Company's long-term debt and equity based on public trading as well as uncertainty in the Company's estimate of timing for future operating results due to the recent economic effects of the COVID-19 pandemic, including related variants. As a result, the Company performed a quantitative impairment test by comparing the fair value of each reporting unit to its carrying value. The fair value for each reporting unit was determined using the DCF method of the income approach. The quantitative impairment test conducted for each reporting unit concluded that the fair value of each reporting unit was less than its carrying value. The excess of carrying value over fair value for each reporting unit exceeded the amount of goodwill that was allocated to the reporting unit, leading the Company to record a full impairment of goodwill at each reporting unit as follows: Year Ended March 31, 2022 Leaf - Africa $ 8,341 Leaf - Asia 6,311 Leaf - Europe 5,566 Leaf - North America 3,901 Leaf - South America 5,730 E-liquids 1,965 Total $ 31,814 Other Intangible Assets, Net The following summarizes the estimated intangible asset amortization expense for the next five years and beyond: For Fiscal Years Ended Customer Relationships Technology (1) Trade Names Total 2024 $ 2,175 $ 1,659 $ 807 $ 4,641 2025 2,175 1,585 807 4,567 2026 2,175 1,465 807 4,447 2027 2,175 1,490 807 4,472 2028 2,175 1,543 807 4,525 Thereafter 9,607 1,133 5,180 15,920 Total $ 20,482 $ 8,875 $ 9,215 $ 38,572 (1) Estimated amortization expense for technology is based on costs accumulated as of March 31, 2023. These estimates will change as new costs are incurred and until the software is placed into service.

Leases

Leases	12 Months Ended
Leases	Mar. 31, 2023
Leases [Abstract]
Leases	Leases The following summarizes lease costs for operating leases: Year Ended March 31, 2023 Year Ended March 31, 2022 Operating lease costs $ 14,203 $ 14,752 Variable and short-term lease costs 8,023 7,991 Total lease costs $ 22,226 $ 22,743 The following summarizes weighted average information associated with the measurement of remaining operating leases: March 31, 2023 March 31, 2022 Weighted average remaining lease term 5.9 years 6.2 years Weighted average discount rate 14.4% 12.8% The following summarizes supplemental cash flow information related to operating leases: Year Ended March 31, 2023 Year Ended March 31, 2022 Cash paid for amounts included in the measurement of lease liabilities - operating cash flows used by operating leases $ 13,607 $ 13,677 Right-of-use assets obtained in exchange for new operating leases - noncash 9,967 7,054 The following reconciles maturities of operating lease liabilities to the lease liabilities reflected in the consolidated balance sheets as of March 31, 2023: 2024 $ 13,014 2025 8,500 2026 6,771 2027 5,726 2028 4,373 Thereafter 13,798 Total future minimum lease payments 52,182 Less: amounts related to imputed interest 17,878 Present value of future minimum lease payments 34,304 Less: operating lease liabilities, current 8,723 Operating lease liabilities, non-current $ 25,581

Property, Plant, and Equipment,

Property, Plant, and Equipment, Net	12 Months Ended
Property, Plant, and Equipment, Net	Mar. 31, 2023
Property, Plant and Equipment [Abstract]
Property, Plant, and Equipment, Net	Property, Plant, and Equipment, Net The following summarizes property, plant, and equipment, net: March 31, 2023 March 31, 2022 Land $ 31,132 $ 32,023 Buildings 43,911 43,465 Machinery and equipment 83,984 77,243 Total 159,027 152,731 Less: accumulated depreciation (1) (25,629) (15,210) Total property, plant, and equipment, net $ 133,398 $ 137,521 (1) This balance was partially reduced by the disposition of certain fully depreciated assets during the year ended March 31, 2023. The following summarizes depreciation expense recorded in cost of goods and services sold and selling, general, and administrative expenses: Year Ended March 31, 2023 Year Ended March 31, 2022 Depreciation expense recorded in cost of goods and services sold $ 10,132 $ 8,908 Depreciation expense recorded in selling, general, and administrative expenses 2,346 2,272 Total depreciation $ 12,478 $ 11,180

Debt Arrangements

Debt Arrangements	12 Months Ended
Debt Arrangements	Mar. 31, 2023
Debt Disclosure [Abstract]
Debt Arrangements	Debt Arrangements The following table summarizes the Company’s debt financing as of the dates set forth below: Outstanding Interest March 31, 2023 March 31, 2022 Long Term Debt Repayment Schedule by Fiscal Year Rate 2024 2025 2026 2027 2028 Later Senior secured credit facilities: ABL Credit Facility 4.8 % (1) $ 25,000 $ 90,000 $ — $ — $ — $ 25,000 $ — $ — DDTL Term Loans (2) 11.2 % (1) — 107,832 — — — — — — Senior secured notes: 10.0% Notes due 2024 (3) 10.0 % (1) 19,931 270,762 — 19,931 — — — — 8.5% Notes due 2027 (4) 8.8 % (1) 253,483 — — — — — 253,483 — Senior secured term loans: Intabex Term Loans (5) 12.8 % (1) 186,194 — — — — — 186,194 — Pyxus Term Loans (6) 12.8 % (1) 133,393 — — — — — 133,393 — Exit Facility Loans (7) 10.9 % (1) — 219,500 — — — — — — Other debt: Other long-term debt 7.5 % (1) 504 239 75 — 429 — — — Notes payable to banks (8) 6.8 % (1) 382,544 378,612 382,544 — — — — — Total debt $ 1,001,049 $ 1,066,945 $ 382,619 $ 19,931 $ 429 $ 25,000 $ 573,070 $ — Short-term (8) $ 382,544 $ 378,612 Long-term: Current portion of long-term debt $ 75 $ 107,856 Long-term debt 618,430 580,477 $ 618,505 $ 688,333 Letters of credit $ 11,684 $ 9,038 (1) Weighted average rate for the twelve months ended March 31, 2023. As the 8.5% Notes due 2027, Intabex Term Loans, and the Pyxus Term Loans have not been outstanding for a trailing twelve-month period, the interest rate is the weighted average from inception through March 31, 2023. (2) The DDTL Term Loans were issued in the refinancing of the prior DDTL facility on July 28, 2022, which included a partial principal payment of $9,000 and an exit fee payment of $5,250. Subsequent to this refinancing, on February 6, 2023, the DDTL Term Loans were exchanged for $102,000 (inclusive of a $2,000 exit fee) of Intabex Term Loans. (3) On February 6, 2023, $260,452 of the 10.0% Notes due 2024 were exchanged for 8.5% Notes due 2027. The remaining 10.0% Notes due 2024 outstanding of $19,931 is net of a debt discount of $460. Total repayment at maturity is $20,391. (4) Balance of $253,483 is net of a debt discount of $6,969. Total repayment at maturity is $260,452. (5) Balance of $186,194 is net of a debt discount of $2,839. Total repayment at maturity is $189,033, which includes a $2,000 exit fee payable upon repayment (6) Balance of $133,393 is net of a debt premium of $2,844. Total repayment at maturity is $130,550. (7) On February 6, 2023, $189,033, representing 40.0%, of the Exit Facility Loans were exchanged for Intabex Term Loans, and $130,550, representing the remaining 60.0%, of the Exit Facility Loans were exchanged for Pyxus Term Loans. (8) Primarily foreign seasonal lines of credit. Outstanding Senior Secured Debt ABL Credit Facility On February 8, 2022, our wholly owned subsidiary, Pyxus Holdings, Inc. ("Pyxus Holdings"), certain subsidiaries of Pyxus Holdings (together with Pyxus Holdings, the "Borrowers"), and the Company and its wholly owned subsidiary, Pyxus Parent, Inc. ("Pyxus Parent"), as guarantors, entered into an ABL Credit Agreement (as amended, the "ABL Credit Agreement"), dated as of February 8, 2022, by and among Pyxus Holdings, as Borrower Agent, the Borrowers and parent guarantors party thereto, the lenders party thereto, and PNC Bank, National Association, as Administrative Agent and Collateral Agent, to establish an asset-based revolving credit facility (the "ABL Credit Facility"), the proceeds of which may be used to provide for the ongoing working capital and general corporate purposes of the Borrowers, the Company, Pyxus Parent, and their subsidiaries. The ABL Credit Facility may be used for revolving credit loans and letters of credit from time to time up to an initial maximum principal amount of $100,000, subject to the limitations described below in this paragraph. The ABL Credit Facility includes a $20,000 uncommitted accordion feature that permits Pyxus Holdings, under certain conditions, to solicit the lenders under the ABL Credit Facility to provide additional revolving loan commitments to increase the aggregate amount of the revolving loan commitments under the ABL Credit Facility not to exceed a maximum principal amount of $120,000. The amount available under the ABL Credit Facility is limited by a borrowing base consisting of certain eligible accounts receivable and inventory, reduced by specified reserves, as follows: • 85% of eligible accounts receivable, plus • the lesser of (i) 85% of the book value of Eligible Extended Terms Receivables (as defined in the ABL Credit Agreement) and (ii) $5,000, plus • 90% of eligible credit insured accounts receivable, plus • the lesser of (i) 70% of eligible inventory valued at the lower of cost (based on a first-in first-out basis) and market value thereof (net of intercompany profits) or (ii) 85% of the net-orderly-liquidation value percentage of eligible inventory, minus • applicable reserves. At March 31, 2023, $75,000 was available for borrowing under the ABL Credit Facility, after reducing availability by the aggregate borrowings under the ABL Credit Facility of $25,000 outstanding on that date and the $20,000 of Domestic Availability (as defined in the ABL Credit Agreement) required to be maintained. Weighted average borrowings outstanding under the ABL Credit Facility during the fiscal year ended March 31, 2023 were $70,247. The ABL Credit Facility permits both base rate borrowings and borrowings based upon the Bloomberg-Short-Term Bank Yield Index rate ("BSBY"). Borrowings under the ABL Credit Facility bear interest at an annual rate equal to one, three, or six-month reserve-adjusted BSBY Rate plus 300 basis points or 200 basis points above base rate, as applicable, with a fee on unutilized commitments at an annual rate of 37.5 basis points. The ABL Credit Agreement was amended on May 23, 2023, which extended the maturity of the ABL Credit Facility to February 8, 2027. The outstanding amount under the ABL Credit Facility is recorded as noncurrent as of March 31, 2023, and the long-term debt repayment schedule in the table above reflects the ABL Credit Facility's extended maturity. Refer to " Note 27. Subsequent Events " for additional information. The ABL Credit Facility may be prepaid from time to time, in whole or in part, without prepayment or premium, subject to a termination fee upon the permanent reduction of commitments under the ABL Credit Facility of 300 basis points for terminations in the first year after entry into the ABL Credit Agreement, 200 basis points for terminations in the second year and 100 basis points for termination in the third year. In addition, customary mandatory prepayments of the loans under the ABL Credit Facility are required upon the occurrence of certain events including, without limitation, outstanding borrowing exposures exceeding the borrowing base, certain dispositions of assets outside of the ordinary course of business in respect of certain collateral securing the ABL Credit Facility and certain casualty and condemnation events. With respect to base rate loans, accrued interest is payable monthly in arrears and, with respect to BSBY loans, accrued interest is payable monthly and on the last day of any applicable interest period. The Borrowers’ obligations under the ABL Credit Facility (and certain related obligations) are (a) guaranteed by Pyxus Parent, and the Company and all of Pyxus Holdings’ wholly owned domestic subsidiaries, and each of Pyxus Holdings’ future wholly owned domestic subsidiaries is required to guarantee the ABL Credit Facility on a senior secured basis (collectively, the "ABL Loan Parties") and (b) secured by the collateral, as described below, which is owned by the ABL Loan Parties. Cash Dominion. Under the terms of the ABL Credit Facility, if (i) an event of default has occurred and is continuing, (ii) excess borrowing availability under the ABL Credit Facility (based on the lesser of the commitments thereunder and the borrowing base) (the "Excess Availability") falls below 10% of the total commitments under the ABL Credit Facility at such time, or (iii) Domestic Availability (as defined in the ABL Credit Agreement) being less than $20,000, the ABL Loan Parties will become subject to cash dominion, which will require daily prepayment of loans under the ABL Credit Facility with the cash deposited in certain deposit accounts of the ABL Loan Parties, including concentration accounts, and will restrict the ABL Loan Parties’ ability to transfer cash from their concentration accounts to their disbursement accounts. Such cash dominion period (a "Dominion Period") shall end when (i) if arising as a result of a continuing event of default, such event of default ceases to exist, (ii) if arising as a result of non-compliance with the Excess Availability threshold, Excess Availability shall be equal to or greater than 10% of the total commitments under the ABL Credit Facility for a period of 30 consecutive days and no event of default is continuing, or (iii) if arising as a result of Domestic Availability being less than $20,000, Domestic Availability is greater than $20,000 for a period of 30 consecutive days and no event of default is continuing. Covenants. The ABL Credit Agreement governing the ABL Credit Facility contains (i) a springing covenant requiring that the Company’s fixed charge coverage ratio be no less than 1.10 to 1.00 during any Dominion Period and (ii) a covenant requiring Domestic Availability greater than $20,000 at all times until audited financial statements for fiscal year ending March 31, 2023 are delivered under the ABL Credit Agreement. The ABL Credit Agreement governing the ABL Credit Facility contains customary representations and warranties, affirmative and negative covenants (subject, in each case, to exceptions and qualifications) and events of defaults, including covenants that limit the Company’s ability to, among other things: • incur additional indebtedness or issue disqualified stock or preferred stock; • make investments; • pay dividends and make other restricted payments; • sell certain assets; • create liens; • enter into sale and leaseback transactions; • consolidate, merge, sell or otherwise dispose of all or substantially all of the Company’s assets; • enter into transactions with affiliates; and • designate subsidiaries as Unrestricted Subsidiaries (as defined in the ABL Credit Agreement). On March 31, 2023, the Borrowers were in compliance with all covenants under the ABL Credit Agreement. Intabex Term Loans Pursuant to (i) an exchange offer (the "DDTL Facility Exchange") made to, and accepted by, holders of 100.0% of the outstanding term loans (the "DDTL Term Loans") under the Amended and Restated Term Loan Credit Agreement, effectuated pursuant to that certain Amendment and Restatement Agreement, dated as of June 2, 2022 (the "DDTL Credit Agreement"), by and among Intabex Netherlands B.V., as borrower ("Intabex"), the guarantors party thereto, the administrative agent and collateral agent thereunder, and the several lenders from time to time party thereto and (ii) an exchange offer (the "Exit Facility Exchange") made to, and accepted by, holders of 100.0% of the outstanding term loans (the "Exit Term Loans") under the Exit Term Loan Credit Agreement, dated as of August 24, 2020 (the "Exit Term Loan Credit Agreement"), by and among Pyxus Holdings, as borrower, the guarantors party thereto, the administrative agent and collateral agent thereunder, and the several lenders from time to time party thereto, on February 6, 2023, Pyxus Holdings entered into the Intabex Term Loan Credit Agreement, dated as of February 6, 2023 (the "Intabex Term Loan Credit Agreement"), by and among, Pyxus Holdings, the guarantors party thereto, the lenders party thereto and Alter Domus (US) LLC ("Alter Domus"), as administrative agent and senior collateral agent. The Intabex Term Loan Credit Agreement established a term loan credit facility in an aggregate principal amount of approximately $189,033 (the "Intabex Credit Facility"), under which term loans in the full aggregate principal amount of the Intabex Credit Facility (the "Intabex Term Loans") were deemed made in exchange for (i) $100,000 principal amount of the DDTL Term Loans, plus an additional $2,000 on account of the exit fee payable under the DDTL Credit Agreement and (ii) approximately $87,033 principal amount of Exit Term Loans, representing 40.0% of the outstanding principal amount thereof (including the applicable accrued and unpaid PIK interest thereon). The Intabex Term Loans bear interest, at Pyxus Holdings’ option, at either (i) a term SOFR rate (subject to a floor of 1.5%) plus 8.0% per annum or (ii) an alternate base rate plus 7.0% per annum. The Intabex Term Loans are stated to mature on December 31, 2027. The Intabex Term Loans may be prepaid from time to time, in whole or in part, without prepayment or penalty. With respect to alternate base rate loans, accrued interest is payable quarterly in arrears on the last business day of each calendar quarter and, with respect to SOFR loans, accrued interest is payable on the last day of each applicable interest period but no less frequently than every three months. The Intabex Term Loan Credit Agreement contains customary representations and warranties, affirmative and negative covenants (subject, in each case, to exceptions and qualifications) and events of defaults, including covenants that limit the Company’s and its restricted subsidiaries’ ability to, among other things, incur additional indebtedness or issue disqualified stock or preferred stock; make investments; pay dividends and make other restricted payments; sell certain assets; incur liens; consolidate, merge, sell or otherwise dispose of all or substantially all their assets; enter into transactions with affiliates; designate subsidiaries as unrestricted subsidiaries; and, in the case of Intabex, undertake business activities and sell certain subsidiaries. On March 31, 2023, Pyxus Holdings and the guarantors under the Intabex Term Loan Credit Agreement were in compliance with all covenants under the Intabex Term Loan Credit Agreement. Pyxus Term Loans Pursuant to the Exit Facility Exchange, on February 6, 2023, Pyxus Holdings entered into the Pyxus Term Loan Credit Agreement, dated as of February 6, 2023 (the "Pyxus Term Loan Credit Agreement"), by and among, Pyxus Holdings, the guarantors party thereto, the lenders party thereto and Alter Domus, as administrative agent and senior collateral agent, to establish a term loan credit facility in an aggregate principal amount of approximately $130,550 (the "Pyxus Credit Facility"), under which term loans in the full aggregate principal amount of the Pyxus Credit Facility (the "Pyxus Term Loans" and, together with the Intabex Term Loans, the "New Term Loans") were deemed made in exchange for 60.0% of the outstanding principal amount of Exit Term Loans (including the applicable accrued and unpaid PIK interest thereon). The Pyxus Term Loans bear interest, at Pyxus Holdings’ option, at either (i) a term SOFR rate (subject to a floor of 1.5%) plus 8.0% per annum or (ii) an alternate base rate plus 7.0% per annum. The Pyxus Term Loans are stated to mature on December 31, 2027. The Pyxus Term Loans may be prepaid from time to time, in whole or in part, without prepayment or penalty. With respect to alternate base rate loans, accrued interest is payable quarterly in arrears on the last business day of each calendar quarter and, with respect to SOFR loans, accrued interest is payable on the last day of each applicable interest period but no less frequently than every three months. The Pyxus Term Loan Credit Agreement contains customary representations and warranties, affirmative and negative covenants (subject, in each case, to exceptions and qualifications) and events of defaults, including covenants that limit the Company’s and its restricted subsidiaries’ ability to, among other things, incur additional indebtedness or issue disqualified stock or preferred stock; make investments; pay dividends and make other restricted payments; sell certain assets; incur liens; consolidate, merge, sell or otherwise dispose of all or substantially all their assets; enter into transactions with affiliates; and designate subsidiaries as unrestricted subsidiaries. On March 31, 2023, Pyxus Holdings and the guarantors under the Pyxus Term Loan Credit Agreement were in compliance with all covenants under the Pyxus Term Loan Credit Agreement. 8.50% Senior Secured Notes due 2027 Pursuant to an exchange offer (the "Notes Exchange" and, together with the DDTL Facility Exchange and the Exit Facility Exchange, the "Debt Exchange Transactions") made by Pyxus Holdings and accepted by holders of approximately 92.7% of the aggregate principal amount of the outstanding 10.0% Senior Secured First Lien Notes due 2024 issued by Pyxus Holdings (the "2024 Notes") pursuant to that certain Indenture, dated as of August 24, 2020 (the "2024 Notes Indenture"), by and among Pyxus Holdings, the guarantors party thereto and the trustee, collateral agent, registrar and paying agent thereunder, on February 6, 2023, Pyxus Holdings issued approximately $260,452 in aggregate principal amount of 8.5% Senior Secured Notes due December 31, 2027 (the "2027 Notes" and, together with the New Term Loans, the "New Secured Debt") to the exchanging holders of the 2024 Notes for an equal principal amount of 2024 Notes. The 2027 Notes were issued pursuant to the Indenture, dated as of February 6, 2023 (the "2027 Notes Indenture"), among Pyxus Holdings, the guarantors party thereto, and Wilmington Trust, National Association, as trustee, and Alter Domus, as collateral agent. The 2027 Notes bear interest at a rate of 8.5% per annum, which interest is computed on the basis of a 360-day year comprised of twelve 30-day months. Interest accrues on the 2027 Notes from the date of issuance and is payable semi-annually in arrears on June 15 and December 15 of each year, commencing on June 15, 2023. The 2027 Notes are stated to mature on December 31, 2027. At any time from time to time, Pyxus Holdings may redeem the 2027 Notes, in whole or in part, at a redemption price equal to 100.0% of the principal amount of 2027 Notes to be redeemed, plus accrued and unpaid interest, if any, to, but not including, the redemption date. The 2027 Notes Indenture contains customary affirmative and negative covenants (subject, in each case, to exceptions and qualifications) and events of defaults, including covenants that limit the Company’s and its restricted subsidiaries’ ability to, among other things, incur additional indebtedness or issue disqualified stock or preferred stock; make investments; pay dividends and make other restricted payments; sell certain assets; incur liens; consolidate, merge, sell or otherwise dispose of all or substantially all their assets; enter into transactions with affiliates; and designate subsidiaries as unrestricted subsidiaries. On March 31, 2023, Pyxus Holdings and the guarantors of the 2027 Notes were in compliance with all covenants under the 2027 Notes Indenture. Guarantees and Collateral The obligations of Pyxus Holdings under the ABL Credit Agreement and the New Secured Debt are fully and unconditionally guaranteed by the Company, Pyxus Parent and all of the Company’s domestic subsidiaries and certain of the Company’s foreign subsidiaries, subject to certain limitations (the "Senior Secured Debt Obligors"). In addition, under the Intabex Term Loan Credit Facility, Intabex and Alliance One International Tabak B.V. (which were obligors under the DDTL Term Loans) also guarantee the Intabex Credit Facility (together, the "Specified Intabex Obligors") but do not guarantee the 2027 Notes, the Pyxus Term Loans or obligations under the ABL Credit Agreement. In addition, certain assets of the Specified Intabex Obligors (which were pledged as collateral for the DDTL Term Loans) are pledged as collateral to secure the Intabex Term Loans (the "Intabex Collateral") but do not secure the 2027 Notes, the Pyxus Term Loans or obligations under the ABL Credit Agreement. The Senior Secured Debt Obligors’ obligations under the ABL Credit Agreement are secured by (i) a first-priority senior lien the ABL Priority Collateral (as defined in the ABL/New Secured Debt Intercreditor Agreement (as defined below)), which includes certain accounts receivable and inventory and certain related intercompany notes, cash, deposit accounts, related general intangibles and instruments, certain other related assets and proceeds of the foregoing of the Senior Secured Debt Obligors, and (ii) a junior-priority lien on substantially all assets of the Senior Secured Debt Obligors other than certain exclusions and the ABL Priority Collateral. The New Secured Debt is secured by (i) a first-priority senior lien on substantially all assets of the Senior Secured Debt Obligors other than certain exclusions and the ABL Priority Collateral and (ii) a junior-priority lien on the ABL Priority Collateral. The Intabex Term Loans are further secured by a first-priority lien on the Intabex Collateral. The obligations under the New Secured Debt share a single lien, held by Alter Domus, as senior collateral agent (the "Senior Collateral Agent"), on the Collateral (as defined below) subject to the payment waterfall pursuant to the intercreditor arrangements described below. Intercreditor Agreements The priority of the obligations under the ABL Credit Agreement and the New Secured Debt are set forth in the two intercreditor agreements entered into in connection with consummation of the DDTL Facility Exchange, the Exit Facility Exchange and the Notes Exchange. ABL/New Secured Debt Intercreditor Agreement . On February 6, 2023, Pyxus Holdings, Inc., the guarantors party thereto, PNC Bank, National Association, as ABL Agent, Alter Domus, as Pyxus Term Loan Administrative Agent, Intabex Term Loan Administrative Agent and Senior Collateral Agent, and Wilmington Trust, National Association, as Senior Notes Trustee entered into an Amended and Restated ABL Intercreditor Agreement, dated as of February 6, 2023 (the "ABL/New Secured Debt Intercreditor Agreement") to provide for the intercreditor relationship between, (i) on one hand, the holders of obligations under the ABL Credit Facility, the guarantees thereof and certain related obligations and (ii) on the other hand, the holders of obligations under the New Secured Debt, the guarantees thereof and certain related obligations. Pursuant to the terms of the ABL/Term Loan/Notes Intercreditor Agreement, Pyxus Holdings’ obligations under the ABL Credit Facility, the guarantees thereof and certain related obligations have first-priority senior liens on the ABL Priority Collateral, which includes certain accounts receivable and inventory and certain related intercompany notes, cash, deposit accounts, related general intangibles and instruments, certain other related assets of the foregoing entities and proceeds of the foregoing, with the obligations under the New Secured Debt having junior-priority liens on the ABL Priority Collateral. Pursuant to the ABL/New Secured Debt Intercreditor Agreement, Pyxus Holdings’ collective obligations under the New Secured Debt, the guarantees thereof and certain related obligations have first-priority senior liens on the collateral that is not ABL Priority Collateral, including owned material real property in the United States, capital stock of subsidiaries owned directly by Pyxus Holdings or a guarantor (other than the Intabex Collateral), existing and after acquired intellectual property rights, equipment, related general intangibles and instruments and certain other assets related to the foregoing and proceeds of the foregoing, with the obligations under the ABL Credit Facility having junior-priority liens on such collateral, other than real property. The ABL Credit Facility is not secured by real property. New Secured Debt Intercreditor Agreement . On February 6, 2023, the New Secured Debt Obligors, together with the representative for the holders of the New Secured Debt and the Senior Collateral Agent, entered into the Intercreditor and Collateral Agency Agreement, dated as of February 6, 2023 (the "New Secured Debt Intercreditor Agreement"), pursuant to which the Senior Collateral Agent, serves as joint collateral agent for the benefit of the holders of the 2027 Notes, the Pyxus Term Loans and the Intabex Term Loans with respect to all common collateral securing such indebtedness (the "Collateral"; which excludes Intabex Collateral). The New Secured Debt Intercreditor Agreement provides that Collateral or proceeds thereof received in connection with or upon the exercise of secured creditor remedies will be distributed (subject to the provisions described in the next paragraph) first to holders of the New Secured Debt on a pro rata basis based on the aggregate principal amount of each class of New Secured Debt, and then to holders of future junior debt secured by such Collateral on a pro rata basis based on the aggregate principal amount of each class of future junior debt (and in each case permitted refinancing indebtedness thereof). Exercise of rights and remedies against the Collateral and certain rights in a bankruptcy or insolvency proceeding (including the right to object to debtor-in-possession financing or to credit bid) by the Senior Collateral Agent will be controlled first by the holders of a majority in principal amount of the New Term Loans (including, in any event, each holder holding at least 20.0% of the New Term Loans as of February 6, 2023, provided such holder holds at least 15.0% of the New Term Loans as of the date of determination), second, after repayment in full of the New Term Loans, by the holders of a majority in principal amount of the 2027 Notes and last, after repayment in full of the New Term Loans and the 2027 Notes, by holders of a majority in principal amount of any future junior debt secured by the Collateral. Any such future junior debt will be subject to certain customary waivers of rights in a bankruptcy or insolvency proceeding in favor of the Senior Collateral Agent, including, but not limited to, with respect to debtor-in-possession financing, adequate protection and credit bidding. Refinanced Senior Secured Debt Exit ABL Credit Facility On August 24, 2020, Pyxus Holdings entered into the Exit ABL Credit Agreement, dated as of August 24, 2020 by and among, amongst others, Pyxus Holdings, certain lenders party thereto and Wells Fargo Bank, National Association, as administrative agent and collateral agent to establish an asset-based revolving credit facility ("the Exit ABL Credit Facility"), which permitted borrowings in an initial maximum principal amount of $75,000, subject to certain limitations. The Exit ABL Credit Facility could be used for revolving credit loans and letters of credit from time to time up to an initial maximum principal amount of $75,000, subject to certain limitations. Under certain conditions, Pyxus Holdings was permitted to solicit the ABL Lenders to provide additional revolving loan commitments under the Exit ABL Credit Facility in an aggregate amount not to exceed $15,000. The Exit ABL Credit Facility was required to be drawn at all times in an amount greater than or equal to the lesser of (i) 25% of total commitments under the Exit ABL Credit Facility and (ii) $18,750. The amount available under the Exit ABL Credit Facility is limited by a borrowing base consisting of eligible accounts receivable and inventory as follows: • 85% of eligible accounts receivable, plus • the lesser of (i) 70% of eligible inventory valued at the lower of cost (based on a first-in first-out basis) and market value thereof (net of intercompany profits) or (ii) 85% of the appraised net-orderly-liquidation value of eligible inventory. On February 8, 2022, Pyxus Holdings terminated the Exit ABL Credit Agreement and repaid $56,500 outstanding thereunder with proceeds from the initial borrowing under the ABL Credit Facility. DDTL Facility On April 23, 2021 (the “DDTL Closing Date”), Intabex entered into a Term Loan Credit Agreement (as amended on May 21, 2021, the "Initial DDTL Facility Credit Agreement"), dated as of April 23, 2021, by and among (i) Intabex, as borrower, (ii) the Company, Pyxus Parent, Pyxus Holdings, Alliance One International, LLC, Alliance One International Holdings, Ltd, as guarantors (collectively, the "Parent Guarantors"), (iii) the lenders thereto, which included certain funds managed by Glendon Capital Management, L.P., Monarch Alternative Capital LP, and Owl Creek Asset Management, L.P. (collectively and, together other lenders that became parties thereto as lenders, the "DDTL Facility Lenders"), and (iv) Alter Domus, as administrative agent and collateral agent. The Initial DDTL Facility Credit Agreement established a $120,000 delayed-draw term loan credit facility (the "Initial DDTL Facility") under which the full amount has been drawn (the "Initial DDTL Loans") by March 31, 2022. The proceeds of the Initial DDTL Loans were used to provide working capital and for other general corporate purposes of Intabex, the guarantors of the Initial DDTL Loans and their subsidiaries. Amounts prepaid or repaid in respect of Initial DDTL Loans were not permitted to be reborrowed under the Initial DDTL Facility. Interest on the aggregate principal amount of outstanding Initial DDTL Loans accrued at an annual rate of LIBOR plus 9.0%, subject to a LIBOR floor of 1.5%, for LIBOR loans or, for loans that are not LIBOR loans, at an annual rate of an alternative base rate (as specified in the Initial DDTL Facility Credit Agreement) plus 8.0%. Pursuant to the Initial DDTL Facility Credit Agreement, the DDTL Facility Lenders received a non-refundable commitment fee equal to 2.0% of the aggregate commitments under the Initial DDTL Facility, paid in cash in full on the DDTL Closing Date and netted from the proceeds of the Initial DDTL Loans borrowed on the DDTL Closing Date. The Initial DDTL Facility Credit Agreement provided for the payment by Intabex to the DDTL Facility Lenders of a non-refundable exit fee (the "Exit Fee") in the amounts set forth in the table below in respect of any Initial DDTL Loans repaid (whether prepaid voluntarily or paid following acceleration or at maturity). The Exit Fee was deemed to have been earned on the DDTL Closing Date, and was due and payable in cash on each date of repayment or termination, as applicable, in respect of the Initial DDTL Loans or commitments repaid or terminated on such date, as applicable. Loan Repayment Date Exit Fee On or before September 30, 2021 1.0% After September 30, 2021 and on or before December 31, 2021 2.5% After December 31, 2021 and on or before March 31, 2022 3.5% After March 31, 2022 5.0% The obligations of Intabex under the Initial DDTL Facility Credit Agreement (and certain related obligations) were (a) guaranteed by the Parent Guarantors and Alliance One International Tabak B.V., an indirect subsidiary of the Company, and each of the Company’s domestic and foreign subsidiaries that was or became a guarantor of borrowings under the Exit Term Loan Credit Agreement and (b) was secured by the pledge of all of the outstanding equity interests of (i) Alliance One Brasil Exportadora de Tabacos Ltda. ("AO Brazil"), which principally operates the Company’s leaf tobacco operations in Brazil, and (ii) Alliance One International Tabak B.V., which owns a 0.001% interest of AO Brazil. The Initial DDTL Credit Facility Agreement was amended and restated by the DDTL Credit Agreement, which established a $100,000 term loan credit facility (the "DDTL Term Loan Facility") and required that Intabex use the net proceeds of the DDTL Term Loans made thereunder and other funds to repay in full its obligations under the Initial DDTL Facility Credit Agreement, including the outstanding principal of, and accrued and unpaid interest on, borrowings under the Initial DDTL Facility and the payment of fees and expenses incurred in connection with repaying such borrowings and incurring the DDTL Term Loans under the DDTL Credit Agreement. The DDTL Credit Agreement provided for a 2.0% fee due with respect to any principal payment made after the one-year anniversary of the incurrence of the DDTL Term Loans, including a payment made at maturity. The DDTL Credit Agreement further provided that amounts of principal that were prepaid may not be reborrowed under the DDTL Term Loan Facility. Interest on the outstanding principal amount of the DDTL Term Loans accrued at an annu

Securitized Receivables

Securitized Receivables	12 Months Ended
Securitized Receivables	Mar. 31, 2023
Transfers and Servicing [Abstract]
Securitized Receivables	Securitized Receivables The Company sells trade receivables to unaffiliated financial institutions under four accounts receivable securitization facilities, two of which are subject to annual renewal. Under the first facility, the Company continuously sells a designated pool of trade receivables to a special purpose entity, which sells 100% of the receivables to an unaffiliated financial institution. Following the sale and transfer of the receivables to the special purpose entity, the receivables are isolated from the Company and its affiliates, and effective control of the receivables is passed to the unaffiliated financial institution, which has all rights, including the right to pledge or sell the receivables. The first facility requires a minimum level of deferred purchase price be retained by the Company in connection with the sales of the receivables to the unaffiliated financial institution. The Company continues to service, administer, and collect the receivables on behalf of the special purpose entity and receives a servicing fee of 0.5% of serviced receivables per annum. As the Company estimates the expected fee it receives in return for its obligation to service these receivables is at fair value, no servicing assets or liabilities are recognized. Servicing fees are recorded as a reduction of selling, general, and administrative expenses within the statements of consolidated operations. As of March 31, 2023, the investment limit of this facility was $100,000 of trade receivables. Under the second facility, the Company offers trade receivables for sale to an unaffiliated financial institution, which are then subject to acceptance by the unaffiliated financial institution. Following the sale and transfer of the receivables to the unaffiliated financial institution, the receivables are isolated from the Company and its affiliates, and effective control of the receivables is passed to the unaffiliated financial institution, which has all rights, including the right to pledge or sell the receivables. Although the Company continues to service, administer, and collect the receivables on behalf of the unaffiliated financial institution, the Company does not receive a servicing fee, and as a result, has established a servicing liability based upon unobservable inputs, primarily discounted cash flow. As of March 31, 2023, the investment limit under the second facility was $110,000 of trade receivables. As servicer for the first and second facilities, the Company may receive funds that are due to the unaffiliated financial institutions which are net settled on the next settlement date. As of March 31, 2023 and 2022, trade receivables, net in the consolidated balance sheets has been reduced by $3,193 and $1,872 as a result of the net settlement, respectively. Refer to " Note 20. Fair Value Measurements " for additional information. Under the third and fourth facilities, the Company offers trade receivables for sale to unaffiliated financial institutions, which are then subject to acceptance by the unaffiliated financial institutions. Following the sale and transfer of the receivables to the unaffiliated financial institution, the receivables are isolated from the Company and its affiliates, and effective control of the receivables is passed to the unaffiliated financial institution, which has all rights, including the right to pledge or sell the receivables. As of March 31, 2023, the investment limits under the third and fourth facilities were variable based on qualifying sales. The following summarizes the Company's accounts receivable outstanding in the securitization facilities, which represents trade receivables sold into the program that have not been collected from the customer, and related beneficial interests, which represents the Company's residual interest in receivables sold that have not been collected from the customer: March 31, 2023 March 31, 2022 Receivables outstanding in facility $ 173,979 $ 131,092 Beneficial interest 19,522 28,072 Cash proceeds from the sale of trade receivables is comprised of a combination of cash and a deferred purchase price receivable. Deferred purchase price receivable is realized after the collection of the underlying trade receivables sold by the purchasers. The following summarizes the Company's cash purchase price and deferred purchase price: Year Ended March 31, 2023 Year Ended March 31, 2022 Cash proceeds for the period ended: Cash purchase price $ 696,404 $ 441,054 Deferred purchase price 165,262 189,440

Guarantees

Guarantees	12 Months Ended
Guarantees	Mar. 31, 2023
Guarantees [Abstract]
Guarantees	Guarantees In certain markets, the Company guarantees bank loans for suppliers to finance their crops. The Company also guarantees bank loans of certain unconsolidated subsidiaries. The following summarizes amounts guaranteed and the fair value of those guarantees: March 31, 2023 March 31, 2022 Amounts guaranteed (not to exceed) $ 152,032 $ 114,208 Amounts outstanding under guarantee (1) 83,420 49,413 Fair value of guarantees 5,262 2,956 Amounts due to local banks on behalf of suppliers for government subsidized rural credit financing 12,529 15,781 (1) Most of the guarantees outstanding at March 31, 2023 expire within one year.

Derivative Financial Instrument

Derivative Financial Instruments	12 Months Ended
Derivative Financial Instruments	Mar. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Financial Instruments	Derivative Financial Instruments The Company uses forward or option currency contracts to manage risks associated with foreign currency exchange rates on foreign operations. These contracts are for green tobacco purchases, processing costs, and selling, general, and administrative expenses. The Company recorded a net gain of $6,764 from its derivative financial instruments in cost of goods and services sold for the year ended March 31, 2023. The Company recorded a net gain of $2,482 from its derivative financial instruments in cost of goods and services sold As of March 31, 2023 and 2022, accumulated other comprehensive income includes $(2,777) and $8,975, respectively, net of $1,690 and $(3,025) of tax, respectively, for net unrealized (losses) and gains related to designated cash flow hedges. As of March 31, 2023 and 2022, the Company recorded current derivative assets as $63,622 and $61,690, respec tively.

Fair Value Measurements

Fair Value Measurements	12 Months Ended
Fair Value Measurements	Mar. 31, 2023
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants. The inputs used to measure fair value are prioritized based on a three-level valuation hierarchy, which is comprised of observable and non-observable inputs. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company's market assumptions. These three levels of inputs create the following fair value hierarchy: • Level 1 inputs - Quoted prices in active markets for identical assets or liabilities. • Level 2 inputs - Quoted prices in active markets for similar assets or liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active, and observable inputs (other than quoted prices) for the assets or liabilities. • Level 3 inputs - Unobservable inputs for the assets or liabilities. The following summarizes assets and liabilities measured at fair value on a recurring basis: March 31, 2023 March 31, 2022 Level 2 Level 3 Total Assets / Level 2 Level 3 Total Assets / Financial assets Derivative financial instruments $ 3,970 $ — $ 3,970 $ 9,867 $ — $ 9,867 Securitized beneficial interests — 19,522 19,522 — 28,072 28,072 Total assets $ 3,970 $ 19,522 $ 23,492 $ 9,867 $ 28,072 $ 37,939 Financial liabilities Long-term debt (1) $ 523,758 $ 514 $ 524,272 $ 447,843 $ 246 $ 448,089 Guarantees — 5,262 5,262 — 2,956 2,956 Total liabilities $ 523,758 $ 5,776 $ 529,534 $ 447,843 $ 3,202 $ 451,045 (1) This fair value measurement disclosure does not affect the consolidated balance sheets. Level 2 measurements • Debt: The fair value of debt is based on the market price for similar financial instruments or model-derived valuations with observable inputs. The primary inputs to the valuation include market expectations, the Company's credit risk, and the contractual terms of the debt instrument. • Derivatives: The fair value of derivatives is based on the discounted cash flow analysis of the expected future cash flows. The primary inputs to the valuation include forward yield curves, implied volatilities, LIBOR rates, and credit valuation adjustments. Level 3 measurements • Guarantees: The fair value of guarantees is based on the discounted cash flow analysis of the expected future cash flows or historical loss rates. The historical loss rate was weighted by the principal balance of the loans. • Securitized beneficial interests: The fair value of securitized beneficial interests is based on the present value of future expected cash flows. The discount rate was weighted by the outstanding interest. Payment speed was weighted by the avera ge days outstanding. • Debt: The fair value of debt is based on the present value of future payments. The primary inputs to this valuation include treasury notes interest and borrowing rates . The borrowing rates were weighted by average loans outstanding. Reconciliation of Change in Recurring Level 3 Balances The following summarizes the changes in Level 3 instruments measured on a recurring basis. Securitized Beneficial Interests Long-Term Debt Guarantees Beginning balance at March 31, 2021 $ 19,370 $ 3,162 $ 1,740 Sales of receivables/issuance of guarantees 205,517 — 3,151 Settlements (192,141) (2,918) (1,749) Additions — 2 — Losses recognized in earnings (4,674) — (186) Ending balance at March 31, 2022 $ 28,072 $ 246 $ 2,956 Sales of receivables/issuance of guarantees 166,165 6,187 Settlements (164,679) (37) (1,864) Additions — 305 — Losses recognized in earnings (10,036) — (2,017) Ending balance at March 31, 2023 $ 19,522 $ 514 $ 5,262 The amount of total losses included in earnings for the years ended March 31, 2023 and 2022 are attributable to the change in unrealized losses relating to assets still held at the respective dates was $659 and $1,148 on securitized beneficial interests. Gains and losses included in earnings are reported in other expense, net. Information about Fair Value Measurements Using Significant Unobservable Inputs The following summarizes significant unobservable inputs and the valuation techniques utilized: Fair value at March 31, 2023 Valuation Technique Unobservable Input Range (Weighted Average) Securitized Beneficial Interests $ 19,522 Discounted Cash Flow Discount Rate 2.3% to 7.3% Payment Speed 38 days to 88 days Guarantees $ 5,262 Historical Loss Historical Loss 1.2% to 40.0% Fair value at March 31, 2022 Valuation Technique Unobservable Input Range (Weighted Average) Securitized Beneficial Interests $ 28,072 Discounted Cash Flow Discount Rate 2.8% to 3.9% Payment Speed 91 days to 103 days Guarantees $ 2,956 Historical Loss Historical Loss 0.6% to 44.6%

Pension and Other Postretiremen

Pension and Other Postretirement Benefits	12 Months Ended
Pension and Other Postretirement Benefits	Mar. 31, 2023
Retirement Benefits [Abstract]
Pension and Other Postretirement Benefits	Pension and Other Postretirement Benefits Defined Benefit Plans On November 19, 2021, the Compensation Committee of the Company's Board of Directors approved a resolution to terminate the Company's U.S. defined benefit pension plan ("U.S. Pension Plan"). During the nine months ended December 31, 2022, the Company settled benefits with vested participants that elected a lump sum payout and made a cash contribution of $5,300 to fully fund the U.S. Pension Plan's liabilities in preparation to purchase a group annuity contract to administer future payments to the remaining U.S. Pension Plan participants. In addition, the Company recorded a pension settlement charge of $2,588 during the nine months ended December 31, 2022, which included the recognition of unrecognized pension gains within accumulated other comprehensive loss within the Company's consolidated statements of operations. Termination of the U.S. Pension Plan occurred during the three-month period ended December 31, 2022. The following summarizes benefit obligations, plan assets, and funded status for the defined benefit pension plans: U.S. Plans Non-U.S. Plans Total Year Ended March 31, 2023 Benefit obligation, beginning $ 62,797 $ 58,931 $ 121,728 Service cost 300 176 476 Interest cost 1,711 1,564 3,275 Plan amendments — 139 139 Actuarial gains (4,106) (10,220) (14,326) Plan settlements (21,390) (720) (22,110) Effects of currency translation — (2,356) (2,356) Benefits paid (3,602) (2,843) (6,445) Benefit obligation, ending $ 35,710 $ 44,671 $ 80,381 Fair value of plan assets, beginning $ 19,812 $ 66,801 $ 86,613 Actual return on plan assets (3,974) (10,027) (14,001) Employer contributions 9,154 1,758 10,912 Plan settlements (21,390) (720) (22,110) Effects of currency translation — (2,942) (2,942) Benefits paid (3,602) (2,843) (6,445) Fair value of plan assets, ending $ — $ 52,027 $ 52,027 Funded status of the plan $ (35,710) $ 7,356 $ (28,354) U.S. Plans Non-U.S. Plans Total Year Ended March 31, 2022 Benefit obligation, beginning $ 76,223 $ 66,433 $ 142,656 Service cost 215 174 389 Interest cost 1,467 1,187 2,654 Actuarial gains (2,948) (3,669) (6,617) Plan settlements (7,600) (114) (7,714) Effects of currency translation — (1,971) (1,971) Benefits paid (4,560) (3,109) (7,669) Benefit obligation, ending $ 62,797 $ 58,931 $ 121,728 Fair value of plan assets, beginning $ 27,109 $ 69,692 $ 96,801 Actual return on plan assets 806 1,038 1,844 Employer contributions 4,057 1,325 5,382 Plan settlements (7,600) (114) (7,714) Effects of currency translation — (2,031) (2,031) Benefits paid (4,560) (3,109) (7,669) Fair value of plan assets, ending $ 19,812 $ 66,801 $ 86,613 Funded status of the plan $ (42,985) $ 7,870 $ (35,115) The following summarizes amounts reported in the consolidated balance sheets for the defined benefit pension plans: U.S. Plans Non-U.S. Plans March 31, 2023 March 31, 2022 March 31, 2023 March 31, 2022 Noncurrent benefit asset recorded in other noncurrent assets $ — $ — $ 13,731 $ 15,443 Accrued current benefit liability recorded in accrued expenses and other current liabilities (3,290) (3,305) (972) (878) Accrued noncurrent benefit liability recorded in pension, postretirement, and other long-term liabilities (32,420) (39,680) (5,403) (6,695) Funded status of the plan $ (35,710) $ (42,985) $ 7,356 $ 7,870 The following summarizes pension obligations for the defined benefit pension plans: U.S. Plans Non-U.S. Plans (1) March 31, 2023 March 31, 2022 March 31, 2023 March 31, 2022 Information for pension plans with accumulated benefit obligation in excess of plan assets: Projected benefit obligation $ 35,710 $ 62,797 $ 6,375 $ 7,573 Accumulated benefit obligation 35,710 62,797 5,998 7,009 Fair value of plan assets — 19,812 — — (1) Certain of the Company's non-U.S. defined benefit pension plans in Europe were over funded as of March 31, 2023 and 2022. The following summarizes activity in accumulated other comprehen sive income for the defined benefit plans: U.S. and Non-U.S. Pension U.S. and Non-U.S. Post-retirement Total Prior service credit $ 56 $ — $ 56 Net actuarial gains 4,645 1,383 6,028 Deferred taxes 459 (215) 244 Balance at March 31, 2022 $ 5,160 $ 1,168 $ 6,328 Prior service cost (138) — (138) Net actuarial gains 1,238 609 1,847 Deferred taxes 372 (74) 298 Total change for 2023 $ 1,472 $ 535 $ 2,007 Prior service cost (82) — (82) Net actuarial gains 5,883 1,992 7,875 Deferred taxes 831 (289) 542 Balance at March 31, 2023 $ 6,632 $ 1,703 $ 8,335 The following assumptions were used to determine the expense for the pension plans: U.S. Plans Non-U.S. Plans March 31, 2023 March 31, 2022 March 31, 2023 March 31, 2022 Discount rate 3.75% 2.83% 2.98% 2.17% Rate of increase in future compensation Not applicable Not applicable 7.31% 5.28% Expected long-term rate of return on plan assets Not applicable 5.75% 2.16% 2.12% Interest crediting rate 4.28% 4.25% Not applicable Not applicable The following weighted average assumptions were used to determine the benefit obligations for the pension plans: U.S. Plans Non-U.S. Plans March 31, 2023 March 31, 2022 March 31, 2023 March 31, 2022 Discount rate 5.08% 3.74% 4.94% 2.98% Rate of increase in future compensation Not applicable Not applicable 5.72% 7.31% Interest crediting rate Not applicable 4.28% Not applicable Not applicable Plan Assets The following summarizes asset allocations and the percentage of the fair value of plan assets by asset category: Non-U.S. Plans March 31, 2023 March 31, 2022 Asset category: Cash and cash equivalents 11.5 % 10.6 % Equity securities 20.3 % 20.7 % Debt securities 14.8 % 66.5 % Insurance contracts 50.9 % — % Real estate and other investments 2.5 % 2.2 % Total 100.0 % 100.0 % The fair values for the pension plans by asset category are as fol lows: Non-U.S. Pension Plans March 31, 2023 Total Level 1 Level 2 Level 3 Cash and cash equivalents $ 5,964 $ 5,964 $ — $ — U.S. equities / equity funds 6,669 6,669 — — International equities / equity funds 3,909 3,909 — — U.S. fixed income funds 5,364 5,364 — — International fixed income funds 2,334 2,334 — — Insurance contracts 26,472 — 26,472 — Real estate and other (1) 1,315 1,315 — — Total $ 52,027 $ 25,555 $ 26,472 $ — Non-U.S. Pension Plans March 31, 2022 Total Level 1 Level 2 Level 3 Cash and cash equivalents $ 7,073 $ 7,073 $ — $ — U.S. equities / equity funds 9,268 9,268 — — International equities / equity funds 2,818 2,818 — — Global equity funds 1,748 1,748 — — U.S. fixed income funds 5,753 5,753 — — International fixed income funds 34,313 10,448 23,865 — Global fixed income funds 4,371 4,371 — — Real estate and other (1) 1,457 — — — Total $ 66,801 $ 41,479 $ 23,865 $ — (1) Certain investments that are measured at fair value using the net asset value per share practical expedient have not been classified in the fair value hierarchy. The following summarizes the plan assets recognized and measured at fair value using the net asset value and the inputs used to determine the fair value: March 31, 2023 March 31, 2022 Fair Value Unfunded Commitments Redemption Frequency Redemption Notice Period Fair Value Unfunded Commitments Redemption Frequency Redemption Notice Period Real estate and other $ 1,315 None Quarterly 60 Days $ 3,907 None Quarterly 60 Days Postretirement Health and Life Insurance Benefits The following summarizes benefit obligations, plan assets, and funded status for the postretirement health and life insurance benefits plans: U.S. Plans Non-U.S. Plans Total March 31, 2023 Benefit obligation, beginning $ 3,977 $ 1,454 $ 5,431 Service cost 5 — 5 Interest cost 134 121 255 Effect of currency translation — (97) (97) Actuarial gains (437) (288) (725) Benefits paid (310) (75) (385) Benefit obligation, ending $ 3,369 $ 1,115 $ 4,484 Fair value of plan assets, beginning $ — $ — $ — Employer contributions 310 75 385 Benefits paid (310) (75) (385) Fair value of plan assets, ending $ — $ — $ — Funded status of the plan $ (3,369) $ (1,115) $ (4,484) U.S. Plans Non-U.S. Plans Total March 31, 2023 Accrued current benefit liability recorded in accrued expenses and other current liabilities $ (297) $ (96) $ (393) Accrued non-current benefit liability recorded in pension, postretirement, and other long-term liabilities (3,072) (1,019) (4,091) Funded status of the plan $ (3,369) $ (1,115) $ (4,484) U.S. Plans Non-U.S. Plans Total March 31, 2022 Benefit obligation, beginning $ 4,458 $ 1,441 $ 5,899 Service cost 6 — 6 Interest cost 97 110 207 Effect of currency translation — 250 250 Actuarial gains (425) (251) (676) Benefits paid (159) (96) (255) Benefit obligation, ending $ 3,977 $ 1,454 $ 5,431 Fair value of plan assets, beginning $ — $ — $ — Employer contributions 159 96 255 Benefits paid (159) (96) (255) Fair value of plan assets, ending $ — $ — $ — Funded status of the plan $ (3,977) $ (1,454) $ (5,431) U.S. Plans Non-U.S. Plans Total March 31, 2022 Accrued current benefit liability recorded in accrued expenses and other current liabilities $ (310) $ (118) $ (428) Accrued non-current benefit liability recorded in pension, postretirement, and other long-term liabilities (3,667) (1,336) (5,003) Funded status of the plan $ (3,977) $ (1,454) $ (5,431) The following assumptions were used to determine postretirement benefit obligations: March 31, 2023 March 31, 2022 U.S. Plans Non-U.S. Plans U.S. Plans Non-U.S. Plans Discount rate 5.09 % 10.58 % 3.75 % 9.50 % Health care cost trend rate assumed for next year 5.49 % 9.40 % 5.62 % 7.90 % Cash Flows The Company expects to contribute the following to its benefit plans: Pension Benefits Postretirement Plans U.S. Plans Non-U.S. Plans U.S. Plans Non-U.S. Plans Fiscal Year 2024 $ 3,290 $ 972 $ 297 $ 96 The Company's contributions to the defined contribution plans are as follows: Year Ended March 31, 2023 Year Ended March 31, 2022 Contributions $5,478 4,589 The following summarizes the expected benefit payments to be paid in future years, as of March 31, 2023: Pension Benefits Other Benefits U.S. Plans Non-U.S. Plans U.S. Plans Non-U.S. Plans Total 2024 $ 3,290 $ 3,325 $ 297 $ 96 $ 7,008 2025 3,319 3,313 289 100 7,021 2026 3,258 3,089 284 104 6,735 2027 3,191 3,186 279 108 6,764 2028 3,115 3,167 275 112 6,669 Thereafter 14,170 17,796 1,257 617 33,840 Total $ 30,343 $ 33,876 $ 2,681 $ 1,137 $ 68,037

Contingencies and Other Informa

Contingencies and Other Information	12 Months Ended
Contingencies and Other Information	Mar. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Contingencies and Other Information	Contingencies and Other Information Brazilian Tax Credits The government in the Brazilian State of Parana ("Parana") issued a tax assessment on October 26, 2007 with respect to local intrastate trade tax credits that result primarily from tobacco transferred between states within Brazil. At March 31, 2023, the assessment for intrastate trade tax credits taken is $2,599 and the total assessment including penalties and interest is $10,104. On March 18, 2014, the government in Brazilian State of Santa Catarina also issued a tax assessment with respect to local intrastate trade tax credits that result primarily from tobacco transferred between states within Brazil. At March 31, 2023, the assessment for intrastate trade tax credits taken is $2,243 and the total assessment including penalties and interest is $6,457. The Company believes it has properly complied with Brazilian law and will contest any assessment through the judicial process. Should the Company lose in the judicial process, the loss of the intrastate trade tax credits would have a material impact on the financial statements of the Company. The Company also has local intrastate trade tax credits in the Brazil State of Rio Grande do Sul. This jurisdiction permits the sale or transfer of excess credits to third parties, however approval must be obtained from the tax authorities. The Company has an agreement with the state government regarding the amounts and timing of credits that can be sold. The tax credits have a carrying value of $17,210. The intrastate trade tax credits are monitored for impairment in future periods based on market conditions and the Company’s ability to use or sell the tax credits. Other Matters In addition to the above-mentioned matters, certain of the Company’s subsidiaries are involved in other litigation or legal matters incidental to their business activities, including tax matters. While the outcome of these matters cannot be predicted

Other Comprehensive Income

Other Comprehensive Income	12 Months Ended
Other Comprehensive Income	Mar. 31, 2023
Equity [Abstract]
Other Comprehensive Income	Other Comprehensive Income The following summarizes changes in each component of accumulated other comprehensive income, net of tax, attributable to the Company: Currency Translation Adjustment Pensions, Net of Tax Derivatives, Net of Tax Accumulated Other Comprehensive Income Balances at March 31, 2021 $ (4,649) $ 541 $ (2,625) $ (6,733) Other comprehensive (loss) income before reclassifications (4,224) 6,209 10,419 12,404 Amounts reclassified to net loss, net of tax — (422) (1,445) (1,867) Other comprehensive (loss) income, net of tax (4,224) 5,787 8,974 10,537 Balances at March 31, 2022 $ (8,873) $ 6,328 $ 6,349 $ 3,804 Other comprehensive income (loss) before reclassifications 2,481 1,873 1,750 6,104 Amounts reclassified to net loss, net of tax — 134 (4,527) (4,393) Other comprehensive income (loss), net of tax 2,481 2,007 (2,777) 1,711 Balances at March 31, 2023 $ (6,392) $ 8,335 $ 3,572 $ 5,515 The following summarizes derivative amounts reclassified from accumulated other comprehensive income to net loss: Affected Line Item in the Consolidated Year Ended March 31, 2023 Year Ended March 31, 2022 Statements of Operations Derivatives: Gain reclassified to cost of goods sold $ (6,764) $ (2,672) Amounts reclassified from equity to the income statement, gross (6,764) (2,672) Cost of goods and services sold Tax effects of amounts reclassified from accumulated other comprehensive income to net loss 2,237 1,227 Amounts reclassified from equity to the income statement, net $ (4,527) $ (1,445)

Stock_Based Compensation

Stock–Based Compensation	12 Months Ended
Stock–Based Compensation	Mar. 31, 2023
Share-Based Payment Arrangement [Abstract]
Stock-Based Compensation	Stock–Based CompensationOn November 18, 2020, the Board of Directors of the Company adopted the Pyxus International, Inc. 2020 Incentive Plan (the "Incentive Plan"), which was approved at the 2021 annual meeting of shareholders on August 19, 2021. The Incentive Plan permits the grant of options, stock appreciation rights (or SARs), stock awards, stock unit awards, performance share awards, and incentive awards. The number of shares of the Company’s common stock eligible to be issued under the Incentive Plan is 2,200 shares. The awards outstanding at March 31, 2023 under the Incentive Plan are restricted stock units for an aggregate of 706 shares that become eligible for vesting, subject to continued employment in equal annual increments generally on March 31 of each year, performance-based restricted stock units for an aggregate of 1,064 shares at the target performance level and stock units awarded to non-employee directors for an aggregate of 117 shares. The performance-based restricted stock units provide for the issuance of shares based of satisfaction of performance criteria over a three-year measurement period ending March 31, 2024, subject to continued employment, with payouts at 50% of the target level upon satisfaction of threshold performance levels, 100% of the target level upon satisfaction of target performance levels and 150% of the target level upon performance equaling or exceeding the maximum performance levels, with payouts interpolated for performance between these levels. Each of such time-vesting and performance-based restricted stock units is subject to an additional condition to vesting that the Company’s common stock be listed for trading on a national securities exchange or an approved foreign securities exchange by a specified date. As of March 31, 2023, the vesting requirements for these awards were not probable to occur. As a result, no stock-based compensation expense was recognized in the years ended March 31, 2023 and 2022.

Related Party Transactions

Related Party Transactions	12 Months Ended
Related Party Transactions	Mar. 31, 2023
Related Party Transactions [Abstract]
Related Party Transactions	Related Party Transactions The Company engages in transactions with its equity method investees primarily for the procuring and processing of inventory. The following summarizes sales and purchases transactions with related parties: Year Ended March 31, 2023 Year Ended March 31, 2022 Sales $ 22,695 $ 25,575 Purchases 158,140 135,261 The Company included the following related party balances in its consolidated balances sheets: March 31, 2023 March 31, 2022 Accounts receivable, related parties $ 3,090 $ 1,896 Other receivables Notes receivable, related parties — 1,431 Other receivables Accounts payable, related parties 20,438 41,747 Accounts payable Advances from related parties 3,494 15,240 Advances from customers Transactions with Significant Shareholders As described in " Note 16. Debt Arrangements ," funds managed by the Glendon Investor, funds managed by the Monarch Investor, and funds managed by Owl Creek Asset Management, L.P., (such funds are collectively referred to as the "Investor-Affiliated Funds") held 2024 Notes and/or Exit Term Loans, were parties to the Initial DDTL Facility Credit Agreement and amendments thereto (including the DDTL Credit Agreement) and the Support Agreement, and received the New Secured Debt pursuant to the Debt Exchange Transactions. The Company paid a total of $1,575 in transaction costs incurred by the parties receiving the New Secured Debt in the Debt Exchange Transactions, of which an aggregate $910 related to costs paid on behalf of the Investor-Affiliated Funds. On December 30, 2021, the Investor-Affiliated Funds received $14,991 of the repayment of $15,375 principal amount of the Initial DDTL Loans. In connection with the effectiveness of the DDTL Credit Agreement on July 28, 2022, in addition to the deemed repayment of the Initial DDTL Loans, the Investor-Affiliated Funds received $5,119 of the aggregate $5,250 in exit fee payments from the repayment of the principal amount under the Initial DDTL Facility. In addition, the Investor-Affiliated Funds received in the aggregate $3,900 of the total $4,000 in commitment and closing fees with respect to the DDTL Credit Agreement, which were reflected as original issue discount, paid to all DDTL Facility Lenders in connection with the aggregate $97,500 principal amount of the DDTL Term Loans made by them of the total $100,000 aggregate principal amount of the DDTL Term Loans made by all DDTL Facility Lenders. Accrued expenses and other current liabilities as presented in the consolidated balance sheets as of March 31, 2023 and 2022, includes $3,653 and $3,984, respectively, of interest payable to Investor-Affiliated Funds and CI Investments, Inc. ("CI Investments"), which is also a beneficial owner of greater than five percent of the Company's common stock. Interest expense as presented in the consolidated statements of operations includes $35,649 and $32,579 for the year ended March 31, 2023 and 2022 that relates to the Investor-Affiliated Funds and CI Investments.

Segment Information

Segment Information	12 Months Ended
Segment Information	Mar. 31, 2023
Segment Reporting [Abstract]
Segment Information	Segment Information The following summarizes segment information, with the All Other category being included for purposes of reconciliation of the respective balances below of the Leaf segment (the Company's sole reportable segment) to the consolidated financial statements: Year Ended March 31, 2023 Year Ended March 31, 2022 Sales and other operating revenues: Leaf $ 1,900,558 $ 1,627,238 All Other 14,323 12,624 Consolidated sales and other operating revenues $ 1,914,881 $ 1,639,862 Segment operating income: Leaf $ 117,056 $ 106,159 All Other (18,593) (24,225) Segment operating income 98,463 81,934 Restructuring and asset impairment charges 4,685 8,031 Goodwill impairment — 32,186 Consolidated operating income $ 93,778 $ 41,717 March 31, 2023 Leaf All Other Total Segment assets $ 1,544,798 $ 37,665 $ 1,582,463 Trade and other receivables, net 199,237 411 199,648 Equity in net assets of investee companies 93,754 6,985 100,739 Depreciation and amortization 16,157 2,980 19,137 Capital expenditures 13,565 2,390 15,955 March 31, 2022 Leaf All Other Total Segment assets $ 1,641,552 $ 56,975 $ 1,698,527 Trade and other receivables, net 255,756 1,105 256,861 Equity in net assets of investee companies 88,118 6,785 94,903 Depreciation and amortization 14,763 1,913 16,676 Capital expenditures 10,159 4,438 14,597 The following summarizes geographic sales and other operating revenues by destination of the product shipped: Year Ended March 31, 2023 Year Ended March 31, 2022 Sales and Other Operating Revenues: China $ 338,174 $ 280,945 United States 220,266 209,953 United Arab Emirates 182,306 82,070 Indonesia 170,492 110,009 Belgium (1) 132,456 89,748 Northern Africa 52,428 52,539 Russia 20,175 57,808 Other 798,584 756,790 Total $ 1,914,881 $ 1,639,862 (1) The Belgium destination represents a customer-owned storage and distribution center from which the tobacco will be shipped on to manufacturing facilities. The following summarizes the customers, including their respective affiliates, that account for more than 10.0% of total sales and other operating revenues for the respective periods, as indicated by an "x": Year Ended March 31, 2023 Year Ended March 31, 2022 Philip Morris International Inc. x x China Tobacco International Inc. x x British American Tobacco x x The following summarizes geographic property, plant, and equipment by location: March 31, 2023 March 31, 2022 Property, Plant, and Equipment, Net: Malawi $ 31,213 $ 30,961 Brazil 29,163 28,707 United States 21,945 21,960 Zimbabwe 21,703 22,217 Other 12,006 12,152 Jordan 11,352 11,571 Tanzania 6,016 9,953 Total $ 133,398 $ 137,521

Subsequent Events

Subsequent Events	12 Months Ended
Subsequent Events	Mar. 31, 2023
Subsequent Events [Abstract]
Subsequent Events	Subsequent EventsOn May 23, 2023, the ABL Credit Agreement was amended to extend the maturity of the ABL Credit Facility to February 8, 2027.

Basis of Presentation and Sum_2

Basis of Presentation and Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Mar. 31, 2023
Accounting Policies [Abstract]
Principles of Consolidation	Principles of Consolidation The consolidated financial statements include the accounts of the Company and its majority-owned and controlled subsidiaries. Intercompany accounts and transactions have been eliminated.
Equity Method Investments	Equity Method InvestmentsThe Company’s equity method investments and its cost method investments are non-marketable securities. When not required to consolidate its investment in another entity, the Company uses the equity method if it (i) can exercise significant influence over the other entity, and (ii) holds common stock and/or in-substance common stock of the other entity. Under the equity method, investments are carried at cost, plus or minus the Company’s equity in the increases or decreases of the investee’s net assets after the date of acquisition. The Company continually monitors its equity method investments for factors indicating other-than-temporary impairment. The Company's proportionate share of the net income or loss of these entities is included in income from unconsolidated affiliates, net within the consolidated statements of operations. Dividends received from the investee reduce the carrying amount of the investment. Distributions from equity method investees are accounted for based on the cumulative earnings approach to determine whether they represent a return of investment, or a return on investment.
Variable Interest Entities	Variable Interest Entities The Company holds variable interests in multiple variable interest entities, which primarily procure or process inventory on behalf of the Company or are securitization entities. These variable interests relate to equity investments, receivables, guarantees, and securitized receivables. The Company is not the primary beneficiary of the majority of these entities as it does not have the power to direct the activities that most significantly impact the economic performance of the entities, due to the entities’ management and board of directors’ structure. As a result, the majority of these variable interest entities are not consolidated. Creditors of the Company’s variable interest entities do not have recourse against the general credit of the Company. The Company's investments in unconsolidated variable interest entities are classified as investments in unconsolidated affiliates in the consolidated balance sheets. The Company's receivables with variable interest entities are classified as notes receivable, related parties and accounts receivable, related parties. See " Note 25. Related Party Transactions " for additional information. The Company's maximum exposure to loss in these variable interest entities is represented by the investments, receivables, guarantees, and the deferred purchase price on the sale of securitized receivables.
Use of Estimates	Use of Estimates The preparation of these consolidated financial statements in conformity with U.S. GAAP requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements. These estimates and assumptions also affect the reported amounts of revenues and expenses during the reporting period. Actual results may differ from the Company's estimates and assumptions. Estimates are used in accounting for, among other things, revenue recognition, pension and postretirement health care benefits, inventory reserves, credit loss reserves, bank loan guarantees to suppliers and unconsolidated subsidiaries, advances to suppliers reserves, useful lives for depreciation and amortization, future cash flows associated with impairment testing for long-lived assets, deferred tax assets an d uncertain income tax positions, intrastate tax credits in Brazil, fair value determinations of financial assets and liabilities, including derivatives, securitized beneficial interests, and counterparty risk.
Reclassifications	Reclassifications Certain prior-period amounts were reclassified to conform to the current-year presentation in the consolidated statements of cash flows. Certain prior-period amounts were reclassified to conform to the current-year presentation in the reconciliation between income tax expense based on income before income taxes, equity in net income of investee companies, and minority interests and the amount computed by applying the U.S. statutory federal income tax rate to income. Certain prior-period amounts were reclassified to conform to the current-year presentation of deferred tax assets (liabilities). See " Note 6. Income Taxes " for additional information.
Segment Information	Segment Information During the year ended March 31, 2022, the Company reevaluated its operating and reportable segments under ASC Topic 280 - Segment Reporting . Based on our reevaluation, the Company concluded that the economic characteristics of our five Leaf region operations in North America, South America, Europe, Asia, and Africa were similar. Each geographic region derives its revenues mainly from shipping processed tobacco to manufacturers of cigarettes and other consumer tobacco products around the world, with a smaller percentage of revenue in each region being derived from performing third-party tobacco processing services. The three product category operating segments other than Leaf do not individually or in the aggregate meet the quantitative and qualitative thresholds to be individually reportable and have been combined and reported in an "All Other" category. The one Leaf reportable segment is consistent with information used by the chief operating decision maker to assess performance, make operating decisions, and allocate resources. The Company evaluates the operating performance of its one segment based upon information included in management reports. Corporate general expenses are allocated to the segments based upon segment selling, general, and administrative expenses. As a result of this reevaluation, effective during the fourth quarter of the year ended March 31, 2022, the Company has eight operating segments organized by geographic area and product category that are aggregated into one reportable segment for financial reporting purposes: Leaf. The All Other category is included for purposes of reconciliation of respective balances for the Leaf segment to the consolidated financial statements.
Revenue Recognition	Revenue Recognition The Company's revenue consists primarily of the sale of processed tobacco and fees charged for processing and related services to the manufacturers of tobacco products. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer. The Company’s performance obligations are satisfied when the transfer of control of the distinct product or service to the customer occurs. For products, control is transferred and revenue is recognized at a point in time, in accordance with the shipping terms of the contract. For services, control is transferred and revenue is recognized over time using the input method based on a kilogram of packed tobacco. A kilogram of processed tobacco (or tobacco processing services resulting in a kilogram of processed tobacco) is the only material and distinct performance obligation for the Company’s tobacco revenue streams. Consideration is attributed to the performance of this obligation. The Company does not disclose information related to its unsatisfied performance obligations with an expected duration of one year or less. Revenue is measured as the amount of consideration to which the Company expects to be entitled to receive in exchange for transferring goods or providing services. Contract costs primarily include labor, material, shipping and handling, and overhead expenses. Contract Balances The Company generally records a receivable when revenue is recognized as the timing of revenue recognition may differ from the timing of payment from customers. Payment terms and conditions vary by contract, although terms generally include a requirement of payment within 30 to 60 days. The Company's trade receivables do not bear interest, and they are recorded at the invoiced amount less an estimated allowance for expected credit losses. In addition to estimating an allowance based on specific identification of certain receivables that have a higher probability of not being paid, the Company also records an estimate for expected credit losses for the remaining receivables in the aggregate using a loss-rate method that considers historical bad debts, age of customer receivable balances, and current customer receivable balances. Additionally, the Company considers future reasonable and supportable forecasts of economic conditions to adjust historical loss rate percentages, as necessary. Balances are written-off when determined to be uncollectible. T he provision for expected credit losses is recorded in selling, general, and administrative expenses in the consolidated statements of operations. Significant Judgments The Company identified two main forms of variable consideration in its contracts with customers: warehousing fees for storing customer-controlled tobacco until the customer requests shipment and claims resulting from tobacco that does not meet customer specifications. Warehousing fees are either included in the price of tobacco based on the customers' best estimate of the date they will request shipment or separately charged using a per-day storage rate. When the Company enters into a contract with a customer, the price communicated is the amount of consideration the Company expects to receive. Price adjustments for tobacco not meeting customer specifications for shrinkage, improper blend, or chemical makeup, etc. are handled through a claims allowance that is assessed quarterly. Since the Company has a large number of customer contracts with similar characteristics, the volume of tobacco sold each year is substantial, and the Company has historical data related to claims, the Company is able to estimate the amount of expected claims using the expected value method. Taxes Collected from Customers Certain subsidiaries are subject to value-added taxes on local sales. Value-added taxes on local sales are recorded in sales and other operating revenues and cost of goods and services sold in the consolidated statements of operations. Shipping and Handling The Company elected to account for shipping and handling as activities to fulfill its performance obligations, regardless of when control transfers. Shipping and handling fees that are billed to customers are recognized in sales and other operating
Income Taxes	Income Taxes Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities reflect the expected future tax consequences of events that are recognized in the consolidated financial statements in different periods than they are recognized for tax purposes. Deferred tax assets and liabilities are established using enacted tax rates in effect for the year in which these items are expected to reverse. The realization of deferred tax assets is dependent on generating sufficient taxable income in the appropriate jurisdiction prior to the expiration of the carryforward periods. Deferred tax assets are reduced by a valuation allowance if it is more likely than not that some portion, or all, of the deferred tax assets will not be realized. When assessing the need for a valuation allowance, the Company considers carryback potential, historical earnings, future reversals of existing taxable temporary differences (including liabilities for unrecognized tax benefits), forecasted operating profits and tax planning strategies. The Company’s provision for income taxes is based on pre-tax income, statutory tax rates, and tax planning opportunities available in the various jurisdictions in which it operates. Tax laws are complex and subject to different interpretations by the taxpayer and respective governmental taxing authorities. The Company recognizes tax benefits from uncertainties if it believes it is more-likely-than-not it will be sustained based on the technical merits. Penalties and interest related to income taxes, if incurred, are included in income tax expense.
Cash and Cash Equivalents	Cash and Cash EquivalentsCash and cash equivalents include cash in banks and highly liquid investments with original maturities of three months or less and are stated at cost, which approximates fair value.
Inventories, Net	Inventories, Net Costs in inventory include processed tobacco inventory, unprocessed tobacco inventory, and other inventory. Costs of unprocessed tobacco inventories are determined by the average cost method, which include the cost of green tobacco. Costs of processed tobacco inventories are determined by the average cost method, which include both the cost of unprocessed tobacco, as well as direct and indirect costs related to processing the product. Costs of other inventory are determined by the first-in, first-out method, which include costs of packing materials, non-tobacco agricultural products, and agricultural supplies including seed, fertilizer, herbicides, and pesticides. Inventories are carried at the lower of cost or net realizable value ("LCM"). The Company evaluates its inventories for LCM adjustments by country and type of inventory. Processed tobacco and unprocessed tobacco are evaluated separately for LCM purposes. The Company compares the cost of its processed tobacco to net realizable value based on the estimated selling price of similar grades when evaluating those balances for LCM adjustments. The Company also considers whether its processed tobacco is committed to a customer, whereby the expected sales price is utilized in determining the net realizable value for committed tobacco. In addition, the Company writes-down inventory balances for estimates of obsolescence. LCM and obsolescence inventory write-downs are recorded in cost of goods and services sold within the consolidated statements of operations.
Advances to Tobacco Suppliers, Net	Advances to Tobacco Suppliers, Net The Company purchases seeds, fertilizer, pesticides, and other products related to growing tobacco and advances them to tobacco suppliers to assist in crop production. These seasonal advances are short term, represent prepaid inventory, and are recorded as advances to tobacco suppliers. Upon delivery of tobacco, part of the purchase price to the supplier is paid in cash and part through a reduction of the advance balance. The advances applied to the delivery are reclassified from advances to unprocessed inventory. The Company also has noncurrent advances, which generally represent the cost of advances to tobacco suppliers for infrastructure, such as curing barns, recovered through the delivery of tobacco to the Company by the tobacco suppliers. Tobacco suppliers may not be able to settle the entire amount of advances due in a given year. In these situations, the Company may allow the farmers to deliver tobacco over future crop years to recover its advances. Noncurrent advances to tobacco suppliers are recorded in other noncurrent assets in the consolidated balance sheets. The Company accounts for its advances to tobacco suppliers using a cost accumulation model, which reports advances at the lower of cost or recoverable amounts exclusive of the mark-up and interest. The mark-up and interest on its advances are recognized upon delivery of tobacco as a decrease in the cost of the current crop. Unrecovered advances are recorded in cost of goods and services sold in the consolidated statements of operations for abnormal yield adjustments or unrecovered advances from prior crops. Normal yield adjustments are capitalized into the cost of the current crop and are recorded in cost of goods and services sold as that crop is sold.
Goodwill and Other Intangible Assets	Goodwill and Other Intangible Assets Goodwill is allocated to each reporting unit. A reporting unit is an operating segment, or one level below an operating segment, referred to as a component. The components within the Company’s operating segments are aggregated into eight reporting units due to their similar economic characteristics. Goodwill is not subject to amortization and is tested for impairment annually, on the first day of the fourth quarter of the fiscal year, or whenever events and circumstances indicate that impairment may have occurred. The Company's annual goodwill impairment test performed for the year ended March 31, 2022 resulted in goodwill being fully impaired. See " Note 13. Goodwill and Other Intangibles, Net " for additional information. The Company utilizes a qualitative assessment to evaluate whether it is more likely than not that the estimated fair value of a reporting unit is less than its carrying value. If the Company's qualitative assessment indicates that it is more likely than not that the estimated fair value of a reporting unit exceeds its carrying value, no further analysis is performed. Otherwise, the Company performs a quantitative assessment using the discounted cash flow ("DCF") method of the income approach. The future cash flows of the Company’s reporting units are projected based on estimates of future revenues, gross margins, operating income, excess net working capital, capital expenditures, and other factors. The Company utilizes estimated revenue growth rates and cash flow projections. The discount rates utilized in the DCF method are based on a weighted-average cost of capital determined from relevant market comparisons and adjusted for specific reporting unit risks, country risk premiums, and capital structure. A terminal value estimated growth rate is applied to the final year of the projected period and reflects the Company’s estimate of perpetual growth. The Company then calculates a present value of the respective cash flows for each reporting unit to arrive at an estimate of fair value under the income approach. The Company has intangible assets with definite useful lives. These intangible assets are assessed annually and tested for impairment whenever factors indicate that the carrying amount may not be recoverable. The trade name, customer relationship, and technology intangibles are amortized on a straight-line basis over fourteen nine three
Leases	Leases The Company has operating leases for land, buildings, automobiles, and other equipment that expire at various dates through 2040. The Company does not have material finance leases. Leases for real estate generally have initial terms ranging from 2 to 15 years, excluding renewal options. Leases for equipment generally have initial terms ranging from 2 to 5 years excluding renewal options. Most leases have fixed rentals, with many of the real estate leases requiring additional payments for real estate taxes. These lease terms may include optional renewals, terminations or purchases, which are considered in the Company’s assessments when such options are reasonably certain to be exercised. The Company measures right-of-use assets and related lease liabilities based on the present value of remaining lease payments, including in-substance fixed payments, the current payment amount when payments depend on an index or rate (e.g., inflation adjustments, market renewals), and the amount the Company believes is probable to be paid to the lessor under residual value guarantees, when applicable. Lease contracts may include fixed payments for non-lease components, such as maintenance, which are included in the measurement of lease liabilities for certain asset classes based on the Company’s election to combine lease and non-lease components. The Company does not recognize short-term leases, those lease contracts with durations of twelve months or less, in the consolidated balance sheets.
Property, Plant, and Equipment, Net	Property, Plant, and Equipment, Net Property, plant, and equipment is stated at cost and depreciated using the straight-line method over the estimated useful lives of the assets. Buildings are depreciated over a range of nine two ther expense, net in the consolidated statements of operations. Long-lived assets are tested for recoverability whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. The evaluation is performed at the lowest level of identifiable cash flows at which the asset could be bought or sold in a current transaction between willing parties and may be estimated using a number of techniques, including
Guarantees	Guarantees The Company's guarantees are primarily related to bank loans to suppliers for crop production financing. The Company guarantees bank loans of certain unconsolidated subsidiaries in Asia and South America. Under longer-term arrangements, the Company may guarantee financing on suppliers’ construction of curing barns or other tobacco production assets. Guaranteed loans are generally repaid concurrent with the delivery of tobacco to the Company. The Company is obligated to repay guaranteed loans should the supplier default. If default occurs, the Company has recourse against its various suppliers and their production assets. The fair value of the Company's guarantees are recorded in accrued expenses and other current liabilities in the consolidated balance sheets and included in crop costs, except for the joint venture in Brazil, which are included in other receivables.
Derivative Financial Instruments	Derivative Financial Instruments The Company uses forward or option currency contracts to manage risks associated with foreign currency exchange rates on foreign operations. These contracts are for green tobacco purchases, processing costs, and selling, general, and administrative expenses. The Company does not hold derivatives contracts for speculative or trading purposes. Derivative financial instruments are recorded in other current assets and other current liabilities in the consolidated balance sheets and are measured at fair value. Changes in fair value are recognized in earnings, unless the derivative is designated and qualifies to be in a hedge accounting relationship. For derivatives designated in a hedge accounting relationship, the Company evaluates hedge effectiveness at inception and on an ongoing basis. If a hedge relationship is no longer expected to be effective, the derivative in that relationship is de-designated and hedge accounting is discontinued. Changes in fair value of foreign currency derivatives designated in cash flow hedging relationships are recorded in accumulated other comprehensive income in the consolidated balance sheets and reclassified to earnings when the hedged item affects earnings. Cash flows from derivatives are classified in the consolidated statements of cash flows in the same category as the cash flows from the underlying hedged items. The Company has elected not to offset fair value amounts recognized for derivative instruments with the same counterparty under a master netting agreement.
Pension and Other Postretirement Benefits	Pension and Other Postretirement Benefits Retirement Benefits The Company maintains various excess benefit and supplemental plans that provide additional benefits to certain individuals in key positions and individuals whose compensation and the resulting benefits that would have actually been paid are limited by regulations imposed by the Internal Revenue Code. In addition, a Supplemental Retirement Account Plan defined contribution plan is maintained. Additional non-U.S. plans sponsored by certain subsidiaries cover certain of the full-time employees located in Germany, Turkey, and the United Kingdom. Postretirement Health and Life Insurance Benefits The Company provides certain health and life insurance benefits to retired U.S. employees (and their eligible dependents) who meet specified age and service requirements. The plan excludes new employees after September 2005 and caps the Company’s annual cost commitment to postretirement benefits for retirees. The Company retains the right, subject to existing agreements, to modify or eliminate these postretirement health and life insurance benefits in the future. The Company provides certain health and life insurance benefits to retired Brazilian directors and certain retirees located in Europe including their eligible dependents who meet specified requirements. Plan Assets The Company's policy is to contribute amounts to the plans sufficient to meet or exceed funding requirements of local governmental rules and regulations. The Company's investment objectives for plan assets are to generate consistent total investment return to pay anticipated plan benefits, while minimizing long-term costs and portfolio volatility. The financial objectives underlying this policy include maintaining plan contributions at a reasonable level relative to benefits provided and assuring unfunded obligations do not grow to a level that would adversely affect the Company's financial health. Portfolio performance is measured against investment objectives and objective benchmarks, including but not limited to: FTSE 90 Day Treasury Bill, Bloomberg Intermediate Govt/Credit, Bloomberg Aggregate, Russell 1000 Value, Russell 1000 Growth, Russell 2500 Value, Russell 2500 Growth, MSCI EAFE, HFR Absolute Return, and HFR Equity Hedge. The portfolio objective is to exceed the actuarial return on assets assumption. The Company is exploring partial risk transfer and or full plan terminations. Management and the plan's consultant regularly review portfolio allocations and periodically rebalance the portfolio to the targeted allocations according to the guidelines set forth in the Company's investment policy. Equity securities do not include the Company's common stock. The Company's diversification and risk control processes serve to minimize the concentration and experience of risk. There are no significant concentrations of risk, in terms of sector, industry, geography, or individual company or companies. The Company’s plan assets primarily consist of cash and cash equivalents, equity and fixed income funds, real estate investments, and diversified investments. Plan assets are measured at fair value annually on March 31, the measurement date. The following are descriptions, valuation methodologies, and inputs used to determine the fair value of each major category of plan assets: • Cash and cash equivalents include short-term investment funds, primarily in diversified portfolios of investment grade money market instruments that are valued using quoted market prices or other valuation methods, and classified within Level 1 or Level 2 of the fair value hierarchy. • Investments in equity and fixed income mutual funds are publicly traded and valued primarily using quoted market prices and generally classified within Level 1 in the fair value hierarchy. Investments in commingled funds used in certain non-U.S. pension plans are not publicly traded, but the underlying assets held in these funds are traded in active markets and the prices for these assets are readily observable. Holdings in these commingled funds are generally classified as Level 2 investments. • Real estate investments include those in private limited partnerships that invest in various domestic and international commercial and residential real estate projects and publicly traded REIT securities. The fair values of private real estate assets are typically determined by using income and/or cost approaches or comparable sales approach, taking into consideration discount and capitalization rates, financial conditions, local market conditions, and the status of the capital markets, and are generally classified within Level 3 in the fair value hierarchy. Publicly traded REIT securities are valued primarily using quoted market prices and are generally classified within Level 1 in the fair value hierarchy. • Diversified investments include mutual funds with an absolute return strategy. Mutual fund investments with absolute return strategies are publicly traded and valued using quoted market prices and are generally classified within Level 1 in the fair value hierarchy.
Foreign Currency Translation and Remeasurement	Foreign Currency Translation and Remeasurement The Company translates assets and liabilities of its foreign subsidiaries from their respective functional currencies to USD using exchange rates in effect at period end. The Company's results of operations and its cash flows are translated using average exchange rates for each reporting period. Resulting currency translation adjustments are reflected as a separate component of accumulated other comprehensive income in the consolidated balance sheets. The financial statements of foreign subsidiaries, for which the USD is the functional currency and which have certain transactions denominated in a local currency, are remeasured into USD. The remeasurement of local currencies into USD results in remeasurement adjustments that are included in net income. Exchange gains (losses) from remeasurement are recorded in cost of goods and services sold and o ther expense, net within the consolidated statements of operations.
Securitized Receivables	Securitized Receivables The Company sells trade receivables to unaffiliated financial institutions under multiple accounts receivable securitization facilities. Under the facilities, the receivables sold for cash are removed from the consolidated balance sheets. Under some of the facilities, a portion of the purchase price for the receivables is paid by the unaffiliated financial institutions in cash and the balance is a deferred purchase price receivable, which is paid as payments on the receivables are collected from account debtors. The net cash proceeds received by the Company in cash at the time of sale (cash purchase price) are disclosed as an operating activity in the statements of consolidated cash flows. The deferred purchase price receivable represents a continuing involvement and a beneficial interest in the transferred financial assets and is recognized at fair value as part of the sale transaction. The deferred purchase price receivables are included in trade and other receivables, net in the consolidated balance sheets and are valued using unobservable inputs (i.e., Level three inputs), primarily discounted cash flow. The net cash proceeds received by the Company as deferred purchase price are disclosed as an investing activity in the consolidated statements of cash flows. Additionally, beneficial interests received for transferring trade receivables in a securitization transaction are disclosed as a noncash investing activity in the consolidated statements of cash flows. The difference between the carrying amount of the receivables sold under these facilities and the sum of the cash and fair value of the other assets received at the time of transfer is recognized as a loss on sale of the related receivables and recorded in o ther expense, net in the consolidated statements of operations. Program costs are recorded in o ther expense, net
Stock-Based Compensation	Stock-Based Compensation The Company’s Board of Directors adopted the 2020 Incentive Plan (the "2020 Plan") on November 18, 2020. The 2020 Plan provides the Company the flexibility to grant a variety of stock-based awards including stock options, stock appreciation rights, restricted stock awards, restricted stock unit awards, performance share awards, and incentive awards to its officers, directors, and employees. For stock-based awards without performance conditions, the Company recognizes stock-based compensation cost on a straight-line basis over the vesting period of the award. For stock-based awards with performance conditions, the Company recognizes stock-based compensation cost using the accelerated attribution method over the requisite service period when the Company determines it is probable that the performance condition will be satisfied. The Company estimates forfeitures of stock-based awards using historical experience. Stock-based compensation expense, if any, is included in selling, general, and administrative expenses in the consolidated statements of operations.
Recently Adopted Accounting Pronouncements	Recently Adopted Accounting Pronouncements In December 2019, the FASB issued Accounting Standards Update ("ASU") No. 2019-12, Simplifying the Accounting for Income Taxes . ASU 2019-12 eliminates certain exceptions related to the approach for intra-period tax allocations, the methodology for calculating income taxes during interim periods when there are changes in tax laws or when year-to-date losses exceed anticipated losses, and the recognition of deferred tax liabilities for outside basis differences in foreign investments. This guidance also simplifies aspects of the accounting for franchise taxes that are partially based on income, separate financial statements of legal entities not subject to tax, and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The guidance became effective for the Company on April 1, 2021. The adoption of this new accounting standard did not have a material impact on the Company's financial condition, results of operations, cash flows, or disclosures. In November 2021, the FASB issued ASU No. 2021-10, Disclosures by Business Entities about Government Assistance . This ASU created ASC Topic 832, Government Assistance , and requires certain information be disclosed regarding assistance received from a government entity when either a grant or contribution accounting model is applied. The new disclosures are required for annual periods for transactions with a government entity that are within the scope of the Topic. The guidance became effective for the Company on April 1, 2022. The adoption of this new accounting standard did not have a material impact on the Company's disclosures for the fiscal year ended March 31, 2023.

Revenue Recognition (Tables)

Revenue Recognition (Tables)	12 Months Ended
Revenue Recognition (Tables)	Mar. 31, 2023
Revenue from Contract with Customer [Abstract]
Schedule of Revenue Disaggregated by Major Source	The following disaggregates sales and other operating revenues by major source, with the All Other category being included for purposes of reconciliation of the respective balances below of the Leaf segment (the Company's sole reportable segment) to the consolidated financial statements : Year Ended March 31, 2023 Year Ended March 31, 2022 Leaf: Product revenue $ 1,812,170 $ 1,531,805 Processing and other revenues 88,388 95,433 Total sales and other operating revenues 1,900,558 1,627,238 All Other: Total sales and other operating revenues 14,323 12,624 Total sales and other operating revenues $ 1,914,881 $ 1,639,862
Schedule of Activity in the Claims Allowance	The following summarizes activity in the claims allowance: Year Ended March 31, 2023 Year Ended March 31, 2022 Balance, beginning of period $ 1,130 $ 1,830 Additions 4,680 1,586 Payments (3,460) (2,286) Balance, end of period $ 2,350 $ 1,130
Schedule of Allowance for Doubtful Accounts and Activity of Claims Allowances	The following summarizes activity in the allowance for expected credit losses: Year Ended March 31, 2023 Year Ended March 31, 2022 Balance, beginning of period $ (24,541) $ (20,900) Additions (2,316) (4,212) Write-offs 2,127 571 Balance, end of period (24,730) (24,541) Trade receivables 210,081 272,218 Trade receivables, net $ 185,351 $ 247,677

Other Expense, Net (Tables)

Other Expense, Net (Tables)	12 Months Ended
Other Expense, Net (Tables)	Mar. 31, 2023
Other Income and Expenses [Abstract]
Schedule of Other (Expense) Income, Net	The following summarizes the significant components of other expense, net: Year Ended March 31, 2023 Year Ended March 31, 2022 Losses on sale of receivables (1) $ (10,434) $ (5,833) Foreign currency gains (losses) 1,057 (2,776) Note receivable write-off (2,050) — Gain on sale of fixed assets 1,389 3,818 Miscellaneous (expense) income, net (985) 1,689 Total $ (11,023) $ (3,102) (1) See " Note 17. Securitized Receivables " for additional information.

Restructuring and Asset Impai_2

Restructuring and Asset Impairment Charges (Tables)	12 Months Ended
Restructuring and Asset Impairment Charges (Tables)	Mar. 31, 2023
Restructuring and Related Activities [Abstract]
Schedule of Restructuring and Asset Impairment Charges	The following summarizes the Company's restructuring and asset impairment charges: Year Ended March 31, 2023 Year Ended March 31, 2022 Employee separation charges $ 650 $ 2,292 Asset impairment and other noncash charges 4,035 5,739 Total restructuring and asset impairment charges $ 4,685 $ 8,031

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
Income Taxes (Tables)	Mar. 31, 2023
Income Tax Disclosure [Abstract]
Schedule of Income Tax Contingencies	The following summarizes the changes to unrecognized tax benefits and related interest and penalties : Year Ended March 31, 2023 Year Ended March 31, 2022 Balance at April 1 $ 17,725 $ 18,358 Increase (decrease) for prior year tax positions 1,449 (660) Increase for current year tax positions 634 — Reduction for settlements (3,480) — Impact of changes in exchange rates (243) 27 Balance at March 31 (1) $ 16,085 $ 17,725 Accrued interest 1,753 1,777 Accrued penalties 1,447 831 Balance at March 31 (1) $ 19,285 $ 20,333 (1) As of March 31, 2023, $11,177 would impact the Company's effective tax rate, if recognized.
Schedule of Income before Income Tax, Domestic and Foreign	The components of (loss) income before income taxes and other items consisted of the following: Year Ended March 31, 2023 Year Ended March 31, 2022 U.S. $ (43,874) $ (68,489) Non-U.S. 21,252 (10,875) Total $ (22,622) $ (79,364)
Schedule of Components of Income Tax Expense (Benefit)	The details of the amount shown for income taxes in the consolidated statements of operations are as follows: Year Ended March 31, 2023 Year Ended March 31, 2022 Current: Federal (1) $ 16,353 $ 12 State 337 — Non-U.S. 17,593 16,515 Total Current 34,283 16,527 Deferred: Federal (592) (243) State 2 — Non-U.S. 434 (3,644) Total Deferred (156) (3,887) Income tax expense $ 34,127 $ 12,640 (1) Primarily due to the Debt Exchange Transactions (as defined below). Refer to " Note 16. Debt Arrangements " for further details regarding the Debt Exchange Transactions.
Schedule of Effective Income Tax Rate Reconciliation	The difference between income tax expense based on (loss) income before income taxes and other items and the amount computed by applying the U.S. statutory federal income tax rate to income are as follows: Year Ended March 31, 2023 Year Ended March 31, 2022 Tax benefit at U.S. statutory rate $ (4,750) $ (16,666) Effect of non-U.S. income taxes (3,418) (961) U.S. taxes on non-U.S. earnings 6,389 205 Increase (decrease) in reserves for uncertain tax positions 2,397 (315) Withholding tax expense 3,058 1,488 Tax credits (3,853) (1,150) Tax incentives (2,280) — Nondeductible interest 2,559 2,610 Waived intercompany interest expense — 3,960 Exchange effects and currency translation 3,101 4,344 Goodwill impairment — 7,148 Change in valuation allowance (1) 30,412 8,053 Other, net 512 3,924 Income tax expense $ 34,127 $ 12,640 (1) The change in valuation allowance, which is presented without exchange effects and currency translation, for the year ended March 31, 2023 was primarily driven by $20,823 of deferred tax assets generated by the Debt Exchange Transactions for which the Company is not likely to realize a future benefit. Refer to " Note 16. Debt Arrangements " for further details regarding the Debt Exchange Transactions.
Schedule of Deferred Tax Assets and Liabilities	The following summarizes deferred tax assets (liabilities): March 31, 2023 March 31, 2022 Deferred tax assets: Non-deductible interest carryforward $ 24,331 $ 23,074 Original issue discount (1) 20,326 — Reserves and accruals 25,734 21,896 Tax loss carryforwards 15,886 13,728 Other 5,686 9,573 Gross deferred tax assets 91,963 68,271 Valuation allowance (1) (59,506) (32,641) Total deferred tax assets $ 32,457 $ 35,630 Deferred tax liabilities: Unremitted earnings of foreign subsidiaries $ (29,045) $ (27,918) Derivative transactions (1,318) (2,790) Intangible assets (1,884) (2,776) Other (3,448) (7,318) Total deferred tax liabilities $ (35,695) $ (40,802) Net deferred tax liability $ (3,238) $ (5,172) (1) The increase in valuation allowance as of March 31, 2023 was primarily driven by $20,823 of deferred tax assets generated by the Debt Exchange Transactions for which the Company is not likely to realize a future benefit. Refer to " Note 16. Debt Arrangements " for further details regarding the Debt Exchange Transactions.
Schedule of Current and Non Current Tax Assets and Liabilities	The following summarizes the breakdown between deferred tax assets (liabilities): March 31, 2023 March 31, 2022 Noncurrent asset $ 6,662 $ 6,498 Noncurrent liability (9,900) (11,670) Net deferred tax liability $ (3,238) $ (5,172)
Schedule of Changes in Valuation Allowance for Deferred Tax Assets	The following summarizes the change in the valuation allowance for deferred tax assets: Balance at March 31, 2021 $ 25,273 Changes to expenses 8,624 Changes to other comprehensive income (1,256) Balance at March 31, 2022 32,641 Changes to expenses (1) 27,598 Changes to other comprehensive income (733) Balance at March 31, 2023 $ 59,506 (1) The increase in valuation allowance as of March 31, 2023 was primarily driven by $20,823 of deferred tax assets generated by the Debt Exchange Transactions for which the Company is not likely to realize a future benefit. Refer to " Note 16. Debt Arrangements " for further details regarding the Debt Exchange Transactions.
Schedule of Operating Loss Carryforwards	The following summarizes the gross amount and expiration dates of our operating loss carryforwards at March 31, 2023: Expiration Date Amounts Non-U.S. net operating loss and tax credit carryforwards 2024-2028 $ 20,927 Non-U.S. net operating loss and tax credit carryforwards Thereafter 5,170 Non-U.S. net operating loss and tax credit carryforwards Indefinite 31,899 Total $ 57,996

Loss Per Share (Tables)

Loss Per Share (Tables)	12 Months Ended
Loss Per Share (Tables)	Mar. 31, 2023
Earnings Per Share [Abstract]
Schedule of Basic and Diluted (Loss) Earnings Per Share	The following summarizes the computation of loss per share: Year Ended March 31, 2023 Year Ended March 31, 2022 Basic and diluted loss per share: Net loss attributable to Pyxus International, Inc. $ (39,141) $ (82,119) Shares: Weighted Average Number of Shares Outstanding 25,000 25,000 Basic and diluted loss per share $ (1.57) $ (3.28)

Inventories, Net (Tables)

Inventories, Net (Tables)	12 Months Ended
Inventories, Net (Tables)	Mar. 31, 2023
Inventory Disclosure [Abstract]
Schedule of Inventories, Net	The following summarizes the composition of inventories, net, with the All Other category being included for purposes of reconciliation of the respective balances below of the Leaf segment to the consolidated financial statements : March 31, 2023 March 31, 2022 Processed tobacco $ 498,398 $ 517,613 Unprocessed tobacco 231,651 193,406 Other tobacco related 39,670 29,694 All Other 5,352 8,714 Total $ 775,071 $ 749,427

Advances to Suppliers, Net (Tab

Advances to Suppliers, Net (Tables)	12 Months Ended
Advances to Suppliers, Net (Tables)	Mar. 31, 2023
Revenue from Contract with Customer [Abstract]
Schedule of Advances to Tobacco Suppliers	The following summarizes the composition of advances to suppliers, net: March 31, 2023 March 31, 2022 Advances to tobacco suppliers, net $ 38,111 $ 46,705 Advances to non-tobacco suppliers 4,194 2,227 Total in current assets 42,305 48,932 Long-term advances to tobacco suppliers, net (1) 1,564 428 Total current and long-term $ 43,869 $ 49,360 (1) Classified as other noncurrent assets in the consolidated balance sheets.

Equity Method Investments (Tabl

Equity Method Investments (Tables)	12 Months Ended
Equity Method Investments (Tables)	Mar. 31, 2023
Equity Method Investments and Joint Ventures [Abstract]
Schedule of Equity Method Investments	The following summarizes the Company's equity method investments as of March 31, 2023: Investee Name Location Primary Purpose The Company's Ownership Percentage Basis Difference (1) Adams International Ltd. Thailand purchase and process tobacco 49 % $ (4,526) Alliance One Industries India Private Ltd. India purchase and process tobacco 49 % (5,770) China Brasil Tobacos Exportadora SA Brazil purchase and process tobacco 49 % 44,199 Oryantal Tutun Paketleme Turkey process tobacco 50 % (416) Purilum, LLC U.S. produce flavor formulations and consumable e-liquids 50 % 4,589 Siam Tobacco Export Company Thailand purchase and process tobacco 49 % (6,098) (1) Basis differences for the Company's equity method investments were primarily due to fair value adjustments recorded during the year ended March 31, 2021. The following summarizes aggregate financial information for these equity method investments: Operations statement: Year Ended March 31, 2023 Year Ended March 31, 2022 Sales $ 489,532 $ 292,777 Gross profit 76,206 56,752 Net income 40,447 22,729 Company's dividends received 12,677 9,671 Balance sheet: March 31, 2023 March 31, 2022 Current assets $ 419,229 $ 375,015 Property, plant, and equipment and other assets 48,174 42,841 Current liabilities 323,899 289,816 Long-term obligations and other liabilities 3,887 2,999

Variable Interest Entities (Tab

Variable Interest Entities (Tables)	12 Months Ended
Variable Interest Entities (Tables)	Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Variable Interest Entities	The following summarizes the Company's financial relationships with its unconsolidated variable interest entities: March 31, 2023 March 31, 2022 Investments in variable interest entities $ 93,754 $ 88,118 Receivables with variable interest entities 2,617 2,211 Guaranteed amounts to variable interest entities (not to exceed) 68,265 55,884

Goodwill and Other Intangible_2

Goodwill and Other Intangible Assets, Net (Tables)	12 Months Ended
Goodwill and Other Intangible Assets, Net (Tables)	Mar. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill and Intangible Asset Rollforward	The following summarizes the changes in the Company's goodwill and other intangible assets, net: Year Ended March 31, 2023 Weighted Average Remaining Useful Life Beginning Carrying Amount, Net Amortization Expense Ending Intangible Assets, Net Intangibles subject to amortization: Customer relationships 9.4 years $ 23,568 $ (3,086) $ 20,482 Technology 5.2 years 11,471 (2,596) 8,875 Trade names 11.4 years 10,022 (807) 9,215 Total $ 45,061 $ (6,489) $ 38,572 Year Ended March 31, 2022 Weighted Average Remaining Useful Life Beginning Carrying Amount, Net Additions Amortization Expense Disposition of Humble Juice (1) Impairment (2) Ending Intangible Assets, Net Intangibles subject to amortization: Customer relationships 10.3 years $ 27,730 $ — $ (2,427) $ (1,735) $ — $ 23,568 Technology 5.8 years 12,858 840 (2,227) — — 11,471 Trade names 12.4 years 10,829 — (807) — — 10,022 Intangibles not subject to amortization: Goodwill 36,853 — — (4,667) (32,186) — Total $ 88,270 $ 840 $ (5,461) $ (6,402) $ (32,186) $ 45,061 (1) See " Note 10. Acquisitions and Dispositions " for additional information. (2) $372 of the impairment occurred during the three-month period ended December 31, 2021. The remaining $31,814 of impairment occurred during the three-month period ended March 31, 2022.
Schedule of Impairment Charges to Goodwill	The excess of carrying value over fair value for each reporting unit exceeded the amount of goodwill that was allocated to the reporting unit, leading the Company to record a full impairment of goodwill at each reporting unit as follows: Year Ended March 31, 2022 Leaf - Africa $ 8,341 Leaf - Asia 6,311 Leaf - Europe 5,566 Leaf - North America 3,901 Leaf - South America 5,730 E-liquids 1,965 Total $ 31,814
Schedule of Estimated Intangible Asset Amortization Expense	The following summarizes the estimated intangible asset amortization expense for the next five years and beyond: For Fiscal Years Ended Customer Relationships Technology (1) Trade Names Total 2024 $ 2,175 $ 1,659 $ 807 $ 4,641 2025 2,175 1,585 807 4,567 2026 2,175 1,465 807 4,447 2027 2,175 1,490 807 4,472 2028 2,175 1,543 807 4,525 Thereafter 9,607 1,133 5,180 15,920 Total $ 20,482 $ 8,875 $ 9,215 $ 38,572 (1) Estimated amortization expense for technology is based on costs accumulated as of March 31, 2023. These estimates will change as new costs are incurred and until the software is placed into service.

Leases (Tables)

Leases (Tables)	12 Months Ended
Leases (Tables)	Mar. 31, 2023
Leases [Abstract]
Schedule of Lease Costs and Other Information	The following summarizes lease costs for operating leases: Year Ended March 31, 2023 Year Ended March 31, 2022 Operating lease costs $ 14,203 $ 14,752 Variable and short-term lease costs 8,023 7,991 Total lease costs $ 22,226 $ 22,743 The following summarizes supplemental cash flow information related to operating leases: Year Ended March 31, 2023 Year Ended March 31, 2022 Cash paid for amounts included in the measurement of lease liabilities - operating cash flows used by operating leases $ 13,607 $ 13,677 Right-of-use assets obtained in exchange for new operating leases - noncash 9,967 7,054
Schedule of Weighted-Average Remaining Lease Term and Discount Rates of Leases	The following summarizes weighted average information associated with the measurement of remaining operating leases: March 31, 2023 March 31, 2022 Weighted average remaining lease term 5.9 years 6.2 years Weighted average discount rate 14.4% 12.8%
Schedule of Maturities of Operating Lease Liabilities	The following reconciles maturities of operating lease liabilities to the lease liabilities reflected in the consolidated balance sheets as of March 31, 2023: 2024 $ 13,014 2025 8,500 2026 6,771 2027 5,726 2028 4,373 Thereafter 13,798 Total future minimum lease payments 52,182 Less: amounts related to imputed interest 17,878 Present value of future minimum lease payments 34,304 Less: operating lease liabilities, current 8,723 Operating lease liabilities, non-current $ 25,581

Property, Plant, and Equipmen_2

Property, Plant, and Equipment, Net (Tables)	12 Months Ended
Property, Plant, and Equipment, Net (Tables)	Mar. 31, 2023
Property, Plant and Equipment [Abstract]
Schedule of Property, Plant and Equipment, Net	The following summarizes property, plant, and equipment, net: March 31, 2023 March 31, 2022 Land $ 31,132 $ 32,023 Buildings 43,911 43,465 Machinery and equipment 83,984 77,243 Total 159,027 152,731 Less: accumulated depreciation (1) (25,629) (15,210) Total property, plant, and equipment, net $ 133,398 $ 137,521 (1) This balance was partially reduced by the disposition of certain fully depreciated assets during the year ended March 31, 2023.
Schedule of Depreciation Expense of Property, Plant, and Equipment, Net	The following summarizes depreciation expense recorded in cost of goods and services sold and selling, general, and administrative expenses: Year Ended March 31, 2023 Year Ended March 31, 2022 Depreciation expense recorded in cost of goods and services sold $ 10,132 $ 8,908 Depreciation expense recorded in selling, general, and administrative expenses 2,346 2,272 Total depreciation $ 12,478 $ 11,180

Debt Arrangements (Tables)

Debt Arrangements (Tables)	12 Months Ended
Debt Arrangements (Tables)	Mar. 31, 2023
Debt Disclosure [Abstract]
Schedule of Debt Financing	The following table summarizes the Company’s debt financing as of the dates set forth below: Outstanding Interest March 31, 2023 March 31, 2022 Long Term Debt Repayment Schedule by Fiscal Year Rate 2024 2025 2026 2027 2028 Later Senior secured credit facilities: ABL Credit Facility 4.8 % (1) $ 25,000 $ 90,000 $ — $ — $ — $ 25,000 $ — $ — DDTL Term Loans (2) 11.2 % (1) — 107,832 — — — — — — Senior secured notes: 10.0% Notes due 2024 (3) 10.0 % (1) 19,931 270,762 — 19,931 — — — — 8.5% Notes due 2027 (4) 8.8 % (1) 253,483 — — — — — 253,483 — Senior secured term loans: Intabex Term Loans (5) 12.8 % (1) 186,194 — — — — — 186,194 — Pyxus Term Loans (6) 12.8 % (1) 133,393 — — — — — 133,393 — Exit Facility Loans (7) 10.9 % (1) — 219,500 — — — — — — Other debt: Other long-term debt 7.5 % (1) 504 239 75 — 429 — — — Notes payable to banks (8) 6.8 % (1) 382,544 378,612 382,544 — — — — — Total debt $ 1,001,049 $ 1,066,945 $ 382,619 $ 19,931 $ 429 $ 25,000 $ 573,070 $ — Short-term (8) $ 382,544 $ 378,612 Long-term: Current portion of long-term debt $ 75 $ 107,856 Long-term debt 618,430 580,477 $ 618,505 $ 688,333 Letters of credit $ 11,684 $ 9,038 (1) Weighted average rate for the twelve months ended March 31, 2023. As the 8.5% Notes due 2027, Intabex Term Loans, and the Pyxus Term Loans have not been outstanding for a trailing twelve-month period, the interest rate is the weighted average from inception through March 31, 2023. (2) The DDTL Term Loans were issued in the refinancing of the prior DDTL facility on July 28, 2022, which included a partial principal payment of $9,000 and an exit fee payment of $5,250. Subsequent to this refinancing, on February 6, 2023, the DDTL Term Loans were exchanged for $102,000 (inclusive of a $2,000 exit fee) of Intabex Term Loans. (3) On February 6, 2023, $260,452 of the 10.0% Notes due 2024 were exchanged for 8.5% Notes due 2027. The remaining 10.0% Notes due 2024 outstanding of $19,931 is net of a debt discount of $460. Total repayment at maturity is $20,391. (4) Balance of $253,483 is net of a debt discount of $6,969. Total repayment at maturity is $260,452. (5) Balance of $186,194 is net of a debt discount of $2,839. Total repayment at maturity is $189,033, which includes a $2,000 exit fee payable upon repayment (6) Balance of $133,393 is net of a debt premium of $2,844. Total repayment at maturity is $130,550. (7) On February 6, 2023, $189,033, representing 40.0%, of the Exit Facility Loans were exchanged for Intabex Term Loans, and $130,550, representing the remaining 60.0%, of the Exit Facility Loans were exchanged for Pyxus Term Loans. (8) Primarily foreign seasonal lines of credit.
Schedule of Debt Instrument Exit Fees	Loan Repayment Date Exit Fee On or before September 30, 2021 1.0% After September 30, 2021 and on or before December 31, 2021 2.5% After December 31, 2021 and on or before March 31, 2022 3.5% After March 31, 2022 5.0%

Securitized Receivables (Tables

Securitized Receivables (Tables)	12 Months Ended
Securitized Receivables (Tables)	Mar. 31, 2023
Transfers and Servicing [Abstract]
Schedule of Accounts Receivable Securitization Information	The following summarizes the Company's accounts receivable outstanding in the securitization facilities, which represents trade receivables sold into the program that have not been collected from the customer, and related beneficial interests, which represents the Company's residual interest in receivables sold that have not been collected from the customer: March 31, 2023 March 31, 2022 Receivables outstanding in facility $ 173,979 $ 131,092 Beneficial interest 19,522 28,072 Cash proceeds from the sale of trade receivables is comprised of a combination of cash and a deferred purchase price receivable. Deferred purchase price receivable is realized after the collection of the underlying trade receivables sold by the purchasers. The following summarizes the Company's cash purchase price and deferred purchase price: Year Ended March 31, 2023 Year Ended March 31, 2022 Cash proceeds for the period ended: Cash purchase price $ 696,404 $ 441,054 Deferred purchase price 165,262 189,440

Guarantees (Tables)

Guarantees (Tables)	12 Months Ended
Guarantees (Tables)	Mar. 31, 2023
Guarantees [Abstract]
Schedule of Guarantees and Associated Fair Values	The following summarizes amounts guaranteed and the fair value of those guarantees: March 31, 2023 March 31, 2022 Amounts guaranteed (not to exceed) $ 152,032 $ 114,208 Amounts outstanding under guarantee (1) 83,420 49,413 Fair value of guarantees 5,262 2,956 Amounts due to local banks on behalf of suppliers for government subsidized rural credit financing 12,529 15,781 (1) Most of the guarantees outstanding at March 31, 2023 expire within one year.

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	12 Months Ended
Fair Value Measurements (Tables)	Mar. 31, 2023
Fair Value Disclosures [Abstract]
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis	The following summarizes assets and liabilities measured at fair value on a recurring basis: March 31, 2023 March 31, 2022 Level 2 Level 3 Total Assets / Level 2 Level 3 Total Assets / Financial assets Derivative financial instruments $ 3,970 $ — $ 3,970 $ 9,867 $ — $ 9,867 Securitized beneficial interests — 19,522 19,522 — 28,072 28,072 Total assets $ 3,970 $ 19,522 $ 23,492 $ 9,867 $ 28,072 $ 37,939 Financial liabilities Long-term debt (1) $ 523,758 $ 514 $ 524,272 $ 447,843 $ 246 $ 448,089 Guarantees — 5,262 5,262 — 2,956 2,956 Total liabilities $ 523,758 $ 5,776 $ 529,534 $ 447,843 $ 3,202 $ 451,045 (1) This fair value measurement disclosure does not affect the consolidated balance sheets.
Schedule of Unobservable Input Reconciliation of Fair Value of Assets Measured on Recurring Basis	The following summarizes the changes in Level 3 instruments measured on a recurring basis. Securitized Beneficial Interests Long-Term Debt Guarantees Beginning balance at March 31, 2021 $ 19,370 $ 3,162 $ 1,740 Sales of receivables/issuance of guarantees 205,517 — 3,151 Settlements (192,141) (2,918) (1,749) Additions — 2 — Losses recognized in earnings (4,674) — (186) Ending balance at March 31, 2022 $ 28,072 $ 246 $ 2,956 Sales of receivables/issuance of guarantees 166,165 6,187 Settlements (164,679) (37) (1,864) Additions — 305 — Losses recognized in earnings (10,036) — (2,017) Ending balance at March 31, 2023 $ 19,522 $ 514 $ 5,262
Schedule of Valuation Techniques of Fair Value Measurements of Recurring and Nonrecurring	The following summarizes significant unobservable inputs and the valuation techniques utilized: Fair value at March 31, 2023 Valuation Technique Unobservable Input Range (Weighted Average) Securitized Beneficial Interests $ 19,522 Discounted Cash Flow Discount Rate 2.3% to 7.3% Payment Speed 38 days to 88 days Guarantees $ 5,262 Historical Loss Historical Loss 1.2% to 40.0% Fair value at March 31, 2022 Valuation Technique Unobservable Input Range (Weighted Average) Securitized Beneficial Interests $ 28,072 Discounted Cash Flow Discount Rate 2.8% to 3.9% Payment Speed 91 days to 103 days Guarantees $ 2,956 Historical Loss Historical Loss 0.6% to 44.6%

Pension and Other Postretirem_2

Pension and Other Postretirement Benefits (Tables)	12 Months Ended
Pension and Other Postretirement Benefits (Tables)	Mar. 31, 2023
Retirement Benefits [Abstract]
Schedule of Benefit Obligations in Excess of Fair Value of Plan Assets	The following summarizes benefit obligations, plan assets, and funded status for the defined benefit pension plans: U.S. Plans Non-U.S. Plans Total Year Ended March 31, 2023 Benefit obligation, beginning $ 62,797 $ 58,931 $ 121,728 Service cost 300 176 476 Interest cost 1,711 1,564 3,275 Plan amendments — 139 139 Actuarial gains (4,106) (10,220) (14,326) Plan settlements (21,390) (720) (22,110) Effects of currency translation — (2,356) (2,356) Benefits paid (3,602) (2,843) (6,445) Benefit obligation, ending $ 35,710 $ 44,671 $ 80,381 Fair value of plan assets, beginning $ 19,812 $ 66,801 $ 86,613 Actual return on plan assets (3,974) (10,027) (14,001) Employer contributions 9,154 1,758 10,912 Plan settlements (21,390) (720) (22,110) Effects of currency translation — (2,942) (2,942) Benefits paid (3,602) (2,843) (6,445) Fair value of plan assets, ending $ — $ 52,027 $ 52,027 Funded status of the plan $ (35,710) $ 7,356 $ (28,354) U.S. Plans Non-U.S. Plans Total Year Ended March 31, 2022 Benefit obligation, beginning $ 76,223 $ 66,433 $ 142,656 Service cost 215 174 389 Interest cost 1,467 1,187 2,654 Actuarial gains (2,948) (3,669) (6,617) Plan settlements (7,600) (114) (7,714) Effects of currency translation — (1,971) (1,971) Benefits paid (4,560) (3,109) (7,669) Benefit obligation, ending $ 62,797 $ 58,931 $ 121,728 Fair value of plan assets, beginning $ 27,109 $ 69,692 $ 96,801 Actual return on plan assets 806 1,038 1,844 Employer contributions 4,057 1,325 5,382 Plan settlements (7,600) (114) (7,714) Effects of currency translation — (2,031) (2,031) Benefits paid (4,560) (3,109) (7,669) Fair value of plan assets, ending $ 19,812 $ 66,801 $ 86,613 Funded status of the plan $ (42,985) $ 7,870 $ (35,115)
Schedule of Net Funded Status	The following summarizes amounts reported in the consolidated balance sheets for the defined benefit pension plans: U.S. Plans Non-U.S. Plans March 31, 2023 March 31, 2022 March 31, 2023 March 31, 2022 Noncurrent benefit asset recorded in other noncurrent assets $ — $ — $ 13,731 $ 15,443 Accrued current benefit liability recorded in accrued expenses and other current liabilities (3,290) (3,305) (972) (878) Accrued noncurrent benefit liability recorded in pension, postretirement, and other long-term liabilities (32,420) (39,680) (5,403) (6,695) Funded status of the plan $ (35,710) $ (42,985) $ 7,356 $ 7,870
Schedule of Accumulated and Projected Benefit Obligations	The following summarizes pension obligations for the defined benefit pension plans: U.S. Plans Non-U.S. Plans (1) March 31, 2023 March 31, 2022 March 31, 2023 March 31, 2022 Information for pension plans with accumulated benefit obligation in excess of plan assets: Projected benefit obligation $ 35,710 $ 62,797 $ 6,375 $ 7,573 Accumulated benefit obligation 35,710 62,797 5,998 7,009 Fair value of plan assets — 19,812 — — (1) Certain of the Company's non-U.S. defined benefit pension plans in Europe were over funded as of March 31, 2023 and 2022.
Schedule of Defined Benefit Plan Amounts Recognized in Other Comprehensive Income	The following summarizes activity in accumulated other comprehen sive income for the defined benefit plans: U.S. and Non-U.S. Pension U.S. and Non-U.S. Post-retirement Total Prior service credit $ 56 $ — $ 56 Net actuarial gains 4,645 1,383 6,028 Deferred taxes 459 (215) 244 Balance at March 31, 2022 $ 5,160 $ 1,168 $ 6,328 Prior service cost (138) — (138) Net actuarial gains 1,238 609 1,847 Deferred taxes 372 (74) 298 Total change for 2023 $ 1,472 $ 535 $ 2,007 Prior service cost (82) — (82) Net actuarial gains 5,883 1,992 7,875 Deferred taxes 831 (289) 542 Balance at March 31, 2023 $ 6,632 $ 1,703 $ 8,335
Schedule of Weighted Average Assumptions Used	The following assumptions were used to determine the expense for the pension plans: U.S. Plans Non-U.S. Plans March 31, 2023 March 31, 2022 March 31, 2023 March 31, 2022 Discount rate 3.75% 2.83% 2.98% 2.17% Rate of increase in future compensation Not applicable Not applicable 7.31% 5.28% Expected long-term rate of return on plan assets Not applicable 5.75% 2.16% 2.12% Interest crediting rate 4.28% 4.25% Not applicable Not applicable
Schedule of Assumptions Used	The following weighted average assumptions were used to determine the benefit obligations for the pension plans: U.S. Plans Non-U.S. Plans March 31, 2023 March 31, 2022 March 31, 2023 March 31, 2022 Discount rate 5.08% 3.74% 4.94% 2.98% Rate of increase in future compensation Not applicable Not applicable 5.72% 7.31% Interest crediting rate Not applicable 4.28% Not applicable Not applicable
Schedule of Asset Allocations and the Percentage of the Fair Value of Plan Assets	The following summarizes asset allocations and the percentage of the fair value of plan assets by asset category: Non-U.S. Plans March 31, 2023 March 31, 2022 Asset category: Cash and cash equivalents 11.5 % 10.6 % Equity securities 20.3 % 20.7 % Debt securities 14.8 % 66.5 % Insurance contracts 50.9 % — % Real estate and other investments 2.5 % 2.2 % Total 100.0 % 100.0 %
Schedule of Fair Value of Pension Plans	The fair values for the pension plans by asset category are as fol lows: Non-U.S. Pension Plans March 31, 2023 Total Level 1 Level 2 Level 3 Cash and cash equivalents $ 5,964 $ 5,964 $ — $ — U.S. equities / equity funds 6,669 6,669 — — International equities / equity funds 3,909 3,909 — — U.S. fixed income funds 5,364 5,364 — — International fixed income funds 2,334 2,334 — — Insurance contracts 26,472 — 26,472 — Real estate and other (1) 1,315 1,315 — — Total $ 52,027 $ 25,555 $ 26,472 $ — Non-U.S. Pension Plans March 31, 2022 Total Level 1 Level 2 Level 3 Cash and cash equivalents $ 7,073 $ 7,073 $ — $ — U.S. equities / equity funds 9,268 9,268 — — International equities / equity funds 2,818 2,818 — — Global equity funds 1,748 1,748 — — U.S. fixed income funds 5,753 5,753 — — International fixed income funds 34,313 10,448 23,865 — Global fixed income funds 4,371 4,371 — — Real estate and other (1) 1,457 — — — Total $ 66,801 $ 41,479 $ 23,865 $ — (1) Certain investments that are measured at fair value using the net asset value per share practical expedient have not been classified in the fair value hierarchy.
Schedule of Plan Assets Recognized and Measured at Fair Value Using Net Asset Value and Inputs Used	The following summarizes the plan assets recognized and measured at fair value using the net asset value and the inputs used to determine the fair value: March 31, 2023 March 31, 2022 Fair Value Unfunded Commitments Redemption Frequency Redemption Notice Period Fair Value Unfunded Commitments Redemption Frequency Redemption Notice Period Real estate and other $ 1,315 None Quarterly 60 Days $ 3,907 None Quarterly 60 Days
Schedule of Changes in Accumulated Postemployment Benefit Obligations	The following summarizes benefit obligations, plan assets, and funded status for the postretirement health and life insurance benefits plans: U.S. Plans Non-U.S. Plans Total March 31, 2023 Benefit obligation, beginning $ 3,977 $ 1,454 $ 5,431 Service cost 5 — 5 Interest cost 134 121 255 Effect of currency translation — (97) (97) Actuarial gains (437) (288) (725) Benefits paid (310) (75) (385) Benefit obligation, ending $ 3,369 $ 1,115 $ 4,484 Fair value of plan assets, beginning $ — $ — $ — Employer contributions 310 75 385 Benefits paid (310) (75) (385) Fair value of plan assets, ending $ — $ — $ — Funded status of the plan $ (3,369) $ (1,115) $ (4,484) U.S. Plans Non-U.S. Plans Total March 31, 2023 Accrued current benefit liability recorded in accrued expenses and other current liabilities $ (297) $ (96) $ (393) Accrued non-current benefit liability recorded in pension, postretirement, and other long-term liabilities (3,072) (1,019) (4,091) Funded status of the plan $ (3,369) $ (1,115) $ (4,484) U.S. Plans Non-U.S. Plans Total March 31, 2022 Benefit obligation, beginning $ 4,458 $ 1,441 $ 5,899 Service cost 6 — 6 Interest cost 97 110 207 Effect of currency translation — 250 250 Actuarial gains (425) (251) (676) Benefits paid (159) (96) (255) Benefit obligation, ending $ 3,977 $ 1,454 $ 5,431 Fair value of plan assets, beginning $ — $ — $ — Employer contributions 159 96 255 Benefits paid (159) (96) (255) Fair value of plan assets, ending $ — $ — $ — Funded status of the plan $ (3,977) $ (1,454) $ (5,431) U.S. Plans Non-U.S. Plans Total March 31, 2022 Accrued current benefit liability recorded in accrued expenses and other current liabilities $ (310) $ (118) $ (428) Accrued non-current benefit liability recorded in pension, postretirement, and other long-term liabilities (3,667) (1,336) (5,003) Funded status of the plan $ (3,977) $ (1,454) $ (5,431)
Schedule of Assumptions Used, Post Employment Benefit Obligations	The following assumptions were used to determine postretirement benefit obligations: March 31, 2023 March 31, 2022 U.S. Plans Non-U.S. Plans U.S. Plans Non-U.S. Plans Discount rate 5.09 % 10.58 % 3.75 % 9.50 % Health care cost trend rate assumed for next year 5.49 % 9.40 % 5.62 % 7.90 %
Schedule of Expected Contributions to Benefit Plans	The Company expects to contribute the following to its benefit plans: Pension Benefits Postretirement Plans U.S. Plans Non-U.S. Plans U.S. Plans Non-U.S. Plans Fiscal Year 2024 $ 3,290 $ 972 $ 297 $ 96
Schedule of Contributions to Defined Contribution Plans	The Company's contributions to the defined contribution plans are as follows: Year Ended March 31, 2023 Year Ended March 31, 2022 Contributions $5,478 4,589
Schedule of Expected Benefit Payments	The following summarizes the expected benefit payments to be paid in future years, as of March 31, 2023: Pension Benefits Other Benefits U.S. Plans Non-U.S. Plans U.S. Plans Non-U.S. Plans Total 2024 $ 3,290 $ 3,325 $ 297 $ 96 $ 7,008 2025 3,319 3,313 289 100 7,021 2026 3,258 3,089 284 104 6,735 2027 3,191 3,186 279 108 6,764 2028 3,115 3,167 275 112 6,669 Thereafter 14,170 17,796 1,257 617 33,840 Total $ 30,343 $ 33,876 $ 2,681 $ 1,137 $ 68,037

Other Comprehensive Income (Tab

Other Comprehensive Income (Tables)	12 Months Ended
Other Comprehensive Income (Tables)	Mar. 31, 2023
Equity [Abstract]
Schedule of Accumulated Other Comprehensive (Loss) Income	The following summarizes changes in each component of accumulated other comprehensive income, net of tax, attributable to the Company: Currency Translation Adjustment Pensions, Net of Tax Derivatives, Net of Tax Accumulated Other Comprehensive Income Balances at March 31, 2021 $ (4,649) $ 541 $ (2,625) $ (6,733) Other comprehensive (loss) income before reclassifications (4,224) 6,209 10,419 12,404 Amounts reclassified to net loss, net of tax — (422) (1,445) (1,867) Other comprehensive (loss) income, net of tax (4,224) 5,787 8,974 10,537 Balances at March 31, 2022 $ (8,873) $ 6,328 $ 6,349 $ 3,804 Other comprehensive income (loss) before reclassifications 2,481 1,873 1,750 6,104 Amounts reclassified to net loss, net of tax — 134 (4,527) (4,393) Other comprehensive income (loss), net of tax 2,481 2,007 (2,777) 1,711 Balances at March 31, 2023 $ (6,392) $ 8,335 $ 3,572 $ 5,515 The following summarizes derivative amounts reclassified from accumulated other comprehensive income to net loss: Affected Line Item in the Consolidated Year Ended March 31, 2023 Year Ended March 31, 2022 Statements of Operations Derivatives: Gain reclassified to cost of goods sold $ (6,764) $ (2,672) Amounts reclassified from equity to the income statement, gross (6,764) (2,672) Cost of goods and services sold Tax effects of amounts reclassified from accumulated other comprehensive income to net loss 2,237 1,227 Amounts reclassified from equity to the income statement, net $ (4,527) $ (1,445)

Related Party Transactions (Tab

Related Party Transactions (Tables)	12 Months Ended
Related Party Transactions (Tables)	Mar. 31, 2023
Related Party Transactions [Abstract]
Schedule of Related Party Transactions	The following summarizes sales and purchases transactions with related parties: Year Ended March 31, 2023 Year Ended March 31, 2022 Sales $ 22,695 $ 25,575 Purchases 158,140 135,261
Schedule of Related Party Balances in Condensed Consolidated Balance Sheets	The Company included the following related party balances in its consolidated balances sheets: March 31, 2023 March 31, 2022 Accounts receivable, related parties $ 3,090 $ 1,896 Other receivables Notes receivable, related parties — 1,431 Other receivables Accounts payable, related parties 20,438 41,747 Accounts payable Advances from related parties 3,494 15,240 Advances from customers

Segment Information (Tables)

Segment Information (Tables)	12 Months Ended
Segment Information (Tables)	Mar. 31, 2023
Segment Reporting [Abstract]
Schedule of Segment Reporting Information by Segment	The following summarizes segment information, with the All Other category being included for purposes of reconciliation of the respective balances below of the Leaf segment (the Company's sole reportable segment) to the consolidated financial statements: Year Ended March 31, 2023 Year Ended March 31, 2022 Sales and other operating revenues: Leaf $ 1,900,558 $ 1,627,238 All Other 14,323 12,624 Consolidated sales and other operating revenues $ 1,914,881 $ 1,639,862 Segment operating income: Leaf $ 117,056 $ 106,159 All Other (18,593) (24,225) Segment operating income 98,463 81,934 Restructuring and asset impairment charges 4,685 8,031 Goodwill impairment — 32,186 Consolidated operating income $ 93,778 $ 41,717 March 31, 2023 Leaf All Other Total Segment assets $ 1,544,798 $ 37,665 $ 1,582,463 Trade and other receivables, net 199,237 411 199,648 Equity in net assets of investee companies 93,754 6,985 100,739 Depreciation and amortization 16,157 2,980 19,137 Capital expenditures 13,565 2,390 15,955 March 31, 2022 Leaf All Other Total Segment assets $ 1,641,552 $ 56,975 $ 1,698,527 Trade and other receivables, net 255,756 1,105 256,861 Equity in net assets of investee companies 88,118 6,785 94,903 Depreciation and amortization 14,763 1,913 16,676 Capital expenditures 10,159 4,438 14,597
Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area	The following summarizes geographic sales and other operating revenues by destination of the product shipped: Year Ended March 31, 2023 Year Ended March 31, 2022 Sales and Other Operating Revenues: China $ 338,174 $ 280,945 United States 220,266 209,953 United Arab Emirates 182,306 82,070 Indonesia 170,492 110,009 Belgium (1) 132,456 89,748 Northern Africa 52,428 52,539 Russia 20,175 57,808 Other 798,584 756,790 Total $ 1,914,881 $ 1,639,862 (1) The Belgium destination represents a customer-owned storage and distribution center from which the tobacco will be shipped on to manufacturing facilities.
Schedule of Customers that Account for More than 10% of Total Sales and Other Operating Revenues	The following summarizes the customers, including their respective affiliates, that account for more than 10.0% of total sales and other operating revenues for the respective periods, as indicated by an "x": Year Ended March 31, 2023 Year Ended March 31, 2022 Philip Morris International Inc. x x China Tobacco International Inc. x x British American Tobacco x x
Schedule of Long-Lived Assets in Individual Foreign Countries	The following summarizes geographic property, plant, and equipment by location: March 31, 2023 March 31, 2022 Property, Plant, and Equipment, Net: Malawi $ 31,213 $ 30,961 Brazil 29,163 28,707 United States 21,945 21,960 Zimbabwe 21,703 22,217 Other 12,006 12,152 Jordan 11,352 11,571 Tanzania 6,016 9,953 Total $ 133,398 $ 137,521

Basis of Presentation and Sum_3

Basis of Presentation and Summary of Significant Accounting Policies (Details)	3 Months Ended	12 Months Ended
	Mar. 31, 2022 segment	Mar. 31, 2023 segment reporting_unit
Product Information [Line Items]
Number of operating segments	8
Number of reportable segments	1	1
Number of reporting units \| reporting_unit		8
Other Regions
Product Information [Line Items]
Number of operating segments		5
Product Other Than Leaf
Product Information [Line Items]
Number of operating segments		3
Trade names
Product Information [Line Items]
Useful life of intangible assets		14 years
Minimum \| Real Estate
Product Information [Line Items]
Lease term		2 years
Minimum \| Equipment
Product Information [Line Items]
Lease term		2 years
Minimum \| Buildings
Product Information [Line Items]
Useful life of property, plant and equipment		9 years
Minimum \| Machinery and equipment
Product Information [Line Items]
Useful life of property, plant and equipment		2 years
Minimum \| Customer relationships
Product Information [Line Items]
Useful life of intangible assets		9 years
Minimum \| Internally developed software
Product Information [Line Items]
Useful life of intangible assets		3 years
Maximum \| Real Estate
Product Information [Line Items]
Lease term		15 years
Maximum \| Equipment
Product Information [Line Items]
Lease term		5 years
Maximum \| Buildings
Product Information [Line Items]
Useful life of property, plant and equipment		40 years
Maximum \| Machinery and equipment
Product Information [Line Items]
Useful life of property, plant and equipment		19 years
Maximum \| Customer relationships
Product Information [Line Items]
Useful life of intangible assets		12 years
Maximum \| License
Product Information [Line Items]
Useful life of intangible assets		8 years
Maximum \| Internally developed software
Product Information [Line Items]
Useful life of intangible assets		5 years

Revenue Recognition - Revenue D

Revenue Recognition - Revenue Disaggregated by Product or Service (Details) - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Disaggregation of Revenue [Line Items]
Consolidated sales and other operating revenues	$ 1,914,881	$ 1,639,862
Leaf
Disaggregation of Revenue [Line Items]
Consolidated sales and other operating revenues	1,900,558	1,627,238
Leaf \| Product revenue
Disaggregation of Revenue [Line Items]
Consolidated sales and other operating revenues	1,812,170	1,531,805
Leaf \| Processing and other revenues
Disaggregation of Revenue [Line Items]
Consolidated sales and other operating revenues	88,388	95,433
All Other
Disaggregation of Revenue [Line Items]
Consolidated sales and other operating revenues	$ 14,323	$ 12,624

Revenue Recognition - Activity

Revenue Recognition - Activity in the Claims Allowance (Details) - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]
Balance, beginning of period	$ 1,130	$ 1,830
Additions	4,680	1,586
Payments	(3,460)	(2,286)
Balance, end of period	$ 2,350	$ 1,130

Revenue Recognition - Allowance

Revenue Recognition - Allowance for Doubtful Accounts (Details) - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Allowance for Doubtful Accounts Receivable [Roll Forward]
Balance, beginning of period	$ (24,541)	$ (20,900)
Additions	(2,316)	(4,212)
Write-offs	2,127	571
Balance, end of period	(24,730)	(24,541)
Trade receivables	210,081	272,218
Trade receivables, net	$ 185,351	$ 247,677

Revenue Recognition - Narrative

Revenue Recognition - Narrative (Details) - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Revenue from Contract with Customer [Abstract]
Value added tax expense	$ 28,302	$ 27,274

Other Expense, Net (Details)

Other Expense, Net (Details) - USD ($) $ in Thousands	12 Months Ended
Other Expense, Net (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Mar. 31, 2022
Other Income and Expenses [Abstract]
Losses on sale of receivables	$ (10,434)	$ (5,833)
Foreign currency gains (losses)	1,057	(2,776)
Note receivable write-off	(2,050)	0
Gain on sale of fixed assets	1,389	3,818
Miscellaneous (expense) income, net	(985)	1,689
Total	$ (11,023)	$ (3,102)

Restructuring and Asset Impai_3

Restructuring and Asset Impairment Charges - Summary (Details) - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2021
Restructuring and Related Activities [Abstract]
Employee separation charges	$ 650		$ 2,292
Asset impairment and other noncash charges	4,035		5,739
Total restructuring and asset impairment charges	$ 4,685	$ 8,031	$ 8,031

Income Taxes - Unrecognized Tax

Income Taxes - Unrecognized Tax Benefits (Details) - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Balance at beginning of period	$ 17,725	$ 18,358
Increase (decrease) for prior year tax positions	1,449
Increase (decrease) for prior year tax positions		(660)
Increase for current year tax positions	634	0
Reduction for settlements	(3,480)	0
Impact from decrease in exchange rates	(243)
Impact from increase in exchange rates		27
Balance at end of period	16,085	17,725
Accrued interest	1,753	1,777
Accrued penalties	1,447	831
Balance at end of period	19,285	20,333
Unrecognized tax benefits that would impact effective tax rate if recognized	11,177
Unrecognized income tax expense (benefit)	(24)	303
Unrecognized tax benefits, penalties expense	$ 616	$ 61

Income Taxes - Income Tax Provi

Income Taxes - Income Tax Provision (Details) - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2021
Income Tax Expense (Benefit), Continuing Operations [Abstract]
U.S.	$ (43,874)	$ (68,489)
Non-U.S.	21,252	(10,875)
Loss before income taxes and other items	(22,622)	(79,364)
Current:
Federal(1)	16,353	12
State	337		$ 0
Non-U.S.	17,593	16,515
Total Current	34,283	16,527
Deferred:
Federal	(592)	(243)
State	2		$ 0
Non-U.S.	434	(3,644)
Total Deferred	(156)	(3,887)
Income tax expense	34,127	12,640
Income Tax Expense (Benefit), Continuing Operations, Income Tax Reconciliation [Abstract]
Tax benefit at U.S. statutory rate	(4,750)	(16,666)
Effect of non-U.S. income taxes	(3,418)	(961)
U.S. taxes on non-U.S. earnings	6,389	205
Increase (decrease) in reserves for uncertain tax positions	2,397	(315)
Withholding tax expense	3,058	1,488
Tax credits	(3,853)	(1,150)
Tax incentives	(2,280)	0
Nondeductible interest	2,559	2,610
Waived intercompany interest expense	0	3,960
Exchange effects and currency translation	3,101	4,344
Goodwill impairment	0	7,148
Change in valuation allowance	30,412	8,053
Other, net	512	3,924
Income tax expense	$ 34,127	$ 12,640

Income Taxes - Deferred Taxes (

Income Taxes - Deferred Taxes (Details) - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Deferred tax assets:
Non-deductible interest carryforward	$ 24,331	$ 23,074
Original issue discount	20,326	0
Reserves and accruals	25,734	21,896
Tax loss carryforwards	15,886	13,728
Other	5,686	9,573
Gross deferred tax assets	91,963	68,271
Valuation allowance(1)	(59,506)	(32,641)
Total deferred tax assets	32,457	35,630
Deferred tax liabilities:
Unremitted earnings of foreign subsidiaries	(29,045)	(27,918)
Derivative transactions	(1,318)	(2,790)
Intangible assets	(1,884)	(2,776)
Other	(3,448)	(7,318)
Total deferred tax liabilities	(35,695)	(40,802)
Net deferred tax liability	(3,238)	$ (5,172)
Change in valuation allowance	$ 20,823

Income Taxes - Deferred Tax Ass

Income Taxes - Deferred Tax Assets by Current and Noncurrent (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Mar. 31, 2022
Income Tax Disclosure [Abstract]
Noncurrent asset	$ 6,662	$ 6,498
Noncurrent liability	(9,900)	(11,670)
Net deferred tax liability	$ (3,238)	$ (5,172)

Income Taxes - Changes in Valua

Income Taxes - Changes in Valuation Allowance (Details) - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at beginning of period	$ 32,641	$ 25,273
Changes to expenses	27,598	8,624
Changes to other comprehensive income	(733)	(1,256)
Balance at end of period	$ 59,506	$ 32,641

Income Taxes - Operating Loss C

Income Taxes - Operating Loss Carryforwards (Details) $ in Thousands	Mar. 31, 2023 USD ($)
Operating Loss Carryforwards [Line Items]
Net operating loss and tax credit carryforwards	$ 57,996
Foreign Tax Authority \| 2024-2028
Operating Loss Carryforwards [Line Items]
Net operating loss and tax credit carryforwards	20,927
Foreign Tax Authority \| Thereafter
Operating Loss Carryforwards [Line Items]
Net operating loss and tax credit carryforwards	5,170
Foreign Tax Authority \| Indefinite
Operating Loss Carryforwards [Line Items]
Net operating loss and tax credit carryforwards	$ 31,899

Loss Per Share - Schedule of Ba

Loss Per Share - Schedule of Basic and Diluted (Loss) Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Basic and diluted loss per share:
Net loss attributable to Pyxus International, Inc.	$ (39,141)	$ (82,119)
Weighted Average Number of Shares Outstanding - basic (in shares)	25,000	25,000
Weighted Average Number of Shares Outstanding - diluted (in shares)	25,000	25,000
Basic loss per share (in USD per share)	$ (1.57)	$ (3.28)
Diluted loss per share (in USD per share)	$ (1.57)	$ (3.28)

Inventories, Net - Schedule of

Inventories, Net - Schedule of Inventories, Net (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Mar. 31, 2022
Inventory Disclosure [Abstract]
Processed tobacco	$ 498,398	$ 517,613
Unprocessed tobacco	231,651	193,406
Other tobacco related	39,670	29,694
All Other	5,352	8,714
Total	$ 775,071	$ 749,427

Advances to Suppliers, Net - Sc

Advances to Suppliers, Net - Schedule of Advances to Tobacco Suppliers (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Mar. 31, 2022
Revenue from Contract with Customer [Abstract]
Advances to tobacco suppliers, net	$ 38,111	$ 46,705
Advances to non-tobacco suppliers	4,194	2,227
Total in current assets	42,305	48,932
Long-term advances to tobacco suppliers, net	1,564	428
Total current and long-term	$ 43,869	$ 49,360

Advances to Suppliers, Net - Na

Advances to Suppliers, Net - Narrative (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Mar. 31, 2022
Revenue from Contract with Customer [Abstract]
Markup and capitalized interest on tobacco advances	$ 22,102	$ 16,619
Unrecoverable advances and other capitalized costs	$ 8,322	$ 6,814

Acquisitions and Dispositions (

Acquisitions and Dispositions (Details) $ in Thousands	12 Months Ended
Acquisitions and Dispositions (Details) $ in Thousands	Mar. 31, 2023 USD ($)
Disposal Group, Disposed of by Sale, Not Discontinued Operations \| Humble Juice Co. LLC
Business Acquisition [Line Items]
Loss on disposition of business	$ 5,374

Equity Method Investments (Deta

Equity Method Investments (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2023	Mar. 31, 2022
Equity Method Investment, Summarized Financial Information, Income Statement [Abstract]
Gross profit									$ 261,017	$ 227,057
Net (loss) income	$ (19,945)	$ (2,237)	$ (1,550)	$ (14,505)	$ (30,346)	$ (30,057)	$ (10,023)	$ (11,628)	(38,237)	(82,054)
Equity Method Investment, Summarized Financial Information, Balance Sheet [Abstract]
Current assets	1,220,565				1,327,647				1,220,565	1,327,647
Current liabilities	715,058				814,374				715,058	814,374
Equity Method Investment, Nonconsolidated Investee or Group of Investees
Equity Method Investment, Summarized Financial Information, Income Statement [Abstract]
Sales									489,532	292,777
Gross profit									76,206	56,752
Net (loss) income									40,447	22,729
Company's dividends received									12,677	9,671
Equity Method Investment, Summarized Financial Information, Balance Sheet [Abstract]
Current assets	419,229				375,015				419,229	375,015
Property, plant, and equipment and other assets	48,174				42,841				48,174	42,841
Current liabilities	323,899				289,816				323,899	289,816
Long-term obligations and other liabilities	$ 3,887				$ 2,999				$ 3,887	$ 2,999
Adams International Ltd.
Schedule of Equity Method Investments [Line Items]
The Company's Ownership Percentage	49%								49%
Basis Difference	$ (4,526)								$ (4,526)
Alliance One Industries India Private Ltd.
Schedule of Equity Method Investments [Line Items]
The Company's Ownership Percentage	49%								49%
Basis Difference	$ (5,770)								$ (5,770)
China Brasil Tobacos Exportadora SA
Schedule of Equity Method Investments [Line Items]
The Company's Ownership Percentage	49%								49%
Basis Difference	$ 44,199								$ 44,199
Oryantal Tutun Paketleme
Schedule of Equity Method Investments [Line Items]
The Company's Ownership Percentage	50%								50%
Basis Difference	$ (416)								$ (416)
Purilum, LLC
Schedule of Equity Method Investments [Line Items]
The Company's Ownership Percentage	50%								50%
Basis Difference	$ 4,589								$ 4,589
Siam Tobacco Export Company
Schedule of Equity Method Investments [Line Items]
The Company's Ownership Percentage	49%								49%
Basis Difference	$ (6,098)								$ (6,098)

Variable Interest Entities (Det

Variable Interest Entities (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Mar. 31, 2022
Schedule of Equity Method Investments [Line Items]
Investments in variable interest entities	$ 100,750	$ 95,420
Variable Interest Entity, Not Primary Beneficiary
Schedule of Equity Method Investments [Line Items]
Investments in variable interest entities	93,754	88,118
Receivables with variable interest entities	2,617	2,211
Guaranteed amounts to variable interest entities (not to exceed)	$ 68,265	$ 55,884

Goodwill and Other Intangible_3

Goodwill and Other Intangible Assets, Net - Goodwill and Intangible Asset Rollforward (Details) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021	Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2021
Schedule of Intangible Assets [Line Items]
Beginning Carrying Amount, Net			$ 45,061
Beginning Carrying Amount, Net					$ 88,270
Additions				$ 840
Amortization Expense	$ (5,461)		(6,489)	(5,461)
Disposition of Humble Juice				(6,402)
Ending Intangible Assets, Net	45,061		38,572	45,061
Goodwill [Roll Forward]
Goodwill at beginning of period			0	36,853
Additions				0
Disposition of Humble Juice				(4,667)
Goodwill impairment	(31,814)	$ (372)	$ 0	(32,186)
Goodwill at end of period	0			$ 0
Customer relationships
Schedule of Intangible Assets [Line Items]
Weighted Average Remaining Useful Life			9 years 4 months 24 days	10 years 3 months 18 days
Beginning Carrying Amount, Net			$ 23,568
Beginning Carrying Amount, Net					27,730
Additions				$ 0
Amortization Expense	(2,427)		(3,086)	(2,427)
Disposition of Humble Juice				(1,735)
Ending Intangible Assets, Net	23,568		$ 20,482	$ 23,568
Technology
Schedule of Intangible Assets [Line Items]
Weighted Average Remaining Useful Life			5 years 2 months 12 days	5 years 9 months 18 days
Beginning Carrying Amount, Net			$ 11,471
Beginning Carrying Amount, Net					12,858
Additions				$ 840
Amortization Expense	(2,227)		(2,596)	(2,227)
Disposition of Humble Juice				0
Ending Intangible Assets, Net	11,471		$ 8,875	$ 11,471
Trade names
Schedule of Intangible Assets [Line Items]
Weighted Average Remaining Useful Life			11 years 4 months 24 days	12 years 4 months 24 days
Beginning Carrying Amount, Net			$ 10,022
Beginning Carrying Amount, Net					$ 10,829
Additions				$ 0
Amortization Expense	(807)		(807)	(807)
Disposition of Humble Juice				0
Ending Intangible Assets, Net	$ 10,022		$ 9,215	$ 10,022

Goodwill and Other Intangible_4

Goodwill and Other Intangible Assets, Net - Goodwill Impairment by Reporting Unit (Details) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021	Mar. 31, 2023	Mar. 31, 2022
Goodwill [Line Items]
Goodwill impairment	$ 31,814	$ 372	$ 0	$ 32,186
Leaf - Africa
Goodwill [Line Items]
Goodwill impairment	8,341
Leaf - Asia
Goodwill [Line Items]
Goodwill impairment	6,311
Leaf - Europe
Goodwill [Line Items]
Goodwill impairment	5,566
Leaf - North America
Goodwill [Line Items]
Goodwill impairment	3,901
Leaf - South America
Goodwill [Line Items]
Goodwill impairment	5,730
E-liquids
Goodwill [Line Items]
Goodwill impairment	$ 1,965

Goodwill and Other Intangible_5

Goodwill and Other Intangible Assets, Net - Estimated Intangible Asset Amortization Expense (Details) $ in Thousands	Mar. 31, 2023 USD ($)
Finite-Lived Intangible Assets [Line Items]
2024	$ 4,641
2025	4,567
2026	4,447
2027	4,472
2028	4,525
Thereafter	15,920
Amortizable intangibles, net	38,572
Customer relationships
Finite-Lived Intangible Assets [Line Items]
2024	2,175
2025	2,175
2026	2,175
2027	2,175
2028	2,175
Thereafter	9,607
Amortizable intangibles, net	20,482
Internally Developed Software Intangible Asset
Finite-Lived Intangible Assets [Line Items]
2024	1,659
2025	1,585
2026	1,465
2027	1,490
2028	1,543
Thereafter	1,133
Amortizable intangibles, net	8,875
Trade names
Finite-Lived Intangible Assets [Line Items]
2024	807
2025	807
2026	807
2027	807
2028	807
Thereafter	5,180
Amortizable intangibles, net	$ 9,215

Leases - Lease Costs (Details)

Leases - Lease Costs (Details) - USD ($) $ in Thousands	12 Months Ended
Leases - Lease Costs (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Mar. 31, 2022
Leases [Abstract]
Operating lease costs	$ 14,203	$ 14,752
Variable and short-term lease costs	8,023	7,991
Total lease costs	$ 22,226	$ 22,743

Leases - Weighted-Average Infor

Leases - Weighted-Average Information of Operating Lease Obligations (Details)	Mar. 31, 2023	Mar. 31, 2022
Leases [Abstract]
Weighted average remaining lease term	5 years 10 months 24 days	6 years 2 months 12 days
Weighted average discount rate	14.40%	12.80%

Leases - Supplemental Cash Flow

Leases - Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash Flow, Lessee [Abstract]
Cash paid for amounts included in the measurement of lease liabilities - operating cash flows used by operating leases	$ 13,607	$ 13,677
Right-of-use assets obtained in exchange for new operating leases - noncash	$ 9,967	$ 7,054

Leases - Maturities of Operatin

Leases - Maturities of Operating Lease Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Mar. 31, 2022
Operating Leases, After Adoption of 842:
2024	$ 13,014
2025	8,500
2026	6,771
2027	5,726
2028	4,373
Thereafter	13,798
Total future minimum lease payments	52,182
Less: amounts related to imputed interest	17,878
Present value of future minimum lease payments	34,304
Less: operating lease liabilities, current	8,723	$ 8,065
Operating lease liabilities, non-current	$ 25,581	$ 28,604

Property, Plant, and Equipmen_3

Property, Plant, and Equipment, Net - Schedule of Property, Plant and Equipment, Net (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Mar. 31, 2022
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 159,027	$ 152,731
Less: accumulated depreciation	(25,629)	(15,210)
Property, plant, and equipment, net	133,398	137,521
Land
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	31,132	32,023
Buildings
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	43,911	43,465
Machinery and equipment
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 83,984	$ 77,243

Property, Plant, and Equipmen_4

Property, Plant, and Equipment, Net - Depreciation Expense (Details) - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Property, Plant and Equipment [Line Items]
Total depreciation	$ 12,478	$ 11,180
Depreciation expense recorded in cost of goods and services sold
Property, Plant and Equipment [Line Items]
Total depreciation	10,132	8,908
Depreciation expense recorded in selling, general, and administrative expenses
Property, Plant and Equipment [Line Items]
Total depreciation	$ 2,346	$ 2,272

Debt Arrangements - Schedule of

Debt Arrangements - Schedule of Debt Financing (Details) - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Feb. 06, 2023	Jul. 28, 2022
Interest Rate
Total debt	$ 1,001,049	$ 1,066,945
Short-term	382,544	378,612
Current portion of long-term debt	75	107,856
Long-term debt	618,430	580,477
Long-term debt including current maturities	618,505	688,333
Letters of credit outstanding	11,684	9,038
Long Term Debt Repayment Schedule by Fiscal Year
2024	382,619
2025	19,931
2026	429
2027	25,000
2028	573,070
Later	0
Repayments of debt	$ 578,162	1,636
Senior notes \| Senior Secured First Lien Notes due 2024
Interest Rate
Interest rate (as a percent)	10%
Total debt	$ 19,931	270,762
Long Term Debt Repayment Schedule by Fiscal Year
2024	0
2025	19,931
2026	0
2027	0
2028	0
Later	0
Unamortized discount of debt instrument	460
Repayments of debt, net of original issue discount	20,391
Repayments of debt	$ 253,483
Senior notes \| Senior Secured First Lien Notes due 2027
Interest Rate
Interest rate (as a percent)	8.80%
Total debt	$ 253,483	0
Long Term Debt Repayment Schedule by Fiscal Year
2024	0
2025	0
2026	0
2027	0
2028	253,483
Later	$ 0
Intabex Term Loan
Interest Rate
Weighted-average interest rate (as a percent)	12.80%
Total debt	$ 186,194	0
Long Term Debt Repayment Schedule by Fiscal Year
2024	0
2025	0
2026	0
2027	0
2028	186,194
Later	$ 0
Pyxus Term Loan
Interest Rate
Weighted-average interest rate (as a percent)	12.80%
Total debt	$ 133,393	0
Long Term Debt Repayment Schedule by Fiscal Year
2024	0
2025	0
2026	0
2027	0
2028	133,393
Later	$ 0
Term Loans
Interest Rate
Weighted-average interest rate (as a percent)	10.90%
Total debt	$ 0	219,500
Long Term Debt Repayment Schedule by Fiscal Year
2024	0
2025	0
2026	0
2027	0
2028	0
Later	$ 0
Other long-term debt
Interest Rate
Weighted-average interest rate (as a percent)	7.50%
Total debt	$ 504	239
Long Term Debt Repayment Schedule by Fiscal Year
2024	75
2025	0
2026	429
2027	0
2028	0
Later	$ 0
Notes payable to banks
Interest Rate
Weighted-average interest rate (as a percent)	6.80%
Total debt	$ 382,544	378,612
Long Term Debt Repayment Schedule by Fiscal Year
2024	382,544
2025	0
2026	0
2027	0
2028	0
Later	$ 0
ABL Credit Facility \| Credit Facility
Interest Rate
Interest rate (as a percent)	4.80%
Total debt	$ 25,000	90,000
Long Term Debt Repayment Schedule by Fiscal Year
2024	0
2025	0
2026	0
2027	25,000
2028	0
Later	$ 0
DDTL Facility \| Credit Facility
Interest Rate
Interest rate (as a percent)	11.20%
Total debt	$ 0	$ 107,832
Long Term Debt Repayment Schedule by Fiscal Year
2024	0
2025	0
2026	0
2027	0
2028	0
Later	0
Annual principal payment			$ 102,000	$ 9,000
Exit fee payable				$ 5,250
Unamortized premium	2,844
DDTL Facility \| Credit Facility \| Senior Secured First Lien Notes due 2027
Long Term Debt Repayment Schedule by Fiscal Year
Unamortized discount of debt instrument	2,839
DDTL Facility \| Senior notes
Long Term Debt Repayment Schedule by Fiscal Year
Unamortized discount of debt instrument	$ 6,969
Intabex Term Loans \| Senior Secured First Lien Notes due 2027
Interest Rate
Exit fee amount			2,000
Long Term Debt Repayment Schedule by Fiscal Year
Face amount of debt instrument			189,033
Pyxus Credit Facility \| Term Loan Credit Agreement
Long Term Debt Repayment Schedule by Fiscal Year
Face amount of debt instrument			$ 130,550
DDTL Facility Loans \| New Intabex Loans
Long Term Debt Repayment Schedule by Fiscal Year
Line of credit facility, exit facility loans, exchange percent			40%
DDTL Facility Loans \| New Senior Secured Term Loans
Long Term Debt Repayment Schedule by Fiscal Year
Line of credit facility, exit facility loans, exchange percent			60%

Debt Arrangements - Narrative (

Debt Arrangements - Narrative (Details)						12 Months Ended
Debt Arrangements - Narrative (Details)	Feb. 06, 2023 USD ($)	Aug. 24, 2022	Feb. 08, 2022 USD ($)	Apr. 23, 2021 USD ($)	Aug. 24, 2020 USD ($)	Mar. 31, 2023 USD ($)	Mar. 31, 2022 USD ($)	Jun. 02, 2022	Dec. 31, 2021	Sep. 03, 2020 shares	Feb. 10, 2020 shares
Debt Instrument [Line Items]
Outstanding borrowings						$ 1,001,049,000	$ 1,066,945,000
Repayments of debt						578,162,000	1,636,000
Short-term debt						382,544,000	378,612,000
Credit Facility
Debt Instrument [Line Items]
Short-term debt, maximum outstanding amount						$ 716,080,000	$ 673,288,000
Weighted-average interest rate (as a percent)						6.80%	6.10%
Restricted cash and investments, current						$ 1,195,000	$ 971,000
Credit Facility \| Other Regions
Debt Instrument [Line Items]
Short-term debt						$ 84,640,000	109,412,000
Glendon Capital Management LP \| Glendon Investor and Monarch Investor
Debt Instrument [Line Items]
Number of common stock owned by related party (in shares) \| shares										7,939,000
Proportion of common stock outstanding owned by related party (as a percent)										31.80%
Monarch Alternative Capital LP \| Glendon Investor and Monarch Investor
Debt Instrument [Line Items]
Number of common stock owned by related party (in shares) \| shares										6,140,000
Proportion of common stock outstanding owned by related party (as a percent)										24.60%
Owl Creek Asset Management LP \| Glendon Investor and Monarch Investor
Debt Instrument [Line Items]
Number of common stock owned by related party (in shares) \| shares											2,405,000
Proportion of common stock outstanding owned by related party (as a percent)									9.60%
Alliance One Brazil \| Alliance One International Tabak B.V.
Debt Instrument [Line Items]
Ownership interest (as a percent)				0.001%
Delayed Draw Term Loan Facility Credit Agreement
Debt Instrument [Line Items]
Outstanding loan percentage (as a percent)						99.70%
Senior Secured First Lien Notes due 2024
Debt Instrument [Line Items]
Outstanding loan percentage (as a percent)						64.10%
Exit Term Loan Credit Agreement
Debt Instrument [Line Items]
Outstanding loan percentage (as a percent)						68.10%
Maximum \| Credit Facility
Debt Instrument [Line Items]
Term of debt instrument						365 days
Minimum \| Credit Facility
Debt Instrument [Line Items]
Term of debt instrument						180 days
Credit Facility \| Delayed Draw Term Loan Facility Credit Agreement
Debt Instrument [Line Items]
Exit fee amount						$ 1,575,000
Credit Facility \| Delayed Draw Term Loan Facility Credit Agreement \| Glendon Investor and Monarch Investor
Debt Instrument [Line Items]
Exit fee amount						910,000
Senior notes \| Senior Secured First Lien Notes due 2027
Debt Instrument [Line Items]
Outstanding borrowings						$ 253,483,000	0
Interest rate (as a percent)						8.80%
Senior notes \| Senior Secured First Lien Notes due 2024
Debt Instrument [Line Items]
Outstanding borrowings						$ 19,931,000	270,762,000
Interest rate (as a percent)						10%
Debt instrument, covenant compliance, shareholder election percent					92.70%
Debt instrument, percentage of outstanding					10%
Repayments of debt						$ 253,483,000
Unamortized discount of debt instrument						460,000
Repayments of debt, net of original issue discount						20,391,000
Senior notes \| 8.50 Percentage Senior Secured Notes Due 2027
Debt Instrument [Line Items]
Interest rate (as a percent)	8.50%
Term Loans
Debt Instrument [Line Items]
Outstanding borrowings						0	219,500,000
Term Loans \| Minimum \| Senior Secured First Lien Notes due 2027
Debt Instrument [Line Items]
Exercise of rights and remedies against collateral, any event, shareholder minimum percent of New Term Loans	20%
Exercise of rights and remedies against collateral, date of determination, shareholder minimum percent of New Term Loans	15%
PNC ABL Credit Facility \| Credit Facility
Debt Instrument [Line Items]
Maximum borrowing capacity of credit facility			$ 100,000,000
Borrowing base, proportion of eligible accounts receivable (as a percent)			85%
Terms receivables borrowing			$ 5,000,000
Borrowing base, proportion of eligible accounts receivable, credit (as a percent)			90%
Borrowing base, proportion of eligible inventory valued at lower of cost and market value (as a percent)			70%
Proportion of liquidation value inventory borrowing base (as a percent)			85%
Commitment fee percentage (in basis points)			0.375%
Lower threshold of excess borrowing ability of credit facility (as a percent)			10%
Less than borrowing ability			$ 20,000,000
Financial covenant threshold of credit facility, consecutive days			30 days
Excess borrowing ability			$ 20,000,000
Fixed charge ratio of credit facility			1.10
Average outstanding amount						70,247,000
Repayments of debt			$ 56,500,000
PNC ABL Credit Facility \| Credit Facility \| Debt Instrument, Redemption, Period One
Debt Instrument [Line Items]
Termination fee (in basis points)			300
PNC ABL Credit Facility \| Credit Facility \| Debt Instrument, Redemption, Period Two
Debt Instrument [Line Items]
Termination fee (in basis points)			200
PNC ABL Credit Facility \| Credit Facility \| Debt Instrument, Redemption, Period Three
Debt Instrument [Line Items]
Termination fee (in basis points)			100
PNC ABL Credit Facility \| Credit Facility \| Maximum \| Bloomberg-Short-Term Bank Yield Index Rate
Debt Instrument [Line Items]
Basis spread on variable rate (as a percent)			3%
PNC ABL Credit Facility \| Credit Facility \| Minimum \| Bloomberg-Short-Term Bank Yield Index Rate
Debt Instrument [Line Items]
Basis spread on variable rate (as a percent)			2%
PNC ABL Credit Facility \| Revolving Line of Credit
Debt Instrument [Line Items]
Maximum borrowing capacity of credit facility			$ 120,000,000
Additional borrowing capacity			$ 20,000,000			20,000,000
Exit ABL Credit Facility \| Credit Facility
Debt Instrument [Line Items]
Maximum borrowing capacity of credit facility					$ 75,000,000
Borrowings outstanding of line of credit						75,000,000
Accordion feature, increase limit					$ 15,000,000
Amount to be drawn, percentage of total commitments					0.25
Amount to be drawn					$ 18,750,000
Borrowing base, proportion of eligible accounts receivable (as a percent)					85%
Borrowing base, proportion of eligible inventory valued at lower of cost and market value (as a percent)					70%
Proportion of liquidation value inventory borrowing base (as a percent)					85%
ABL Credit Facility \| Credit Facility
Debt Instrument [Line Items]
Outstanding borrowings						$ 25,000,000	90,000,000
Interest rate (as a percent)						4.80%
Delayed Draw Term Loan Facility Credit Agreement \| Delayed Draw Term Loan Facility Credit Agreement
Debt Instrument [Line Items]
Outstanding term loan								100%
Delayed Draw Term Loan Facility Credit Agreement \| Credit Facility
Debt Instrument [Line Items]
Outstanding borrowings						$ 0	$ 107,832,000
Interest rate (as a percent)						11.20%
Delayed Draw Term Loan Facility Credit Agreement \| Credit Facility \| Senior Secured First Lien Notes due 2027
Debt Instrument [Line Items]
Unamortized discount of debt instrument						$ 2,839,000
Delayed Draw Term Loan Facility Credit Agreement \| Senior notes
Debt Instrument [Line Items]
Unamortized discount of debt instrument						$ 6,969,000
Exit Term Loans \| Delayed Draw Term Loan Facility Credit Agreement
Debt Instrument [Line Items]
Outstanding term loan					100%
Intabex Term Loans
Debt Instrument [Line Items]
Redemption price (as a percent)	40%
Intabex Term Loans \| Senior Secured First Lien Notes due 2027
Debt Instrument [Line Items]
Face amount of debt instrument	$ 189,033,000
Exit fee amount	2,000,000
Intabex Term Loans \| Existing Notes
Debt Instrument [Line Items]
Face amount of debt instrument	87,033,000
Term Loan Credit Facility \| Term Loan Credit Agreement
Debt Instrument [Line Items]
Maximum borrowing capacity of credit facility				$ 100,000	$ 213,418,000
Commitment fee percentage (in basis points)				3%
Face amount of debt instrument	$ 100,000,000
Interest rate (as a percent)				2%
Line of credit facility closing fee (as a percentage)				1%
Term Loan Credit Facility \| Base Rate \| Term Loan Credit Agreement
Debt Instrument [Line Items]
Basis spread on variable rate (as a percent)				6.50%
Term Loan Credit Facility \| SOFR \| Term Loan Credit Agreement
Debt Instrument [Line Items]
Basis spread on variable rate (as a percent)				7.50%
Term Loan Credit Facility \| Minimum \| SOFR \| Term Loan Credit Agreement
Debt Instrument [Line Items]
Interest rate (as a percent)				1%
Term Loan Credit Facility \| Term Loans \| Base Rate
Debt Instrument [Line Items]
Basis spread on variable rate (as a percent)					7%
Term Loan Credit Facility \| Term Loans \| London Interbank Offered Rate (LIBOR)
Debt Instrument [Line Items]
Basis spread on variable rate (as a percent)					8%
Paid-in-kind interest (in basis points)					0.0100
Period increase of paid-in-kind interest (in basis points)		0.0100			0.0100
Pyxus Credit Facility
Debt Instrument [Line Items]
Redemption price (as a percent)	60%
Pyxus Credit Facility \| Term Loan Credit Agreement
Debt Instrument [Line Items]
Face amount of debt instrument	$ 130,550,000
Pyxus Term Loan \| Base Rate \| Term Loan Credit Agreement
Debt Instrument [Line Items]
Basis spread on variable rate (as a percent)	7%
Pyxus Term Loan \| Maximum \| SOFR \| Term Loan Credit Agreement
Debt Instrument [Line Items]
Basis spread on variable rate (as a percent)	8%
Pyxus Term Loan \| Minimum \| Base Rate \| Term Loan Credit Agreement
Debt Instrument [Line Items]
Interest rate (as a percent)	1.50%
New Pyxus Credit Facility \| Senior Secured First Lien Notes due 2024
Debt Instrument [Line Items]
Interest rate (as a percent)						10%
New Pyxus Credit Facility \| 8.50 Percentage Senior Secured Notes Due 2027
Debt Instrument [Line Items]
Face amount of debt instrument	$ 260,452,000
Interest rate (as a percent)	8.50%
Credit Facility \| Delayed Draw Term Loan Facility Credit Agreement
Debt Instrument [Line Items]
Maximum borrowing capacity of credit facility				$ 120,000,000
Commitment fee percentage (in basis points)				2%
Floor on LIBOR rate (as a percent)				1.50%
Credit Facility \| Base Rate \| Delayed Draw Term Loan Facility Credit Agreement
Debt Instrument [Line Items]
Basis spread on variable rate (as a percent)				8%
Credit Facility \| London Interbank Offered Rate (LIBOR) \| Delayed Draw Term Loan Facility Credit Agreement
Debt Instrument [Line Items]
Basis spread on variable rate (as a percent)				9%
TDB Facility \| Credit Facility
Debt Instrument [Line Items]
Outstanding borrowings						$ 131,840,000

Debt Arrangements - Exit Fees (

Debt Arrangements - Exit Fees (Details)	Apr. 01, 2022	Mar. 31, 2022	Dec. 31, 2021	Sep. 30, 2021
Credit Facility \| Delayed Draw Term Loan Facility Credit Agreement
Line of Credit Facility [Line Items]
Exit fee (as a percent)	5%	3.50%	2.50%	1%

Securitized Receivables - Narra

Securitized Receivables - Narrative (Details) $ in Thousands	12 Months Ended
	Mar. 31, 2023 USD ($) program	Mar. 31, 2022 USD ($)
Derecognized Assets, Securitized or Asset-backed Financing Arrangement Assets and any Other Financial Assets Managed Together [Line Items]
Number of accounts receivable securitization programs \| program	4
Receivables sold, face value discounted (as a percent)	100%
Reductions of trade and other receivables due to settlements	$ 3,193	$ 1,872
Accounts Receivable Securitization, Program One
Derecognized Assets, Securitized or Asset-backed Financing Arrangement Assets and any Other Financial Assets Managed Together [Line Items]
Servicing fee rate (as a percent)	0.50%
Trade receivables, maximum amount	$ 100,000
Accounts Receivable Securitization, Program Two
Derecognized Assets, Securitized or Asset-backed Financing Arrangement Assets and any Other Financial Assets Managed Together [Line Items]
Trade receivables, maximum amount	$ 110,000

Securitized Receivables - Sched

Securitized Receivables - Schedule of Accounts Receivable Securitization Information (Details) - USD ($) $ in Thousands	7 Months Ended	12 Months Ended
	Mar. 31, 2021	Mar. 31, 2023	Mar. 31, 2022
Transfers and Servicing [Abstract]
Receivables outstanding in facility		$ 173,979	$ 131,092
Beneficial interest		19,522	$ 28,072
Cash proceeds for the period ended:
Cash purchase price	$ 441,054	696,404
Deferred purchase price	$ 189,440	$ 165,262

Guarantees (Details)

Guarantees (Details) - USD ($) $ in Thousands	12 Months Ended
Guarantees (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Mar. 31, 2022
Guarantees [Abstract]
Amounts guaranteed (not to exceed)	$ 152,032	$ 114,208
Amounts outstanding under guarantee	83,420	49,413
Fair value of guarantees	5,262	2,956
Amounts due to local banks on behalf of suppliers for government subsidized rural credit financing	$ 12,529	$ 15,781
Guarantee expiration term (in years)	1 year

Derivative Financial Instrume_2

Derivative Financial Instruments (Details) - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Derivative [Line Items]
Gain (loss) recognized in income	$ 6,764	$ (2,482)
Accumulated other comprehensive income	5,515	3,804
Current derivative assets	3,970	9,867
Derivative contracts outstanding	$ 63,622	$ 61,690
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Cost of goods and services sold	Cost of goods and services sold
Derivative Asset, Current, Statement of Financial Position [Extensible Enumeration]	Other current assets	Other current assets
Loss on Derivatives
Derivative [Line Items]
Accumulated other comprehensive income	$ (2,777)	$ 8,975
Tax on accumulated other comprehensive income (loss), net	$ 1,690	$ (3,025)

Fair Value Measurements - Asset

Fair Value Measurements - Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Mar. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Asset, Statement of Financial Position [Extensible Enumeration]	Other current assets	Other current assets
Estimate of Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative financial instruments	$ 3,970	$ 9,867
Securitized beneficial interests	19,522	28,072
Total assets	23,492	37,939
Long-term debt	524,272	448,089
Guarantees	5,262	2,956
Total liabilities	529,534	451,045
Estimate of Fair Value \| Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative financial instruments	3,970	9,867
Securitized beneficial interests	0	0
Total assets	3,970	9,867
Long-term debt	523,758	447,843
Guarantees	0	0
Total liabilities	523,758	447,843
Estimate of Fair Value \| Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative financial instruments	0	0
Securitized beneficial interests	19,522	28,072
Total assets	19,522	28,072
Long-term debt	514	246
Guarantees	5,262	2,956
Total liabilities	$ 5,776	$ 3,202

Fair Value Measurements - Narra

Fair Value Measurements - Narrative (Details) - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Securitized Beneficial Interests
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis, Valuation Techniques [Line Items]
Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss)	$ 659	$ 1,148

Fair Value Measurements - Recon

Fair Value Measurements - Reconciliation of Change in Recurring Level 3 Balances (Details) - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Long-Term Debt
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at beginning of period	$ 246	$ 3,162
Settlements	(37)	(2,918)
Additions	305	2
Balance at end of period	514	246
Securitized Beneficial Interests
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at beginning of period	28,072	19,370
Sales of receivables/issuance of guarantees	166,165	205,517
Settlements	(164,679)	(192,141)
Losses recognized in earnings	(10,036)	(4,674)
Balance at end of period	19,522	28,072
Guarantees
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at beginning of period	2,956	1,740
Sales of receivables/issuance of guarantees	6,187	3,151
Settlements	(1,864)	(1,749)
Losses recognized in earnings	(2,017)	(186)
Balance at end of period	$ 5,262	$ 2,956

Fair Value Measurements - Infor

Fair Value Measurements - Information about Fair Value Measurements using Significant Unobservable Inputs (Details) - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2021
Securitized Beneficial Interests
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis, Valuation Techniques [Line Items]
Fair value of unobservable inputs of asset	$ 19,522	$ 28,072	$ 19,370
Discounted Cash Flow \| Securitized Beneficial Interests
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis, Valuation Techniques [Line Items]
Fair value of unobservable inputs of asset	$ 19,522	$ 28,072
Discounted Cash Flow \| Minimum \| Securitized Beneficial Interests
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis, Valuation Techniques [Line Items]
Securitized market rate (as a percent)	2.30%	2.80%
Payment speed period	38 days	91 days
Discounted Cash Flow \| Maximum \| Securitized Beneficial Interests
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis, Valuation Techniques [Line Items]
Securitized market rate (as a percent)	7.30%	3.90%
Payment speed period	88 days	103 days
Historical Loss \| Guarantees of Farmers
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis, Valuation Techniques [Line Items]
Fair value of unobservable inputs of asset	$ 5,262	$ 2,956
Historical Loss \| Minimum \| Guarantees of Farmers
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis, Valuation Techniques [Line Items]
Historical loss rate (as a percent)	1.20%	0.60%
Historical Loss \| Maximum \| Guarantees of Farmers
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis, Valuation Techniques [Line Items]
Historical loss rate (as a percent)	40%	44.60%

Pension and Other Postretirem_3

Pension and Other Postretirement Benefits - Narrative (Details) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Dec. 31, 2022	Mar. 31, 2023	Mar. 31, 2022
Defined Benefit Plan Disclosure [Line Items]
Loss on pension settlement	$ 2,588	$ 2,588	$ 0
Pension Plan
Defined Benefit Plan Disclosure [Line Items]
Cash contributions to fully fund liabilities upon termination	$ 5,300

Pension and Other Postretirem_4

Pension and Other Postretirement Benefits - Reconciliation of Benefit Obligations (Details) - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]
Benefit obligation, beginning	$ 121,728	$ 142,656
Service cost	476	389
Interest cost	3,275	2,654
Plan amendments	139
Actuarial gains	(14,326)	(6,617)
Plan settlements	(22,110)	(7,714)
Effects of currency translation	(2,356)	(1,971)
Benefits paid	(6,445)	(7,669)
Benefit obligation, ending	80,381	121,728
Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]
Fair value of plan assets, beginning	86,613	96,801
Actual return on plan assets	(14,001)	1,844
Employer contributions	10,912	5,382
Plan settlements	(22,110)	(7,714)
Effects of currency translation	(2,942)	(2,031)
Benefits paid	(6,445)	(7,669)
Fair value of plan assets, ending	52,027	86,613
Funded status of the plan	$ (28,354)	$ (35,115)
Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Interest Cost, Statement of Income or Comprehensive Income [Extensible Enumeration]	Interest Income (Expense), Net	Interest Income (Expense), Net
U.S. Plans
Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]
Benefit obligation, beginning	$ 62,797	$ 76,223
Service cost	300	215
Interest cost	1,711	1,467
Plan amendments	0
Actuarial gains	(4,106)	(2,948)
Plan settlements	(21,390)	(7,600)
Effects of currency translation	0	0
Benefits paid	(3,602)	(4,560)
Benefit obligation, ending	35,710	62,797
Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]
Fair value of plan assets, beginning	19,812	27,109
Actual return on plan assets	(3,974)	806
Employer contributions	9,154	4,057
Plan settlements	(21,390)	(7,600)
Effects of currency translation	0	0
Benefits paid	(3,602)	(4,560)
Fair value of plan assets, ending	0	19,812
Funded status of the plan	(35,710)	(42,985)
Non-U.S. Plans
Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]
Benefit obligation, beginning	58,931	66,433
Service cost	176	174
Interest cost	1,564	1,187
Plan amendments	139
Actuarial gains	(10,220)	(3,669)
Plan settlements	(720)	(114)
Effects of currency translation	(2,356)	(1,971)
Benefits paid	(2,843)	(3,109)
Benefit obligation, ending	44,671	58,931
Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]
Fair value of plan assets, beginning	66,801	69,692
Actual return on plan assets	(10,027)	1,038
Employer contributions	1,758	1,325
Plan settlements	(720)	(114)
Effects of currency translation	(2,942)	(2,031)
Benefits paid	(2,843)	(3,109)
Fair value of plan assets, ending	52,027	66,801
Funded status of the plan	$ 7,356	$ 7,870

Pension and Other Postretirem_5

Pension and Other Postretirement Benefits - Net Funded Status (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Mar. 31, 2022
Defined Benefit Plan Disclosure [Line Items]
Accrued noncurrent benefit liability recorded in pension, postretirement, and other long-term liabilities	$ (52,511)	$ (60,927)
Funded status of the plan	(28,354)	(35,115)
U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Noncurrent benefit asset recorded in other noncurrent assets	0	0
Accrued current benefit liability recorded in accrued expenses and other current liabilities	(3,290)	(3,305)
Accrued noncurrent benefit liability recorded in pension, postretirement, and other long-term liabilities	(32,420)	(39,680)
Funded status of the plan	(35,710)	(42,985)
Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Noncurrent benefit asset recorded in other noncurrent assets	13,731	15,443
Accrued current benefit liability recorded in accrued expenses and other current liabilities	(972)	(878)
Accrued noncurrent benefit liability recorded in pension, postretirement, and other long-term liabilities	(5,403)	(6,695)
Funded status of the plan	$ 7,356	$ 7,870

Pension and Other Postretirem_6

Pension and Other Postretirement Benefits - Pension Obligations for all Defined Benefit Pension Plans (Details) - Pension Plan - USD ($) $ in Thousands	Mar. 31, 2023	Mar. 31, 2022
U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Projected benefit obligation	$ 35,710	$ 62,797
Accumulated benefit obligation	35,710	62,797
Fair value of plan assets	0	19,812
Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Projected benefit obligation	6,375	7,573
Accumulated benefit obligation	5,998	7,009
Fair value of plan assets	$ 0	$ 0

Pension and Other Postretirem_7

Pension and Other Postretirement Benefits - Amounts Showing in Other Comprehensive Income (Details) - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Defined Benefit Plan Disclosure [Line Items]
Prior service credit	$ (82)	$ 56
Net actuarial gains	7,875	6,028
Deferred taxes	542	244
Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]
Beginning balance	6,328
Prior service cost	(138)
Net actuarial gains	1,847
Deferred taxes	298
Total change for 2023	2,007
Ending balance	8,335
Pension Plan
Defined Benefit Plan Disclosure [Line Items]
Prior service credit	(82)	56
Net actuarial gains	5,883	4,645
Deferred taxes	831	459
Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]
Beginning balance	5,160
Prior service cost	(138)
Net actuarial gains	1,238
Deferred taxes	372
Total change for 2023	1,472
Ending balance	6,632
Postretirement Benefits Plan
Defined Benefit Plan Disclosure [Line Items]
Prior service credit	0	0
Net actuarial gains	1,992	1,383
Deferred taxes	(289)	$ (215)
Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]
Beginning balance	1,168
Prior service cost	0
Net actuarial gains	609
Deferred taxes	(74)
Total change for 2023	535
Ending balance	$ 1,703

Pension and Other Postretirem_8

Pension and Other Postretirement Benefits - Weighted-Average Assumptions (Details)	12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]
Discount rate	2.98%	2.17%
Rate of increase in future compensation	7.31%	5.28%
Expected long-term rate of return on plan assets	2.16%	2.12%
U.S. Plans
Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]
Discount rate	3.75%	2.83%
Expected long-term rate of return on plan assets		5.75%
Interest crediting rate	4.28%	4.25%
Pension Plan \| U.S. Plans
Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract]
Discount rate	5.08%	3.74%
Interest crediting rate		4.28%
Pension Plan \| Non-U.S. Plans
Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract]
Discount rate	4.94%	2.98%
Rate of increase in future compensation	5.72%	7.31%

Pension and Other Postretirem_9

Pension and Other Postretirement Benefits - Plan Assets (Details) - Non-U.S. Plans	Mar. 31, 2023	Mar. 31, 2022
Defined Benefit Plan Disclosure [Line Items]
Plan asset allocations (as a percent)	100%	100%
Cash and cash equivalents
Defined Benefit Plan Disclosure [Line Items]
Plan asset allocations (as a percent)	11.50%	10.60%
Equity securities
Defined Benefit Plan Disclosure [Line Items]
Plan asset allocations (as a percent)	20.30%	20.70%
Debt securities
Defined Benefit Plan Disclosure [Line Items]
Plan asset allocations (as a percent)	14.80%	66.50%
Insurance contracts
Defined Benefit Plan Disclosure [Line Items]
Plan asset allocations (as a percent)	50.90%	0%
Real estate and other investments
Defined Benefit Plan Disclosure [Line Items]
Plan asset allocations (as a percent)	2.50%	2.20%

Pension and Other Postretire_10

Pension and Other Postretirement Benefits - Fair Value of Plan Assets (Details) - Estimate of Fair Value - USD ($) $ in Thousands	Mar. 31, 2023	Mar. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets	$ 23,492	$ 37,939
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets	3,970	9,867
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets	19,522	28,072
Pension Plan \| Non-U.S. Plans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	5,964	7,073
U.S. equities / equity funds	6,669	9,268
International equities / equity funds	3,909	2,818
Global equity funds		1,748
U.S. fixed income funds	5,364	5,753
International fixed income funds	2,334	34,313
Insurance contracts	26,472
Global fixed income funds		4,371
Real estate and other	1,315	1,457
Total assets	52,027	66,801
Pension Plan \| Non-U.S. Plans \| Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	5,964	7,073
U.S. equities / equity funds	6,669	9,268
International equities / equity funds	3,909	2,818
Global equity funds		1,748
U.S. fixed income funds	5,364	5,753
International fixed income funds	2,334	10,448
Insurance contracts	0
Global fixed income funds		4,371
Real estate and other	1,315	0
Total assets	25,555	41,479
Pension Plan \| Non-U.S. Plans \| Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	0	0
U.S. equities / equity funds	0	0
International equities / equity funds	0	0
Global equity funds		0
U.S. fixed income funds	0	0
International fixed income funds	0	23,865
Insurance contracts	26,472
Global fixed income funds		0
Real estate and other	0	0
Total assets	26,472	23,865
Pension Plan \| Non-U.S. Plans \| Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	0	0
U.S. equities / equity funds	0	0
International equities / equity funds	0	0
Global equity funds		0
U.S. fixed income funds	0	0
International fixed income funds	0	0
Insurance contracts	0
Global fixed income funds		0
Real estate and other	0	0
Total assets	$ 0	$ 0

Pension and Other Postretire_11

Pension and Other Postretirement Benefits - Plan Asset Redemptions (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	$ 52,027	$ 86,613	$ 96,801
U.S. Plans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	0	19,812	$ 27,109
Real estate and other \| U.S. Plans \| Fair Value Measured at Net Asset Value Per Share
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	$ 1,315	$ 3,907

Pension and Other Postretire_12

Pension and Other Postretirement Benefits - Postretirement Health and Life Insurance Benefits (Details) - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]
Benefit obligation, beginning	$ 121,728	$ 142,656
Service cost	476	389
Interest cost	3,275	2,654
Effect of currency translation	2,356	1,971
Actuarial gains	14,326	6,617
Benefits paid	(6,445)	(7,669)
Benefit obligation, ending	80,381	121,728
Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]
Fair value of plan assets, beginning	86,613	96,801
Employer contributions	10,912	5,382
Benefits paid	(6,445)	(7,669)
Fair value of plan assets, ending	52,027	86,613
Accrued non-current benefit liability recorded in pension, postretirement, and other long-term liabilities	(52,511)	(60,927)
Funded status of the plan	(28,354)	(35,115)
Postretirement Benefits Plan
Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]
Benefit obligation, beginning	5,431	5,899
Service cost	5	6
Interest cost	255	207
Effect of currency translation	(97)	250
Actuarial gains	(725)	(676)
Benefits paid	(385)	(255)
Benefit obligation, ending	4,484	5,431
Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]
Fair value of plan assets, beginning	0	0
Employer contributions	385	255
Benefits paid	(385)	(255)
Fair value of plan assets, ending	0	0
Accrued current benefit liability recorded in accrued expenses and other current liabilities	(393)	(428)
Accrued non-current benefit liability recorded in pension, postretirement, and other long-term liabilities	(4,091)	(5,003)
Funded status of the plan	(4,484)	(5,431)
U.S. Plans
Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]
Benefit obligation, beginning	62,797	76,223
Service cost	300	215
Interest cost	1,711	1,467
Effect of currency translation	0	0
Actuarial gains	4,106	2,948
Benefits paid	(3,602)	(4,560)
Benefit obligation, ending	35,710	62,797
Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]
Fair value of plan assets, beginning	19,812	27,109
Employer contributions	9,154	4,057
Benefits paid	(3,602)	(4,560)
Fair value of plan assets, ending	0	19,812
Accrued current benefit liability recorded in accrued expenses and other current liabilities	(3,290)	(3,305)
Accrued non-current benefit liability recorded in pension, postretirement, and other long-term liabilities	(32,420)	(39,680)
Funded status of the plan	(35,710)	(42,985)
U.S. Plans \| Postretirement Benefits Plan
Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]
Benefit obligation, beginning	3,977	4,458
Service cost	5	6
Interest cost	134	97
Effect of currency translation	0	0
Actuarial gains	(437)	(425)
Benefits paid	(310)	(159)
Benefit obligation, ending	3,369	3,977
Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]
Fair value of plan assets, beginning	0	0
Employer contributions	310	159
Benefits paid	(310)	(159)
Fair value of plan assets, ending	0	0
Accrued current benefit liability recorded in accrued expenses and other current liabilities	(297)	(310)
Accrued non-current benefit liability recorded in pension, postretirement, and other long-term liabilities	(3,072)	(3,667)
Funded status of the plan	(3,369)	(3,977)
Non-U.S. Plans
Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]
Benefit obligation, beginning	58,931	66,433
Service cost	176	174
Interest cost	1,564	1,187
Effect of currency translation	2,356	1,971
Actuarial gains	10,220	3,669
Benefits paid	(2,843)	(3,109)
Benefit obligation, ending	44,671	58,931
Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]
Fair value of plan assets, beginning	66,801	69,692
Employer contributions	1,758	1,325
Benefits paid	(2,843)	(3,109)
Fair value of plan assets, ending	52,027	66,801
Accrued current benefit liability recorded in accrued expenses and other current liabilities	(972)	(878)
Accrued non-current benefit liability recorded in pension, postretirement, and other long-term liabilities	(5,403)	(6,695)
Funded status of the plan	7,356	7,870
Non-U.S. Plans \| Postretirement Benefits Plan
Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]
Benefit obligation, beginning	1,454	1,441
Service cost	0	0
Interest cost	121	110
Effect of currency translation	(97)	250
Actuarial gains	(288)	(251)
Benefits paid	(75)	(96)
Benefit obligation, ending	1,115	1,454
Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]
Fair value of plan assets, beginning	0	0
Employer contributions	75	96
Benefits paid	(75)	(96)
Fair value of plan assets, ending	0	0
Accrued current benefit liability recorded in accrued expenses and other current liabilities	(96)	(118)
Accrued non-current benefit liability recorded in pension, postretirement, and other long-term liabilities	(1,019)	(1,336)
Funded status of the plan	$ (1,115)	$ (1,454)

Pension and Other Postretire_13

Pension and Other Postretirement Benefits - Assumptions Used to Determine Benefit Obligations (Details) - Postretirement Benefits Plan	Mar. 31, 2023	Mar. 31, 2022
U.S. Plans
Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract]
Discount rate	5.09%	3.75%
Health care cost trend rate assumed for next year	5.49%	5.62%
Non-U.S. Plans
Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract]
Discount rate	10.58%	9.50%
Health care cost trend rate assumed for next year	9.40%	7.90%

Pension and Other Postretire_14

Pension and Other Postretirement Benefits - Expected Contributions (Details) $ in Thousands	Mar. 31, 2023 USD ($)
Non-U.S. Plans \| Pension Plan
Defined Benefit Plan Disclosure [Line Items]
Fiscal Year 2024	$ 972
Non-U.S. Plans \| Postretirement Benefits Plan
Defined Benefit Plan Disclosure [Line Items]
Fiscal Year 2024	96
U.S. Plans \| Pension Plan
Defined Benefit Plan Disclosure [Line Items]
Fiscal Year 2024	3,290
U.S. Plans \| Postretirement Benefits Plan
Defined Benefit Plan Disclosure [Line Items]
Fiscal Year 2024	$ 297

Pension and Other Postretire_15

Pension and Other Postretirement Benefits - Contributions (Details) - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Postretirement Benefits Plan
Defined Benefit Plan Disclosure [Line Items]
Employer contributions	$ 5,478	$ 4,589

Pension and Other Postretire_16

Pension and Other Postretirement Benefits - Expected Future Benefit Payments (Details) $ in Thousands	Mar. 31, 2023 USD ($)
Defined Benefit Plan Disclosure [Line Items]
2024	$ 7,008
2025	7,021
2026	6,735
2027	6,764
2028	6,669
Thereafter	33,840
Total	68,037
Pension Plan \| U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
2024	3,290
2025	3,319
2026	3,258
2027	3,191
2028	3,115
Thereafter	14,170
Total	30,343
Pension Plan \| Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
2024	3,325
2025	3,313
2026	3,089
2027	3,186
2028	3,167
Thereafter	17,796
Total	33,876
Postretirement Benefits Plan \| U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
2024	297
2025	289
2026	284
2027	279
2028	275
Thereafter	1,257
Total	2,681
Postretirement Benefits Plan \| Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
2024	96
2025	100
2026	104
2027	108
2028	112
Thereafter	617
Total	$ 1,137

Contingencies and Other Infor_2

Contingencies and Other Information (Details) - Tax Assessment - USD ($) $ in Thousands	Mar. 31, 2023	Mar. 18, 2014	Oct. 26, 2007
Brazilian State of Parana
Loss Contingencies [Line Items]
Loss contingency, estimate of possible loss	$ 10,104		$ 2,599
Brazilian State of Santa Catarina
Loss Contingencies [Line Items]
Loss contingency, estimate of possible loss	6,457	$ 2,243
Brazil State of Rio Grande do Sul and the State of Santa Catarina
Loss Contingencies [Line Items]
Loss contingency, estimate of possible loss	$ 17,210

Other Comprehensive Income - Ac

Other Comprehensive Income - Accumulated Other Comprehensive Income (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2023	Mar. 31, 2022
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Balance at beginning of period				$ 175,281					$ 175,281
Total other comprehensive income, net of tax	$ 6,029	$ 4,406	$ (8,131)	(556)	$ 13,847	$ (3,338)	$ (4,999)	$ 5,017	1,748	$ 10,527
Balance at end of period	137,851				175,281				137,851	175,281
Accumulated Other Comprehensive Income
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Balance at beginning of period				3,804				(6,733)	3,804	(6,733)
Other comprehensive (loss) income before reclassifications									6,104	12,404
Amounts reclassified to net loss, net of tax									(4,393)	(1,867)
Total other comprehensive income, net of tax									1,711	10,537
Balance at end of period	5,515				3,804				5,515	3,804
Currency Translation Adjustment
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Balance at beginning of period				(8,873)				(4,649)	(8,873)	(4,649)
Other comprehensive (loss) income before reclassifications									2,481	(4,224)
Amounts reclassified to net loss, net of tax									0	0
Total other comprehensive income, net of tax	1,480	4,855	(4,801)	947	(1,569)	(1,753)	(1,591)	689	2,481	(4,224)
Balance at end of period	(6,392)				(8,873)				(6,392)	(8,873)
Pensions, Net of Tax
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Balance at beginning of period				6,328				541	6,328	541
Other comprehensive (loss) income before reclassifications									1,873	6,209
Amounts reclassified to net loss, net of tax									134	(422)
Total other comprehensive income, net of tax	3,647	(78)	(1,562)		6,334	(35)	(512)	0	2,007	5,787
Balance at end of period	8,335				6,328				8,335	6,328
Derivatives, Net of Tax
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Balance at beginning of period				6,349				(2,625)	6,349	(2,625)
Other comprehensive (loss) income before reclassifications									1,750	10,419
Amounts reclassified to net loss, net of tax									(4,527)	(1,445)
Total other comprehensive income, net of tax	865	$ (371)	$ (1,768)	$ (1,503)	9,092	$ (1,550)	$ (2,896)	$ 4,328	(2,777)	8,974
Balance at end of period	$ 3,572				$ 6,349				$ 3,572	$ 6,349

Other Comprehensive Income - Co

Other Comprehensive Income - Components Reclassified from AOCI to Earnings (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2023	Mar. 31, 2022
Reclassification Out Of Accumulated Other Comprehensive Income [Line Items]
Cost of goods and services sold									$ 1,653,864	$ 1,412,805
Tax effects of amounts reclassified from accumulated other comprehensive income to net loss									(34,127)	(12,640)
Net loss	$ (19,945)	$ (2,237)	$ (1,550)	$ (14,505)	$ (30,346)	$ (30,057)	$ (10,023)	$ (11,628)	(38,237)	(82,054)
Derivatives \| Reclassification out of Accumulated Other Comprehensive Income
Reclassification Out Of Accumulated Other Comprehensive Income [Line Items]
Cost of goods and services sold									(6,764)	(2,672)
Tax effects of amounts reclassified from accumulated other comprehensive income to net loss									2,237	1,227
Net loss									$ (4,527)	$ (1,445)

Stock_Based Compensation (Detai

Stock–Based Compensation (Details) - 2020 Incentive Plan	Aug. 19, 2021 shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of remaining shares available for issuance (in shares)	2,200,000
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Awards outstanding (in shares)	706
Performance Shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Awards outstanding (in shares)	1,064
Award vesting period	3 years
Payout rate upon threshold performance level achieved (as a percent)	50%
Payout rate upon target performance level achieved (as a percent)	100%
Payout rate upon exceeding performance level achieved (as a percent)	150%
Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Awards outstanding (in shares)	117

Related Party Transactions - Sc

Related Party Transactions - Schedule of Related Party Transactions (Details) - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Related Party Transactions [Abstract]
Sales	$ 22,695	$ 25,575
Purchases	$ 158,140	$ 135,261

Related Party Transactions - _2

Related Party Transactions - Schedule of Related Party Balances in Condensed Consolidated Balance Sheets (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Mar. 31, 2022
Other Receivables
Related Party Transaction [Line Items]
Accounts receivable, related parties	$ 3,090	$ 1,896
Notes receivable, related parties	0	1,431
Accounts Payable
Related Party Transaction [Line Items]
Accounts payable, related parties	20,438	41,747
Contract with Customer, Liability, Current
Related Party Transaction [Line Items]
Advances from related parties	$ 3,494	$ 15,240

Related Party Transactions - Na

Related Party Transactions - Narrative (Details) - USD ($)			12 Months Ended
Related Party Transactions - Narrative (Details) - USD ($)	Jul. 28, 2022	Dec. 30, 2021	Mar. 31, 2023	Mar. 31, 2022
Related Party Transaction [Line Items]
Repayments of long-term lines of credit			$ 110,250,000	$ 15,375,000
Repayments of debt			578,162,000	1,636,000
Interest expense from related parties			35,649,000	32,579,000
Glendon Investor and Monarch Investor
Related Party Transaction [Line Items]
Interest payable to related parties			3,653,000	$ 3,984,000
Delayed Draw Term Loan Facility Credit Agreement \| Credit Facility
Related Party Transaction [Line Items]
Exit fee amount			1,575,000
Delayed Draw Term Loan Facility Credit Agreement \| Credit Facility \| Glendon Investor and Monarch Investor
Related Party Transaction [Line Items]
Exit fee amount			$ 910,000
Delayed Draw Term Loan Facility Credit Agreement \| Intabex \| Credit Facility \| Owl Creek Asset Management LP
Related Party Transaction [Line Items]
Proceeds from related party	$ 5,119,000
Delayed Draw Term Loan Facility Credit Agreement \| Intabex \| Credit Facility \| DDTL Facility
Related Party Transaction [Line Items]
Proceeds from related party	5,250,000
Term Loan Credit Agreement \| Credit Facility \| Intabex
Related Party Transaction [Line Items]
Repayments of debt	97,500,000
Face amount of debt instrument	100,000,000
Term Loan Credit Agreement \| Intabex \| Credit Facility
Related Party Transaction [Line Items]
Repayment of credit agreement, aggregate amount receivable	3,900,000
Repayment of credit agreement, payment received	$ 4,000,000
Credit Facility \| Delayed Draw Term Loan Facility Credit Agreement
Related Party Transaction [Line Items]
Repayments of long-term lines of credit		$ 15,375,000
Credit Facility \| Delayed Draw Term Loan Facility Credit Agreement \| Investor-Affiliated Funds
Related Party Transaction [Line Items]
Repayments of long-term lines of credit		$ 14,991

Segment Information - Analysis

Segment Information - Analysis of Segment Information (Details) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021	Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2021
Segment Reporting Information [Line Items]
Consolidated sales and other operating revenues			$ 1,914,881	$ 1,639,862
Segment and consolidated operating income (loss)			93,778	41,717
Restructuring and asset impairment charges			4,685	8,031	$ 8,031
Goodwill impairment	$ 31,814	$ 372	0	32,186
Segment assets	1,698,527		1,582,463	1,698,527
Trade and other receivables, net	256,861		199,648	256,861
Equity in net assets of investee companies	94,903		100,739	94,903
Depreciation and amortization			19,137	16,676
Capital expenditures			15,955	14,597
Operating Segments
Segment Reporting Information [Line Items]
Segment and consolidated operating income (loss)			98,463	81,934
Leaf
Segment Reporting Information [Line Items]
Consolidated sales and other operating revenues			1,900,558	1,627,238
Segment assets	1,641,552		1,544,798	1,641,552
Trade and other receivables, net	255,756		199,237	255,756
Equity in net assets of investee companies	88,118		93,754	88,118
Depreciation and amortization			16,157	14,763
Capital expenditures			13,565	10,159
Leaf \| Operating Segments
Segment Reporting Information [Line Items]
Segment and consolidated operating income (loss)			117,056	106,159
All Other
Segment Reporting Information [Line Items]
Consolidated sales and other operating revenues			14,323	12,624
Segment assets	56,975		37,665	56,975
Trade and other receivables, net	1,105		411	1,105
Equity in net assets of investee companies	$ 6,785		6,985	6,785
Depreciation and amortization			2,980	1,913
Capital expenditures			2,390	4,438
All Other \| Operating Segments
Segment Reporting Information [Line Items]
Segment and consolidated operating income (loss)			$ (18,593)	$ (24,225)

Segment Information - Geographi

Segment Information - Geographical Locations (Details) - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Revenues from External Customers and Long-Lived Assets [Line Items]
Sales and other operating revenues	$ 1,914,881	$ 1,639,862
Property, plant and equipment, net	133,398	137,521
China
Revenues from External Customers and Long-Lived Assets [Line Items]
Sales and other operating revenues	338,174	280,945
United States
Revenues from External Customers and Long-Lived Assets [Line Items]
Sales and other operating revenues	220,266	209,953
Property, plant and equipment, net	21,945	21,960
United Arab Emirates
Revenues from External Customers and Long-Lived Assets [Line Items]
Sales and other operating revenues	182,306	82,070
Indonesia
Revenues from External Customers and Long-Lived Assets [Line Items]
Sales and other operating revenues	170,492	110,009
Belgium
Revenues from External Customers and Long-Lived Assets [Line Items]
Sales and other operating revenues	132,456	89,748
Northern Africa
Revenues from External Customers and Long-Lived Assets [Line Items]
Sales and other operating revenues	52,428	52,539
Russia
Revenues from External Customers and Long-Lived Assets [Line Items]
Sales and other operating revenues	20,175	57,808
Jordan
Revenues from External Customers and Long-Lived Assets [Line Items]
Property, plant and equipment, net	11,352	11,571
Brazil
Revenues from External Customers and Long-Lived Assets [Line Items]
Property, plant and equipment, net	29,163	28,707
Zimbabwe
Revenues from External Customers and Long-Lived Assets [Line Items]
Property, plant and equipment, net	21,703	22,217
Malawi
Revenues from External Customers and Long-Lived Assets [Line Items]
Property, plant and equipment, net	31,213	30,961
Tanzania
Revenues from External Customers and Long-Lived Assets [Line Items]
Property, plant and equipment, net	6,016	9,953
Other
Revenues from External Customers and Long-Lived Assets [Line Items]
Sales and other operating revenues	798,584	756,790
Property, plant and equipment, net	$ 12,006	$ 12,152

Uncategorized Items - pyx-20230

Label	Element	Value
Cash and Cash Equivalents, at Carrying Value	us-gaap_CashAndCashEquivalentsAtCarryingValue	$ 92,705,000
Restricted Cash and Cash Equivalents	us-gaap_RestrictedCashAndCashEquivalents	$ 5,008,000